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Sommario 
 
Lo sviluppo di nuove tecnologie di microscala volte a generare tessuti e organi umani 
on a chip si sta rivelando una nuova strategia per compiere esperimenti multi-
parametrici a basso costo per sviluppo di modelli di malattia e screening di specifiche 
strategie terapeutiche, come ampiamente riconosciuto dalla comunità scientifica, 
dalle maggiori compagnie farmaceutiche e da agenzie governative. 
La generazione di organi umani on a chip, in cui le tecnologie di microscale, come la 
tecnologia microfluidica, sono combinate colture cellulari umane allo scopo di 
mimare l’intero ambiente di un organo vivente, offre un’opportunità unica per 
studiare la fisiologia e la fisiopatologia umane, in modo rappresentativo delle 
condizioni in vivo. Questa prospettiva tecnologica potrebbe fornire una soluzione 
efficace alle attuali limitazioni dei modelli animali, che si dimostrano altamente 
costosi e non predittivi della fisiologia umana, e dei modelli convenzionali di colture 
cellulari che non sono in grado di rappresentare i complessi processi che 
caratterizzano una patologia a livello di organo. 
La possibilità di rappresentare l’organogenesi direttammente on a chip partendo da 
cellule staminali umane pluripotenti, che hanno il potenziale per generare tutti I tipi 
cellular presenti nel corpo umano, consentirebbe di superare i limiti legati alla 
disponibilità di cellule primarie umane, come epatociti o cardiomiociti umani. Per di 
più, la generazione di cellule staminali umane pluripotenti indotte da cellule 
somatiche adulte ottenuta di recente tramite l’espressione ectopica di fattori di 
trascrizione definiti, fornisce un nuovo mezzo per ottenere cellule staminali paziente-
specifiche con diversità genetica specifica. 
Questo studio è volto allo sviluppo di tessuti funzionali umani on a chip partendo da 
cellule staminali pluripotenti, da usare nello sviluppo di nuovi modelli di patologie in 
vitro o per screening di farmaci e test di tossicità, con più capacità predittiva degli 
attuali modelli animali, superando i problemi legati al reclutamento di fonti cellulari 
primari.  
A questo proposito, è stato sviluppato un sistema su microscale integrato, basato sulla 
tecnologia microfluidica, al fine di derivare tessuti cardiaco ed epatico funzionali on a 
chip da cellule staminali umani pluripotenti, tramite la somministrazione accurata di 
composti chimici e fattori di crescita, all’interno del microambiente cellulare, e 
un’appropriata regolazione dei fattori esogeni ed endogeni, che hanno un effetto 
riconosciuto nello sviluppo embrionale in vivo.  
Queste cellule funzionalmente differenziate on a chip possono essere usate 
direttamente screening multi-parametrici e su larga scala di farmaci o per sviluppare 
modelli micro-ingegnerizzati di organo umano. Quest’ultimo aspetto richiede inoltre 
di progettare nuove tecnologie che assistano gli esperimenti in vitro e sviluppare 
nuove strategie terapeutiche o per scrinare potenziali cure cliniche. In particolare, la 
sono stati progettati test funzionali appropriati per valutare la risposta a farmaci o 
stimoli esterni, come lo stress meccanico o l’ipossia, in un contesto fisiologico o 
patologico. 
Grazie allo sviluppo di uno scambiatore di gas microfluidico per rimuovere 
velocemnete il contenuto di ossigeno nel medium di coltura, è stato analizzto il ruolo 
di un’ipossia acuta sulle dinamiche dei flussi del calcio, mimando gli effetti iniziali di 
un’ischemia nel microambiente cardiaco. 
Inoltre, è stato analizzato il ruolo dello stress meccanico ciclico, che svolge un ruolo 
cruciale nello studio di nuove risposte fisiologiche e patologiche al microambiente 
cellulare, in un modello in vitro di Distrofia Muscolare di Duchenne (DMD), tramite 
un dispositivo di stretching cellulare basato sulla tecnologia microfluidica con cui è 
possibile riprodurre in modo accurato deformazioni meccaniche cicliche nel tempo. 
Combinando lo sviluppo di tessuti on a chip e microtecnologie che assistano test 
funzionali on a chip si aprono nuove e sostanziali prospettive nella generazione di un 
modello umano in vitro che riassuma le caratteristiche fisio-patologiche dei tessuti e 
organi all’interno del corpo umano. 
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Summary 
 
The development of new microscale technologies aimed at generating human tissues 
and organs on a chip is emerging as a novel effective strategy to perform cost 
effective and multi-parametric assays for disease modeling investigations and 
screening specific therapeutic strategies, as broadly recognized from the scientific 
community, the major pharmaceutical companies and the governmental agencies.  
The generation of human organs on a chip, in which microscale technologies, such as 
microfluidics, are combined with cultured human cells in order to mimic whole living 
organ environment, offers a unique opportunity to study human physiology and 
pathophysiology, resembling in vivo conditions. This technological perspective could 
provide an effective solution to the current limitations of animal models, which result 
highly expensive and non predictive of human physiology, and conventional cell 
culture models that fail to recapitulate complex, organ-level disease processes. 
The possibility of developing direct organogenesis on a chip from human pluripotent 
stem cells, which have the potential to generate all cellular types of the human body, 
could overcome the limited availability of human primary cells, such as human 
hepatocytes or cardiomyocytes. Moreover, the recent generation of human induced 
pluripotent stem cells (hiPSCs) from adult somatic cells through the ectopic 
expression of defined transcription factors, provides a new effective tool to obtain 
populations of patient-specific stem cells with distinctive genetic diversity. 
This work is aimed at the development of functional human tissues on a chip from 
pluripotent stem cells, to be used in developing new in vitro disease models or drug 
screening and toxicity assays, more predictive than current animal models, 
overcoming issues related to primary cell sources recruitment. 
To this purpose, an integrated microscale system, based on the microfluidic 
technology, was developed, in order to derive functional cardiac and hepatic tissues 
on a chip, from human pluripotent stem cells, through the accurate delivery of 
chemical compounds and growth factors, within cellular microenvironment, and 
proper regulation of exogenous and endogenous factors, which are known to affect 
embryonic development in vivo. 
These functionally differentiated cells on a chip can be directly used for multi-
parametric and large-scale drug screening or for developing micro-engineered human 
organ models. This last aspect also requires to design new technology for assisting in 
vitro assays and developing new therapeutic strategies or for screening among 
potential clinical cures. In particular, design of proper functional assays to test 
cellular responses to drugs or external stimuli, such as mechanical stress or hypoxia, 
in a physiologic or pathologic context has been addressed. 
Thanks to the development of a microfluidic gas exchanger for generating rapid 
depletion of oxygen content in culture medium, the role of acute hypoxia in calcium 
handling machinery of a cardiomyocytes population was investigated, mimicking 
early effects of ischemia on cardiac microenvironment. Moreover, the role of cyclic 
mechanical stress, which plays a crucial role in the investigation of new physiological 
and pathological responses to cell culture microenvironment, was analyzed in a 
human Duchenne Muscular Dystrophy (DMD) in vitro model, through a 
microfluidic-based cell stretching device accurately reproducing cyclic mechanical 
deformations along time. 
The combination of tissues development on a chip and micro-technology assisting for 
functional assay on a chip opens new and substantial perespective in generating a 
human in vitro model that properly resemble the physiological and 
pathophysiological behaviro of a tissues or organs within humna body. 
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Chapter 1 
Introduction and aim  
 
 
1.1 Tissues on a chip development 
Emerging micro-fabrication technologies, developed in recent years, opened new 
perspectives in deriving cost-effective in vitro models of relevant human diseases 
for high-throughput patho-physiologic investigations and drug screening assays. 
These new capabilities, arisen from the convergence of micro-engineering with 
cell biology, have led to development of “Tissues on a chip” and, later, “Organs 
on a chip”, that reconstitute the structural tissue arrangements and functional 
complexity of living organs, using cells cultured in engineered devices with 
relevant micro-architecture and micro-environmental signals1,2,3.  
 
1.1.1   Potentialities of tissues and organs on a chip 
These micro-scale tissues and organs on a chip permit study of biological 
processes in ways that are not possible using conventional cell culture systems, or 
animal models, which result poor predictive of human physiology4. Engineering 
microenvironments that simulate in vivo organ systems provide critical insight 
into the cellular basis for pathologies, development and homeostasis, while 
curtailing the high experimental costs and complexities associated with in vivo 
studies5. Indeed, in vivo models can be expensive, highly variable, difficult to 
manipulate, and experimental results could be confounded or challenging to 
interpret. As a result, in the pharmaceutical industry, in vivo studies require 
exorbitant resources, but often fail to translate promising in vitro results for drug 
compounds to clinically viable solutions5. 
For this reason, chemical and pharmaceutical industries are now demonstrating an 
increasing interest in developing costly effective human tissues on a chip. They 
recognize the ability of micro-fabrication techniques, and in particular of 
microfluidic technology, to recapitulate key structures and functions of human 
tissues and organs in vitro, thanks to the possibility to accurately control flow 
dynamics and, consequently, pharmacodynamics and pharmacokinetics, and other 
cellular features such as morphology and substrate stiffness.  
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A growing number of in vitro models based on lab on a chip technology are being 
developed for disease and toxicity studies. These range from cell-free assays to 
cell-based systems (including single-cell arrays and three-dimensional cell culture 
system), in addition to small multicellular “organism on a chip”. These on chip 
devices have shown the capability to immobilize, manipulate and transport 
particles, biological parts or cells. They have generated stable static or dynamic 
gradients of chemical and biochemical compounds, provided a constant or 
intermittent supply of nutrients and removal of metabolites and allowed 
multiplexed analyses including parallel read-outs of cell-culture parameters by on 
chip integrated sensors. Integrating these tools with cell culture facilities and cell-
based assays will lead to more and advanced culture techniques, highly 
sophisticated, and integrated devices as well as higher-throughput and 
multiplexed assays6. As a result, these microsystems offer the unique opportunity 
to study cells functions in an organ-specific context, thanks to the possibility to 
accurate reproduce spatial and temporal gradients to which they are exposed in 
vivo, and topological and mechanical cues that cells experience in the human 
body, as well. 
Indeed, in their normal environment, cells are subjected to multiple cues that vary 
in time and space, including variations of soluble molecules, biochemical and 
mechanical interactions with the extracellular matrix and cell-cell contacts7. 
Physiologic stresses or pathologic conditions may arise from genetic diseases or 
external cues and in both cases cells are exposed to different stimuli such as 
mechanical stress or decreased nutrients supply to the tissues, which may lead to 
altered cellular homeostasis. 
Micro-fabricated systems allow cells to experience these cues in vitro in a 
controllable and reproducible fashion that cannot easily be achieved by standard 
tissue culture systems. Moreover, they can be used to link cell culture with 
integrated analytical devices that can probe the biochemical processes governing 
cell behavior in both physiologic and pathologic conditions.  
 
1.1.2   Microfluidic technology 
Micro-fabrication techniques allow creating devices with structures of dimensions 
that are relevant for biological systems, such as cell sizes (on the order of 10 µm) 
and the sizes of human blood vessels with spacing between capillaries on the 
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order of 100 or 200 µm. At this size scale, it is possible to create more 
physiological growth environments with relevant shear stress, liquid-to-cell ratios, 
and physiological fluid resistance times in tissue compartments. Only small 
quantities of reagents and cells are needed, and parallel processing is possible. 
Laminar flow allows producing highly controlled microenvironments with 
defined composition of nutrient and factors into the media, generation of temporal 
and spatial concentration gradients and regulation of shear stress induced on cells. 
The small physical dimensions of microfluidic culture systems inherently contain 
small numbers of cells, leading to mass-limited quantities of molecules to be 
analyzed and placing further constraints on the required sensitivity of analytical 
methodologies. The optical transparency of many common device materials such 
as polydimethylsiloxane, poly(methyl-methacrylate), and glass readily 
accommodates optical measurements, and the sizes of both microfluidic device 
features and eukaryotic cells are commensurate with the size scales accessible via 
optical microscopy8.   
The control of cellular microenvironment through microfluidic systems represents 
a valuable tool to investigate pathways controlling cell phenotype and behaviors 
by monitoring cellular responses to controlled perturbations in the extracellular 
microenvironment. 
 
1.1.3   Organs on a chip: state of the art  
Recently several studies reported about generation of organs on a chip in order to 
recapitulate key structures of living organs in vivo. 
Few years ago, Ingber and colleagues developed a biomimetic microsystem 
reconstituting the critical functional alveolar-capillary interface of the human lung 
and able to reproduce complex integrated organ-level responses to bacteria and 
inflammatory cytokines introduced in the alveolar space9 (Fig. 1.1). The device 
was used to reproduce drug-toxicity induced pulmonary edema observed in 
human cancer patients treated with interleukin-2 drug10. 
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Figure 1.1 Artificial lung on a chip. The system, developed by microfluidic technology, 
reproduces integrated organ-level responses to bacteria and inflammatory cytokines present in the 
alveolar space. 
 
This in vitro artificial lung well represents the main goal of tissue and organ on a 
chip development, which is not to make replacement tissues or organ for 
transplants, but replicate organs’ functions in vitro. This makes the chips useful in 
testing substances for therapeutic and toxic effects or to investigate the onset and 
the evolution of specific diseases mimicking in vivo physiologic and pathologic 
stimuli (i.e. shear stress, mechanical stress, hypoxia, etc.). 
Many other works focused on recapitulation of human organ functions on a chip 
include heart, liver and gut11,12,13,14,15,16. Liver and cardiac toxicity is among the 
most common biological reasons for drug candidates to be pulled from clinical 
development, so it is important to be able to predict it. In this perspective, Toh et 
al., 2009, developed a microfluidic 3D hepatocyte chip for in vitro drug toxicity 
testing, based on multiplexed microfluidic channels in which hepatocytes 
maintain in vivo synthetic and metabolic functions17.  
Micro-fabrication techniques were also employed to develop an array of 
anisotropic cardiac micro-tissues recapitulating laminar architecture of the heart 
ventricle through mini-cantilevers of soft elastomers. Deflection of these 
cantilevers, during muscle contraction allows calculation of diastolic and systolic 
stresses generated by the engineered tissues16. 
 
1.1.4   Cell sources for in vitro models development: current limitations and 
perspectives 
As mentioned before, animal models have a low potential to represent human 
physiology and pathophysiology, basically due to intrinsic differences among 
species. Drug-toxicity tests carried out using animal models often fail to be 
predictive of toxicity in humans, due to significant differences in interspecies 
metabolic capacities, physiologies, and ignored disease adaptation mechanisms. 
Indeed, functional differences in drug handling by kidneys and drug absorption in 
cascade leading to intra-alveolar fibrin deposition (25, 26) (Fig. 1A).
Here, we focused on establishing a human lung disease model on-chip
that reconstitutes these toxic side effects of IL-2 and resultant pulmo-
nary edema in patients. We also investigated the possibility that me-
chanical breathing motions might contribute to pulmonary toxicity of
IL-2 and tested whether therapeutics such as angiopoietin-1 (Ang-1)
and a new inhibitor of transient receptor potential vanilloid 4 (TRPV4),
GSK2193874 (GlaxoSmithKline), can suppress pulmonary vascular
leakage in this in vitro human disease model, and hence have the
potential to treat human patients.
RESULTS
Mimicking pulmonary edema in the human lung-on-a-chip
To explore whether we could mimic the dose-limiting toxicity of IL-2
in vitro, we used a lung-on-a-chip microfluidic device made of an op-
tically transparent silicone elastomer that contains closely apposed
layers of human alveolar epithelial and pulmonary microvascular en-
dothelial cells cultured in two parallel microchannels separated by a
thin (10 mm), porous, flexible membrane coated with ECM (4) (Fig.
1B). In the upper channel, the alveolar epithelium was exposed to air
to mimic the alveolar air space; culture medium was flowed through
the microvascular channel; and cyclic vacuum was applied to hollow
side chambers to cyclically stretch the tissue layers (10% cyclic strain
at 0.2 Hz) and thus reproduce physiological breathing movements
(Fig. 1B).
To develop a drug toxicity–induced human pulmonary edema model
on-chip, we perfused a clinically relevant dose of IL-2 (1000 U/ml)
through the microvascular channel of this device. Phase-contrast mi-
croscopic imaging revealed that clear liquid began to leak across the
endothelium lining the microvascular channel and into the previous-
ly air-filled alveolar compartment, initially accumulating preferential-
ly in a meniscus at the sides of the channel (Fig. 1C). This leakage
occurred continuously over a period of
4 days, causing a progressive reduction
in the volume of the air space until the en-
tire alveolar microchannel became com-
pletely flooded (Fig. 1C). Moreover, when
we introduced IL-2 and physiological con-
centrations of the human blood plasma
proteins—prothrombin and fluorescently
labeled fibrinogen—into the microvas-
cular channel, we observed extensive for-
mation of fluorescent fibrin clots on the
apical surface of the alveolar epithelium
(Fig. 1, D and E, and movie S1). These
clots also were organized as porous, fi-
brous, network structures (Fig. 1F), con-
firming that they mimic natural fibrin
clots. Clot formation is likely due to acti-
vation of factor X to Xa by tissue factor
expressed or released by inflamed cells
during IL-2–induced leakage of plasma
proteins into the alveolar space, which
then cleaves prothrombin to thrombin,
which acts as a procoagulant to convert
fibrinogen to fibrin (27).
Pathological changes in
barrier integrity
We then quantitatively examined these
pathological changes in lung fluid trans-
port by measuring the permeability of
the microengineered alveolar-capillary bar-
rier to fluorescein isothiocyanate (FITC)–
conjugated inulin that had been injected
into the microvascular channel (Fig. 2A).
The fluorescence intensity of fluids collected
from the alveolar compartment wasmon-
itored during endothelial exposure to IL-2.
In the absence of cyclic mechanical strain,
a gradual increase in fluorescence was de-
tectedover time,whichwas small but signif-
icant (Fig. 2B). However, when the tissue
Fig. 1. A microengineered model of human pulmonary edema. (A) IL-2 therapy is associated with
vascular leakage that causes excessive fluid accumulation (edema) and fibrin deposition in the alveolar
air spaces. (B) IL-2–induced pulmonary edema is modeled in a microengineered lung-on-a-chip that
reproduces the ung microarchitecture and breathing-induced cyclic mechanical distortion of the
alveolar-capillary interface. The top “air” portion is the alveolar channel; the bottom “liquid” portion is
the vascular channel. The phase-contrast image shows a top-down view of the apical surface of the
alveolar epithelium maintained at an air-liquid interface in the upper microchannel. Scale bar, 200 mm.
(C) Endothelial exposure to IL-2 (1000 U/ml) causes liquid in the lower microvascular channel to leak
into the alveolar chamber (days 1 to 3) and eventually fill the entire air space (day 4). The meniscus
between air (A) and liquid (L) appears as dark bands in the phase-contrast images. Scale bars, 200 mm.
(D) During IL-2 treatment, prothrombin (100 mg/ml) and fluorescently labeled fibrinogen (2 mg/ml) in-
troduced into the microvascular channel form fluorescent fibrin clots (white) over the course of 4 days.
Dotted lines represent channel walls. Scale bar, 200 mm. (E) A fluorescence confocal microscopic image
shows that the fibrin deposits (red) in (D) are found on the upper surface of the alveolar epithelium
(green). Scale bar, 50 mm. (F) The clots in (D) and (E) are highly fibrous networks, as visualized at high
magnification by confocal fluorescence mi roscopy. Images are epresentative of three independent
experiments. Scale bar, 5 mm.
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cascade leading to intra-alveolar fibrin deposition (25, 26) (Fig. 1A).
Here, we focused on establishing a human lung disease model on-chip
that reconstitutes these toxic side effects of IL-2 and resultant pulmo-
nary edema in patients. We also investigated the possibility that me-
chanical breathing motions might contribute to pulmonary toxicity of
IL-2 and tested whether therapeutics such as angiopoietin-1 (Ang-1)
and a new inhibitor of transient receptor potential vanilloid 4 (TRPV4),
GSK2193874 (GlaxoSmithKline), can suppress pulmonary vascular
leakage in this in vitro human disease model, and hence have the
potential to treat human patients.
RESULTS
Mimicking pulmonary edema in the human lung-on-a-chip
To explore whether we could mimic the dose-limiting toxicity of IL-2
in vitro, we used a lung-on-a-chip microfluidic device made of an op-
tically transparent silicone elastomer that contains closely apposed
layers of human alveolar epithelial and pulmonary microvascular en-
dothelial cells cultured in two parallel microchannels separated by a
thin (10 mm), porous, flexible membrane coated with ECM (4) (Fig.
1B). In the upper channel, the alveolar epithelium was exposed to air
to mimic the alveolar air space; culture medium was flowed through
the microvascular channel; and cyclic vacuum was applied to hollow
side chambers to cyclically stretch the tissue layers (10% cyclic strain
at 0.2 Hz) and thus reproduce physiological breathing movements
(Fig. 1B).
To develop a drug toxicity–induced human pulmonary edema model
on-chip, we perfused a clinically relevant dose of IL-2 (1000 U/ml)
through the microvascular channel of this device. Phase-contrast mi-
croscopic imaging revealed that clear liquid began to leak across the
endothelium lining the microvascular channel and into the previous-
ly air-filled alveolar compartment, initially accumulating preferential-
ly in a meniscus at the sides of the channel (Fig. 1C). This leakage
occurred continuously over a period of
4 days, causing a progressive reduction
in the volu e of the air space until the en-
tire alveolar icrochannel beca e co -
pletely flooded (Fig. 1 ). oreover, hen
e i tro ce I -2 a ysiological co -
centrati s f t e a l las a
protei s r t r i fl r s tly
labele fi i i t t i as-
cular c l, i f r-
atio f fl t e
apical s rf it li
(Fig. 1, . ese
clots als s, fi-
brous, t . , -
fir i t l fi ri
clots. l t f t cti-
vatio f f f ct r
expresse ells
duri g I i l f l s a
protei s i t t l l r s , ic
then cle es r t r i t t r i ,
hic acts as a r c ag la t t c vert
fibrinogen to fibrin (27).
Pathological changes in
barrier integrity
e then quantitatively exa ined these
pathological changes in lung fluid trans-
port by measuring the permeability of
the microengineered alveolar-capillary bar-
rier to fluorescein isothiocyanate (FITC)–
conjugated inulin that had been injected
into the microvascular channel (Fig. 2A).
The fluorescence intensity of fluids collected
from the alveolar compartment wasmon-
itored during endothelial exposure to IL-2.
In the absence of cyclic mechanical strain,
a gradual increase in fluorescence was de-
tectedover time,whichwas small but signif-
icant (Fig. 2B). However, when the tissue
Fig. 1. A microengineered model of human pulmonary edema. (A) IL-2 therapy is associated with
vascular leakage that causes excessive fluid accumulation (edema) an fibrin deposition in the alveolar
air spaces. (B) IL-2–induced pulmonary edema is modeled in a microengineered lung-on-a-chip that
reproduces the lung microarchitecture and breathing-induced cyclic mechanical distortion of the
alveolar-capillary interface. The top “air” portion is the alveolar channel; the bottom “liquid” portion is
the vascular channel. The phase-contrast image shows a top-down view of the apical surface of the
alveolar epithelium maintained at an air-liquid interface in the upper microchannel. Scale bar, 200 mm.
(C) Endothelial exposure to IL-2 (1000 U/ml) causes liquid in the lower microvascular channel to leak
into the alveolar chamber (days 1 to 3) and eventually fill the entire air space (day 4). The meniscus
between air (A) and liquid (L) appears as dark bands in the phase-contrast images. Scale bars, 200 mm.
(D) During IL-2 treatment, prothrombin (100 mg/ml) and fluorescently labeled fibrinogen (2 mg/ml) in-
troduced into the microvascular channel form fluorescent fibrin clots (white) over the course of 4 days.
Dotted lines represent channel walls. Scale bar, 200 mm. (E) A fluorescence confocal microscopic image
shows that the fibrin d posits (red) in (D) are found on the upper surface of the alveolar epithelium
(green). Scale bar, 50 mm. (F) The clots in (D) and (E) are highly fibrous networks, as visualized at high
magnification by confocal fluorescence microscopy. Images are representative of three independent
experiments. Scale bar, 5 mm.
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the digestive tract, drug-protein interactions and metabolic mechanisms are 
recognized18. Therefore multiple species testing in combination with human cell 
line assays might better predict eventual toxicity profiles.  
In vivo animal models also result in highly expensive and low-throughput 
experimental tools, to which human in vitro models are good alternatives, with the 
advantage of a better representation of human physiology. Ex-vivo tissue slices 
have been widely used for biomedical studies and they are suitable for assays that 
may require visual analysis like immunocytochemistry. The main restrictions of 
using organ culture are careful and laborious preparation, lack of standardized 
protocols and short-term survival.  
Primary cells, directly derived from tissues harvests represent the main tool for in 
vitro culture as they can be easily expanded in standard petri dish, with lower 
costs compared to animal models. Compared to immortalized cell lines, they can 
maintain wild-type un-altered nature, which translates to in vitro cultures with 
cells preserving better structural and biochemical complexity found in vivo. 
However, limitations due to contaminations by minority cells of distinct origins, 
dedifferentiation in culture and sensitivity to passaging result in altered 
phenotypes, slow proliferation rate and early senescence after few expansion 
passages. Moreover, intrinsic limits in human cells recruitment exist for 
cardiomyocytes and hepatocytes, due to the impossibility of ex-vivo extractions. 
On the other hand, immortalized cell lines, derived from primary cells and 
genetically modified in order to obtain more proliferative cells, stable and 
resistant to dedifferentiation, have been demonstrated to possess altered genomic 
content, abnormal expression of intracellular proteins and functional alterations 
such as loss of contact inhibition18, thus failing to be representative of human 
physiology. 
In this perspective, human pluripotent stem cells (hPSCs), with their ability to 
potentially give rise to any cell type of the human body, offer a great advantage 
for deriving functional tissue-specific cells which can be used both in the 
development of relevant diseases in vitro model and for testing toxicity of new 
drugs. Though the perspective for human embryonic stem cells in clinical 
medicine has been centered on their potential for cell replacement and tissue 
repair, for many diseases and injures is still clearly a distant goal. Instead, the 
ability to generate pluripotent stem cells (PSCs) from adult somatic cells and 
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improved methods for directing differentiation, has shifted the focus to using 
PSCs for disease modeling and drug development19.  
 
1.2   Human pluripotent stem cells 
Human pluripotent stem cells (hPSCs) comprise human embryonic stem cells 
(hESCs), derived from the inner cell mass of the blastocyst of a human embryo, 
and induced pluripotent stem cells (hiPSCs), derived from adult somatic cells 
through a process of reprogramming with the use of specific factors. They have 
distinctive features of pluripotency and self-renewal and the potential to generate 
all cellular types of the human body, allowing generation of tissue-specific 
functional cells to be used in disease modeling and drug screening applications 
(Fig. 1.2). 
 
Figure 1.2 Human pluripotent stem cells (hPSCs) can be derived from inner cell mass of 
embryonic blastocyst or from adult somatic cells of healthy donors or diseased patients through 
overexpression of reprogramming factors. HPSCs cultured in vitro have the potential to generate 
all cell types of the human body, included neuronal, cardiac and blood cells. 
 
Human induced pluripotent stem cells were derived for the first time in 2006 from 
Yamanaka and coworkers starting from adult somatic cells through the retrovirus-
mediated transduction of four specific genes (Oct4, Sox2, Klf4 and c-Myc). These 
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cells are identical to embryonic stem cells with the advantage they can be 
generated from specific diseased patients. 
Thus, induced pluripotent stem cells technology provides a unique opportunity to 
generate ‘disease phenotypes in a dish’ for use as in vitro model systems and 
substrates for small molecules screens. While it is unlikely that an in vitro system 
can adequately represent all aspects of a multi-faceted disease, the ability to 
generate any human tissue cells from any genotype or disease provides 
unparalleled access for these studies. 
 
1.2.1   Pluripotency and self-renewal 
HPSCs have unique features of pluripotency and self-renewal, meaning that they 
can proliferate indefinitely in culture while maintaining their characteristic 
phenotype and the potentiality to differentiate into all embryonic germ layers, i.e. 
endoderm, mesoderm and ectoderm. HPSCs can be cultured in standard Petri dish 
in both feeder-layer, consisting in mouse or human embryonic fibroblasts, and 
feeder-free conditions20,21. They possess typical round-shape morphology and 
grow in homogeneous colonies with defined smooth edges. Beside these features, 
expression of core transcriptional factors Nanog, Oct4 and Sox2 is essential to 
maintain their characteristic phenotype, as well as expression of several other 
markers involved in pluripotency and self-renewal maintenance. 
Although there is still incomplete elucidation about all the signaling pathways 
sustaining undifferentiated proliferation of hPSCs, several signals have been 
found to play a central role. Among them fibroblasts growth factor (FGF) and 
transforming growth factor β (TGFβ)/Activin family members are recognized to 
play a central role in promoting hPSCs self-renewal22,23,24,25. 
FGF-pathway plays also an important role in maintaining pluripotency and self-
renewal, as elevated concentrations of exogenous b-FGF permit hPSCs culture 
even in the absence of feeder layer or feeder-conditioned medium26. 
The effect of TGFβ signaling is mediated by binding to cell-surface type I and 
type II receptors with threonine/serine kinase activity. Upon ligand binding, the 
type II receptor phosphorylates the type I receptor, which in turn phosphorylates 
intracellular receptor-Smads (R-Smads). Upon phosphorylation, the R-Smads 
associate with Smad4 and localize to the nucleus, activating transcription. 
Maintenance of hESCs is associated with active Smad2/3, whereas Smads 1/5/8 
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activation, induced by bone morphogenic protein BMP signaling, promote 
differentiation27. 
IGF/PI3K signaling is also associated with maintenance of pluripotency in vitro. 
PI3K maintains human pluripotent cells by suppressing the ability of specification 
factors, such as ActivinA, to promote differentiation. This finding indicates that 
PI3K/Akt cooperates with ActivinA to promote the pluripotent state and suggests 
that ActivinA has context-dependent functions in promoting and antagonizing 
self-renewal pathways22. 
Despite the addition of exogenous factors that manipulate the activation of 
pluripotency-associated signaling pathways, the local cellular microenvironment 
and hence the signaling inputs vary significantly in hESC maintenance cultures. 
In fact, it is likely that hESCs are exposed to a wide range of signaling 
environments by virtue of the properties of hESC colonies (size, distribution and 
culture condition-specific associated differentiated cells), and individual hESC 
position in a particular colony, consistently with properties of the in vivo stem cell 
niche. Localized effects in ESCs niches are likely mediated by interactions 
between exogenously controlled parameters and autocrine and paracrine secretion 
of endogenously produced factors27. Indeed, continuous wash-out of cell culture 
medium in a continuously perfused microfluidic cell culture system has been 
shown to lead to pluripotency markers expression down-regulation and premature 
differentiation into neuro-ectoderm28, suggesting that extrinsic and endogenous 
signaling cooperate to maintain stem cells pluripotency and self-renewal. 
Fig. 1.3 shows a schematic representation of the recognized role of both 
exogenous and endogenous cell-secreted factors comprising members of FGF2, 
TGFβ and IGF pathways in promoting pluripotency and self-renewal of hPSCs. 
 
Figure 1.3 Cultured pluripotent stem cells require proper exogenous and endogenous factors 
supply. Among them, members of FGF2, TGFβ and IGF pathways play central role in maintaining 
pluripotency and self-renewal. 
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1.2.2   Germ-layers specification 
Embryology has offered important insights into key pathways regulating ESC 
differentiation, resulting in advances in modeling gastrulation in culture and in the 
efficient induction of embryonic germ layers and many of their downstream 
derivatives29. One of the most important events during embryogenesis is the 
generation of the three primary germ layers: ectoderm, mesoderm, and endoderm 
during the process of gastrulation (Fig. 1.4a). Whereas embryonic gastrulation in 
mouse has been widely investigated in vivo, human embryonic development still 
remains an open question. Moreover, mouse and human ESCs represent different 
stages of development and clearly display different requirements for growth and 
maintenance in the undifferentiated state30. However, the signaling pathways that 
regulate hESC differentiation are similar to those that regulate these processes in 
mouse ESC cultures. 
 
Figure 1.4 (a) In vivo gastrulation in embryonic development. Ectoderm, endoderm and 
mesoderm germ layers formation occurs at different time stages. (b) Specific derivation of the 
three germ layers in vitro is achieved through manipulation of key pathways (i.e. TGFβ and Wnt 
pathways) regulating embryonic development in vivo. 
 
Gene-targeting studies have shown that members of the TGFβ family including 
BMP4 and Nodal as well as members of the Wnt family are essential for these 
developmental steps. Thus, manipulation of these pathways in hESC cultures in 
vitro allows the regulation of germ layers development, as summarized in Fig. 
1.4b.  
High levels of Activin/Nodal, in combination with WNT3A stimulation, induce 
endoderm formation in vitro, whereas lower doses specify mesoderm identity. 
Alternatively, canonical mesoderm markers, such as GATA2, can be induced 
using ActivinA, BMP4, VEGF, and FGF2 treatment. After transient up-regulation 
of early mesendodermal markers, activation of mesodermal markers such as 
GATA2, HAND2, SOX9, and TAL1 is detected specifically in the mesoderm 
conditions, whereas definitive endoderm is characterized by expression of 
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markers EOMES, FOXA2 GATA6, SOX17, and HHEX. These hESCs can also 
be differentiated into a neuroectoderm-like progenitor population, positive for 
SOX2 and PAX6, by inhibition of TGFβ, Wingless/integrase1 (WNT), and bone 
morphogenetic protein (BMP) signaling.  
 
1.3   HPSCs-based in vitro models for disease and drug screening 
assays 
In vitro models representative of human tissues have become indispensable tools 
for representing human physiology and studying diseases pathogenesis and 
possible therapies31. Functional cardiac and hepatic cells, expressing a mature 
phenotype, were efficiently derived from hPSCs as new tools for drug screening 
and toxicity assays and in vitro disease modeling. 
 
1.3.1   HPSCs-derived cardiomyocytes 
With cardiac diseases being the primary cause of morbidity and mortality in 
Western countries, and with paucity in therapeutic interventions, the identification 
of novel and experimental cardiac drug targets has recently received renewed 
interest.  
One reason for slow cardiac drug target discovery is the limited predictive value 
and high costs of animal-based model systems. From the human heart itself, 
harvesting mature cardiomyocytes is confounded by limitations in cell numbers, 
proliferative capacity, variability in preparation, disease state and viability, 
especially from cadavers32. Recent repots have provided promising preliminary 
data that hiPSC-CMs from disease models display expected responses to anti-
arrhythmic compounds and can also be used to validate the efficacy of 
experimental therapeutic interventions.  
Because hPSCs can generate the major cardiomyocytes subtypes (atrial, 
ventricular and pacemaker cells) and many cardiac diseases are autonomous to the 
cardiomyocyte, hPSCs represent potential in vitro paradigms for understanding 
disease pathophysiology and for identifying pathways to target in ameliorating the 
conditions.  
Essential for modeling cardiac disease are robust, reproducible differentiation 
protocols to obtain functional cardiomyocytes in vitro, able to mimic 
developmental cues occurring in early embryonic development in vivo33. These 
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includes regulation of bone morphogenetic proteins (BMPs), Nodal/ActivinA and 
fibroblast growth factors signaling pathways to induce mesoderm formation and 
specification, which precedes cardio genesis. Signaling through the canonical Wnt 
pathway also plays discrete time-specific roles, with expression of Wnts 
promoting the formation of cardiogenic mesoderm, but repressing the subsequent 
specification to cardiomyocytes19. 
During hPSCs differentiation into beating cardiomyocytes, pluripotency markers, 
such as Oct4 and Nanog are down-regulated concurrently with the up-regulation 
of cardiac transcription factors (NKX2.5, TBX5, MEF2C) and subsequently genes 
encoding structural proteins (MYH6, MYH7, cTnT). Immunofluorescence can 
show presence of structural proteins, like α-actinin, even with relatively organized 
striations32. 
HPSCs-derived cardiomyocytes usually display gene expression and microRNA 
expression profiles, ion channel functionality, ultra-structures, and 
pharmacological responses sharing similarities with an embryonic/fetal cardiac 
phenotype. However, further maturation of the cells has also been reported after 
long- term culture in vitro34. Increasing number and organization of myofibrils 
and progressive withdrawal from the cell cycle in beating hPSCs-derived 
cardiomyocytes are first evidences of cellular maturation towards an adult 
phenotype.  
 
1.3.2   HPSCs-derived hepatocytes 
The liver is a major location for the detoxification of drugs or other xenobiotics as 
well as endogenous substrates; therefore, metabolic function is a critical role of 
hepatocytes in vitro and in vivo35. Many studies focused in the last years in the 
derivation of functional hepatocytes from both hESCs and hiPSCs able to respond 
to drugs and potentially utilizable for in vitro hepatotoxicity assays. 
Mature hepatocytes can be recognized first of all through morphological analysis, 
presence of bi-nucleated cells and markers expression. Albumin (ALB), alpha1-
antitrypsin (α1-AT), tyrosine aminotransferase (TAT), hepatic nuclear factor 4α 
(HNF4α) and glucose 6 phosphatase (G-6-P) are all indicators of mature 
hepatocytes.  
Metabolic activity is the most important function of hepatocytes in vitro and in 
vivo; this function is performed by the complex bio-transforming system, which 
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consists of phase I and II metabolizing enzymes and phase III transporters. 
Metabolizing enzymes such as cytochrome P450 and glutathione S-transferase 
and transporting proteins such as multidrug-resistant protein 1 (MRP1), organic 
anion transporting polypeptide 2 (OATP2), and glucose transporter 2 (Glut2) are 
important for drug screening and hepatotoxicity investigations. Functionality of 
hPSCs-derived hepatocytes can also be assessed through cellular uptake and 
excretion of indocianine green, ICG, which is a unique characteristic of primary 
hepatocytes, as well as the capacity of accumulate glycogen, revealed by PAS 
staining, and the secretion of functioning proteins, such as albumin. 
Toxicity phenotypes using live cells include characterization of cell shape, cell 
adhesion and spreading, nuclear condensation, accumulation of lipids, 
cytoskeleton integrity, in addition to short-term and long-term changes of MP36, 
but cell loss, cell cycle arrest, DNA degradation/apoptosis, nuclear size, oxidative 
stress, stress kinase activation, DNA damage, mitochondrial membrane potential, 
mitochondrial mass, mitotic arrest are also indicators of hepatotoxicity. 
Usually all these parameters are evaluated in a dose-dependent manner and 
different exposure time, i.e. 30 min (acute effect), 24h and 72h (chronic effect). 
Certainly the possibility to accurate control drug delivery with different temporal 
pattern of exposure, maybe by using microfluidic-based systems could greatly 
improve the sphere of possible read-outs. 
 
1.4   Motivations and aim of the thesis 
The development of new microscale technologies, which allow performing cost 
effective and multi-parametric assays for disease modeling investigations or for 
screening specific therapeutic strategies, has been recognized of paramount 
importance from the scientific community, the major pharmaceutical companies 
and the governmental agencies.  
Indeed, the generation of human organs on a chip, in which the microscale 
engineering technologies are combined with cultured human cells in order to 
recapitulate whole living organ environment, offers a unique opportunity to study 
human physiology and pathophysiology, closely mimicking in vivo conditions. 
This technological perspective could provide an effective solution to the 
limitations of both animal models, which result highly expensive and non 
predictive of human physiology, and conventional cell culture models that fail to 
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recapitulate complex, organ-level disease processes in humans. 
Recently, successful examples of organ on a chip development have been 
provided37,38,39,40, however, they were obtained from primary animal cells and, in 
few cases, from primary human cells. The possibility of developing direct 
organogenesis on a chip from human pluripotent stem cells, which have the 
potential to generate all cellular types of the human body, could overcome the 
limited availability of human primary cells, such as human hepatocytes or 
cardiomyocytes. Human embryonic stem cells and induced pluripotent stem cells 
grown in culture also showed intrinsic and unexpected levels of emergent self-
organization for generating highly ordered structures and tissues41,42,43, thus 
opening a wide perspective for multi-organ generation on a chip.  
Moreover, the recent generation of human induced pluripotent stem cells (hiPSCs) 
from adult somatic cells through the ectopic expression of four defined 
transcription factors, provided a new effective tool to get patient-specific stem 
cells, skipping ethical issues related to embryos manipulation. 
In this new perspective, patient-specific reprogrammed cells or human embryonic 
stem cells can be integrated within microscale devices, differentiated into 
functional tissue-specific cells on a chip and used for in vitro assays, aimed at 
developing new disease models and drug testing. Design of proper functional 
assays to test cellular responses to drugs or external stimuli, such as mechanical 
stress or hypoxia, in a physiologic or pathologic context allow investigations of 
new therapies and effective drugs. 
Hypothetically, a screen of genetic diversity panels of cardiomyocytes or 
hepatocytes to identify rare responders, analyze drug toxicity, or perform ‘clinical 
trials on a chip’ using hiPSC-derived diseased cells allows a safe and efficient 
study of potential therapies of genetic defects before initiating Phase I studies in 
patients. 
In this context, the general aim of this work is to design and develop an integrated 
microscale system, based on the microfluidic technology, to derive functional 
cardiac and hepatic tissues on a chip, from human pluripotent stem cells, through 
the accurate delivery of chemical compounds and growth factors, within cellular 
microenvironment, and proper regulation of exogenous and endogenous factors, 
which are known to affect embryonic development in vivo.  
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Evaluation of the functionality of these cells in a physiologic or pathologic 
context require to develop new tools for supporting in vitro models development 
of human diseases (disease on a chip). Specifically, the role of early hypoxia-
induced effects on cardiac tissue will be investigated and the role of the 
mechanical stress in a skeletal muscle human model of Duchenne Muscular 
Dystrophy.  
To address this aim, specific microscale-based devices will be developed in order 
to achieve long-term culture of mammalian cells, and in particular stem cells, 
within microfluidic platforms, controlled delivery of factors and nutrients to drive 
germ layer commitment and functional differentiation. Moreover, ad hoc devices 
for the temporal regulation of oxygen partial pressure in the culture medium and 
the control of mechanical stress on the cells, will be designed and developed. 
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Chapter 2 
Microscale technologies development and 
validation 
 
 
The development of functional human tissues on a chip require to proper design 
and develop technologies based on the microscale (i.e. microfluidic platforms) to 
efficiently control stem cells culture integration, delivery of nutrients and growth 
factors or vectors. 
Control of oxygen content with possibility of generating accurate spatial and 
temporal gradients will be achieved through the development of a microfluidic 
oxygen exchanger. Similarly, an ad hoc cell-stretching device will be designed in 
order to induce specific mechanical stresses to the cells. 
 
2.1 Microfluidic platforms fabrication: soft-lithography technique 
Microfluidic devices are usually fabricated by standard soft-lytography 
technique1,2, which is suitable to construct features measured on the micrometer to 
the nanometer scale. An elastomeric stamp made in polidymethylsiloxane 
(PDMS) is prepared by replica molding by casting a liquid prepolymer and curing 
agent solution (Sylgard 184 from Dow Corning) onto a premade master with 
patterned relief structure in its surface. 
Photolithography is the most common method to fabricate micro-patterned molds. 
Depending on the characteristic length of the structure, which has to be patterned, 
chrome masks or cheaper masks in polymer sheets can be designed. Generally, 
when masters’ features size is greater than or equal to 20µm, patterns can be 
drawn in AUTOCAD and printed onto polymer sheets, through commercially 
available printers. Photomasks are used to selectively polymerize UV-sensible 
photoresists, previously spun onto a silicon wafer with defined film-thickness. 
Parameters such as viscosity of the photoresist, UV-light intensity and baking 
time should be taken into account in order to achieve selective polymerization of 
the desired structure. 
Chapter 2 a 
! 20 
Elastomeric stamps obtained through soft-lithography technique offer several 
properties proper to coupling with biological systems. PDMS is chemically inert 
which makes microfluidic platform biocompatible, but appropriate surface 
functionalization is required when using adherent cells. It is homogeneous, 
isotropic, and optically transparent down to about 300nm, which makes possible 
coupling with detection analysis instruments like fluorescence microscopy. It is 
highly permeable to several gases, included oxygen and carbon dioxide, allowing 
fast equilibration time in standard cell culture incubators. It is a durable elastomer, 
allowing long-term experiments to be performed and its surface properties can be 
rapidly modified by plasma treatment. Air or oxygen-base treatments lead to the 
formation of OH- groups, which permit covalent bonding between the stamp and 
glass slides or other PDMS substrates. 
Soft-lithography technique has been used in this work in order to develop 
microfluidic platforms to carry out stem cells culture expansion and 
differentiation, experiments of viral infections and functional differentiation. Each 
microfluidic device contains 10 channels (18mm long, 1.5mm wide and 0.2mm 
high), working in parallel. Photomask shown in Fig. 2.1a, was designed in 
AUTOCAD, printed onto a transparent polymer sheet and photolitographically 
patterned onto a silicon wafer with SU8-2100 negative photoresist, to obtain a 
final thickness of 200µm, according to manufacturer instructions. The master was 
then treated with hexamethyldisilazane (HDMS) at room temperature for 1h under 
vacuum, in order to facilitate extraction of PDMS mold from silicon wafer. A 
10:1 solution of PDMS pre-polymer and curing agent was cast and cured for 2h at 
70°C in an oven. PDMS mold was cut and peeled off, punched to obtain liquid 
inlets and outlets and sealed to a previously cleaned glass slide by plasma bonding 
(Fig. 2.1b).  
 
Figure 2.1 Microfluidic device for cell cultures integration. (a) Photomask with microfluidic 
channels. (b) Microfluidic chip with 10 independent channels. 
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Before cell culture integration, microfluidic platforms were rinsed with 
isopropanol and sterilized in autoclave, to prevent bacterial contaminations. Glass 
surface has to be opportunely functionalized, with proper adhesion protein 
solutions, in order to promote cellular adhesion, survival and growth. 
 
2.2   Cell cultures integration into microfluidic devices 
Efficient cell cultures integration into microfluidic devices can be achieved 
through proper supply of nutrients and growth factors along time. Human 
pluripotent stem cells are highly sensitive to microenvironment compositions in 
terms of both exogenous factors, provided with external medium, and endogenous 
cell-secreted factors. Different strategies of medium delivery can also affect 
homogeneity of the cell population inside microfluidic channels. 
 
2.2.1   System for automatic control of medium delivery  
Microfluidic cell culture systems allow accurate control of medium perfusion, 
delivery of exogenous factors or drug compounds, generation of concentration 
gradient and temporal defined soluble microenvironment composition.  
Syringe pumps are the most common delivery system employed in microfluidic 
applications, as they ensure an accurate control of shear stress induced on cells. 
Here, CAVRO pumps, obtained from Tecan, have been employed. CAVRO 
pumps XLP6000 are fully programmable syringe pumps, that can be used as a 
stand alone module or, when controlled by an external computer or 
microprocessor, can automate pipetting, diluting and dispensing operations in the 
5 µL to 25 mL range. A multiport head has been integrated within the pump in 
order to obtain 10 different operating channels, and 1 single discharge channel, 
with the advantage to independently control each of them. Labview software has 
been used to create a user-friendly interfacial window to automatically set up 
experimental parameters, such as medium flowrate, frequency of medium delivery 
(number of medium changes per day) and number of cycles. Fig. 2.2 shows the 
experimental set-up adopted for performing biological experiments within 
microfluidic platforms. 
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Figure 2.2 Experimental set-up. Medium delivery in microfluidic chips, placed in standard cell 
culture incubators, is controlled by a multi-port delivery system. Flowrate, frequency of medium 
delivery, temporal delay and total number of cycle are set independently in every microfluidic 
channel and automatically controlled through labview software. 
 
A standard cell culture incubator at 37°C, with 5%CO2 and 100% humidity 
atmosphere was used to arrange microfluidic devices with integrated cell cultures. 
High PDMS permeability allows fast equilibration of temperature and gas content 
in the culture medium. 
Each independent channel of microfluidic chips was provided with a built-in 
medium reservoir of ~70 µL, obtained by sealing an additional PDMS block to the 
top of the device by plasma bonding, and connected to Cavro pumps (one per 
chip), through Tygon micro-tubings (500µm diameter). Automatic delivery was 
used to control the medium flow rate from the reservoirs into the microfluidic 
channels. Medium flowrate, frequency of medium delivery (f), temporal delay 
between two different cycles and total number of cycles were set independently in 
every single microfluidic channel. If continuous perfusion is adopted, f is equal to 
0 and temporal delay does not need to be set. Periodic refill of medium reservoirs 
has been made with manual intervention. 
 
2.2.2   Continuous versus intermittent flow perfusion 
Once cells are injected and seeded into microfluidic channels, a continuous or an 
intermittent flowrate with specific frequency of medium delivery can be chosen. 
Importantly, shear stress imposed on cells should be accurately calculated in order 
to not infer detrimental effects. For microfluidic perfusion culture in 2D Poiseuille 
flow systems, the resulting parabolic flow profile yields a simple estimate of shear 
stress at the wall: 
τ =
6µQ
h2w , 
where µ is the viscosity of the medium (kg m-1 s-1), Q is the flow rate (m3 s-1), h is 
the channel height (m), and w the channel width (m)3. Beside this, the content of 
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the soluble microenvironment, the effects on nutrient delivery and secreted factors 
must also be considered. 
In order to evaluate proper conditions to culture pluripotent stem cells within a 
microfluidic platform, human embryonic stem cells were injected in microfluidic 
channels and cultured up to 5 days with a continuous medium perfusion or with 
an intermittent delivery with f=2d-1. Flowrate and frequency parameters were 
chosen in order to deliver the same volume of medium during all 5 days in both 
conditions. Cells were compared with standard hESCs culture on Petri dish, 
showing similar colony morphology. However, significant differences in cell 
growth from inlet to the outlet of the channel was observed in the first condition, 
whereas homogeneous growth was observed by using an intermittent perfusion, as 
reported in Fig. 2.3a. 
 
Figure 2.3 HESCs cultured in microfluidic channels in both continuous and discontinuous 
medium delivery conditions. (a) Bright field and nuclei staining pictures show significant 
differences in colonies growth in continuous perfusion from inlet to outlet of the channel, whereas 
no inlet/outlet effects are observed in discontinuous delivery conditions. (b) Quantification of 
mean colonies diameters in three distinct regions of the channel (inlet, middle and outlet) for 
continuous (left) and discontinuous (right) conditions confirms previous result. 
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Quantification of colonies diameter in three distinct regions of the channel (i.e. 
inlet, middle and outlet) confirmed previous result, as shown in Fig.2.3b for 
continuous (left) and discontinuous (right). 
This result proves discontinuous medium delivery is an efficient method to 
maintain homogenous culture condition inside the channel without inlet/outlet 
effects, as a continuous perfusion was found to induce dramatic reduction of 
colony growth from the inlet to the outlet of the channel. 
In this culture condition both embryonic and induced pluripotent stem cells 
display similar morphology to cells cultured in standard Petri dish (Fig. 2.4a).  
 
Figure 2.4 HPSCs culture in microfluidics. (a) HESCs and hiPSCs cultured in microfluidic 
channels up to 5 days display standard morphology as in standard Petri dish. Scale bars are 
200µm. (b) HESCs and hiPSCs cultured in microfluidic channels homogenously express 
pluripotency markers (Oct4, Sox2, Tra1-60 and Tra1-80) as revealed by immunofluorescence 
analysis. Scale bars are 50µm. 
 
Moreover, they homogeneously express pluripotency markers such as Oct4, Sox2, 
Tra1-60 and Tra1-81, as revealed through immunofluorescence analysis (Fig. 
2.4b). 
 
2.2.3   Adenoviral vectors-mediated gene delivery 
Beside the delivery of growth factors and nutrients, the efficient introduction of 
genetic material inside the cells is another aspect to take into account for 
biological investigations, such as optimization of gene therapies, RNA 
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interference experiments, induced pluripotent stem cell production or for 
promoting stem cell differentiation. Viral particles are widely used as genetic 
material carriers, as they ensure stable and efficient insertion of genomic material 
in host cells. In particular, adenoviruses have the advantage to introduce 
transgenes into the cells without uncontrollable random integrations in host 
DNA4, minimizing perturbations of cells homeostasis. 
As proof of concept, non-replicating adenoviral vectors (AdVs), carrying 
enhanced green fluorescent protein (EGFP) were used as reporter for infection of 
a human fibroblast cell line in the microfluidic system. Optimal conditions for 
high efficiency of infection and minimal toxic effects on the cells were 
investigated. High efficiency of infection can be obtained by tuning the following 
parameters: 
- viral concentration, defined by the MOI (number of viral particles, PFU, 
for cell); 
- frequency of virus-containing medium delivery; 
- medium flowrate. 
In order to predict the percentage of infected cells and the associated infecting-
virus distribution in the cell population, a stochastic mathematical model, which 
accounts for the discrete nature of cells and viruses, was developed and 
experimentally validated, as reported in Appendix B. The developed model was 
adopted in order to predict not only the efficiency of infection but also the 
distribution of the viral population (i.e. number of viruses per cell). 
Two different medium delivery strategies were analyzed by using the same global 
MOI equal to 20. A continuous convection-driven perfusion (Pe=300) was 
compared to a diffusion-driven process (Pe=0). Simulated time was set to 90 min, 
which is the time (tf) required for a viral particle to travel a distance s equal to 200 
mm (the channel height) by Brownian motion, calculated from the Einstein’s 
relation: 
, 
where D is the diffusion coefficient of the virus in the medium. Given the 
stochasticity of the model, one hundred computational simulations were 
performed and results were reported as mean with corresponding stochastic 
variability. Fig. 2.5a shows results derived from the simulation in which colored 
t f =
s2
2 ⋅D
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dots represent cells. Red dots represent non-infected cells, whereas the other dots 
represent infected cells with the corresponding number of viruses as reported in 
the legend. A convection-driven infection with continuous perfusion of virus-
containing medium leads to marked inlet/outlet effects in the number of infected 
cells and number of number of viruses (Fig. 2.5a up). On the other hand, a 
homogeneous infection can be observed in a diffusion-driven infection (Fig. 2.5a 
down). 
 
Figure 2.5 (a) Results of stochastic simulations with MOI 20 of continuous channel perfusion 
(Pe=300) for 90 min (up) and of discontinuous channel perfusion (Pe=0) for 90 min (down). 
Inlet/outlet heterogeneity in number of infected cells and number of viruses per cell can be 
observed in the first case (up), whereas no significant inlet/outlet differences in the second case are 
observed (down). Black arrow indicates flow direction. (b, c) Percentage of EGFP+ cells in each of 
the 10 equal sectors of the channel indicated by the dotted lines showing differences in infection 
homogeneity in continuous (b) and discontinuous (c) virus-containing medium delivery. Error bars 
indicate mean ± standard deviation of 100 simulations. Cell concentration is 150 cell/mm2. (d) 
Efficient cell infection in the microfluidic channel obtained with a discontinuous delivery of virus-
containing medium as revealed by EGFP fluorescence and nuclei staining. 
 
The length of the channel was also divided in 10 sectors and in each sector the 
percentage of EGFP+ cells, i.e., of cells infected by at least one virus, was 
calculated. The results are shown in Fig. 2.5b-c, confirming previous results of 
spatial heterogeneity in viral infection.  
Spatial heterogeneity is a relevant phenomenon introduced by perfusion that 
EGFP%
b c 
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affects the quality of the resulting cell population. Thus, a discontinuous flow 
protocol better preserves cell microenvironment, while ensuring a homogenous 
transfection along the microfluidic channel as experimentally demonstrated (Fig. 
2.5d). 
The effect of MOI on the percentage of EGFP+ cells and the infecting-viruses 
distribution was also computationally investigated, by simulating the transduction 
process in a microfluidic channel for a cell density of 150 cell/mm2 at four 
different MOIs: 1 (equal to a concentration of 750 PFU/mL), 5 (3750 PFU/mL), 
10 (7500 PFU/mL) and 20 (15,000 PFU/mL). Fig. 2.6a shows the resulting 
probability and complementary cumulative distributions of the percentage of cells 
infected with increasing MOI values from 1 to 20, as calculated by the model. At 
MOI 1, almost all the cells infected have only one virus, but at higher MOIs, 
heterogeneity is visible in the cell population. As expected, the efficiency of the 
infection process increases at higher MOIs. 
 
Figure 2.6 (a) Probability and complementary cumulative distributions of the percentage of cells 
infected with increasing MOI values from 1 (left) to 20 (right), as calculated by the stochastic 
model. (b) Comparison of theoretical number of infected cells, as predicted from the stochastic 
model, and experimental results obtained by measuring the number of fluorescent cells, for 
different MOIs. (c) Cumulative distribution, associated at the level of fluorescence intensity, If, of 
infected cells at different MOIs.  
 
Experiments of viral transduction in the microfluidic platform were performed 
under the same conditions simulated above and cell population was characterized 
at 24h after the beginning of infection. This period of time was assumed sufficient 
for infected cells to express EGFP protein, as reported previously in de Martin et 
a 
c b 
If 
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al.5. Very good agreement between the percentages of EGFP+ cells obtained from 
experimental data and predicted by the model (Fig. 2.6b) demonstrates the 
stochastic model fairly describes the overall infection process within the 
microfluidic platform.  
The experimental heterogeneity of the cell population expressing EGFP was 
investigated at the single-cell level, through quantification of the intensity of 
fluorescence, If, of each cell by image analysis, as described in Appendix B. The 
results are shown in Fig. 2.6c, in terms of complementary cumulative distributions 
for different MOIs. Besides increasing the percentage of cells expressing EGFP, 
AdV transduction performed at higher MOIs enhances the amount of exogenous 
RNA and consequently the amount of EGFP produced by single cells. This could 
be related to the increase in the number of viruses infecting each cell, as explored 
computationally. 
Although high efficiency of infection can be achieved, this results transient, thus 
long-term expression (several days) of transfected genetic material requires 
further investigations. In this perspective, different infection strategies can be 
followed, such as a single high-dose infection or low-dose repeated infections.  
These two strategies were first explored computationally, through the stochastic 
model, by comparing the outcome of a single viral transduction at MOI 20 (MOI 
20 × 1) with that of two infections at MOI 10 (MOI 10 × 2), and of four infections 
at MOI 5 (MOI 5 × 4). The total number of viruses entering the system was thus 
the same, but three different regular temporal sequences were used (Fig. 2.7a-c). 
Theoretically the same outcome is achievable with a single high-dose infection or 
with a low-dose multi-infection strategy, in terms of percentage of EGFP+ cells 
and of the distribution of the number of viruses per cell as shown in Fig. 2.7a-c. 
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Figure 2.7 Single high dose infection vs. multiple low dose infections. (a-c) Distribution of 
EGFP-expressing cells, calculated through the stochastic model, for a single infection with MOI 
20 (MOI 20 × 1) (a), two repeated infections with MOI 10 (MOI 10 × 2)  (b) and four repeated 
infections with MOI 5 (MOI 5 × 4) (c). Cell concentration was 150 cell/mm2. Error bars indicate 
mean ± standard deviation of 100 simulations at each condition. (d) Fluorescence intensity 
distribution of EGFP expressing cells experimentally analyzed at four different time-points (24h, 
36h, 48h and 60h) for the three different infection strategies. After 60h from the beginning of the 
experiment multiple low dose infection (MOI 5 × 4) protocol gives a higher percentage of cells 
expressing more EGFP, compared to a single high dose infection (MOI 20 × 1). 
 
The three simulated strategies of infection were experimentally reproduced and 
efficiency of infection, in terms of fluorescence distribution, was analyzed at 
different time-points: 24h, 36h, 48h and 60h. Despite an initial condition in which 
single high-dose infection results more efficient, as more cells express more 
fluorescence signal, at 60 h from beginning of the experiment, an higher 
percentage of cells result more fluorescent if using the multi-infection protocol 
(MOI 5 × 4), probably due to a loss of EGFP expression (or protein degradation) 
over time, occurred using the single high-dose infection (Fig. 2.7d). 
Thus, low dose multi-infection could be an effective solution when long-term 
expression is required, ensuring a higher percentage of infected cells and avoiding 
potential issues related to viral dose toxicity.  
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2.3   Temporal control of oxygen concentration 
It is well recognized that oxygen regulates nearly every cellular process, from cell 
metabolism, to differentiation and cell division. In the laboratory, cells are 
commonly cultured in air supplemented with 5% CO2 to complement the sodium 
bicarbonate buffer in the growth medium, which balances the pH. Oxygen 
concentration is commonly regulated in conventional humidified chambers or 
incubators with a controlled oxygen partial pressure in the gas phase.  
One of the major goals in biological studies is to recreate spatial and temporal pO2 
gradients, arising in vivo in both physiological and pathological conditions. In this 
perspective, technology developed at the microscale level is an effective solution 
to accurately control oxygen partial pressure at cellular-size level. This is feasible, 
thanks to the laminar flow regime and the time scale of diffusive mass transport 
phenomena that are closely related to the characteristic length of the system.  
While spatial gradients of oxygen concentration are easily achievable by using 
parallel steady-state laminar flows at decreasing oxygen concentration in the same 
microfluidic device6,7,8, the generation of fast and sudden oxygen depletion in the 
cell culture medium, for example to mimic oxygen concentration drop in blood 
vessels when an ischemic event occurs, requires specific technological 
improvements, compared to standard devices. The major issues that have to be 
considered concern: 
i)  an almost perfect insulation of the system from external environment; 
ii)  the fast oxygen removal from cellular solution without perturbing cell 
microenvironment. 
In this perspective a system with separate compartments for liquid and gas phase 
was designed. Each of them has defined height, inlet and outlet flowrates and 
oxygen partial pressure, whereas a thin, non-porous and highly permeable 
membrane, made in PDMS, allows rapid oxygen exchange from the gas to the 
liquid layer, without any perturbation of the detection system. A schematic 
representation of the system is reported in Fig. 2.8a. 
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Figure 2.8 Microfluidic gas exchanger design. (a) Schematic representation of gas exchange 
system with different compartment for liquid and gas flow, with defined inlet and outlet flowrates 
(L and G) and oxygen partial pressure. Oxygen exchange occurs along x-coordinate through a thin, 
permeable PDMS membrane. (b) Top-view of the fluidic layer channel network (all dimension 
values are in µm). (c) 3D schematic view of the three layer-microfluidic gas exchanger. 
 
The fluidic layer is formed by a network of microfluidic channels etched in a 
glass substrate, in order to achieve complete gas sealing. The imprinting of micro-
channels in the glass slide was obtained by an acid solution-based wet-etching 
technique. Flow channels network is characterized by a series of gas exchanger 
unit, and each unit is formed by 8 parallel microchannels 100 mm wide (Fig. 
2.8b). This modular design allows to add series of units, until obtaining the total 
length required for a given exchange efficiency.  
The micrometric thickness of the gas permeable membrane ensures low oxygen 
diffusion resistance. The gas domain is a low-volume rectangular chamber that 
allows high gas flow rate and, consequently, almost uniform oxygen partial 
pressure within the gas chamber. 
The oxygen concentration profile, and consequently the oxygen partial pressure, 
within the liquid phase domain of the microfluidic gas exchanger was described 
by a simplified analytical model and by computational solution of the species 
mass balance, as reported in Appendix A. The theoretical model was solved 
through computational analysis and used for proper gas exchanger design. Fig. 
2.9a shows oxygen partial pressure profile along x-coordinate for different values 
of medium flowrate, L, (50, 100 and 200 µL min-1), at constant channel height, 
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and different channel heights, hL, (40, 70 and 100 µm), at constant flowrate for 
eight exchanger units, with total length CL equal to 8 cm.  
In order to satisfy a specific target value of oxygen partial pressure L, hL or the 
number of exchange units can be varied. 
 
Figure 2.9 (a) Oxygen partial pressure profile as a function of x-coordinate, parametric in liquid 
flowrate, L, and channel height, hL. (b) Oxygen partial pressure dynamic in the liquid phase during 
a step impulse of oxygen partial pressure in the gas phase (from 21 to 0%) analyzed at different 
medium flowrate with a ruthenium complex-based, Ru(ddp), fluorescent sensor. (c) LOp 2 profile for 
five different GOp 2  with L =100 µl min
-1 (left). Equilibrium and operating curves obtained by 
calibration (right). 
 
The dynamics of oxygen depletion, following a step pulse from 21 to 0% of 
oxygen partial pressure in the gas phase, was also investigated for three different 
values of medium flowrate with hL equal to and 8 exchange units (Fig. 2.9b). As 
predicted from the model, different stationary state values of oxygen partial 
pressures can be achieved. However, the dynamic of the process results in the 
order of seconds, meaning the system could be efficiently used for mimicking fast 
oxygen depletion in cell culture medium. This last aspect is of particular interest 
for investigating in vitro physio-pathologic effects occurring in cardiac tissue 
during ischemia, when a rapid drop of oxygen supply to cardiac cells occurs.  
Thus, the developed device allows fast and accurate tuning of oxygen partial 
pressure in cell culture medium by simply tuning oxygen partial pressure in the 
gas compartment.! Constant gas flow rate and oxygen composition were 
maintained in the gas chamber using air and nitrogen mass flow meters and 
regulating their flowrates ratio. A multiple step experiment was designed by 
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setting GOp 2  at 5 different values from 21% to 0% with 5% interval. The resulting 
L
Op 2  step profile is shown in Fig. 2.9c (left). Corresponding values of 
L
Op 2  and 
G
Op 2  
were correlated to obtain operating curve shown in Fig. 2.9c (right). Interestingly, 
the operating curve only slightly differs (about 2%) from the equilibrium curve, 
allowing almost anoxic conditions to be reproduced in the culture medium.  
 
2.4   Control of mechanical stress 
Mechanical stress plays a crucial role in the investigation of new physiological 
and pathological responses to cell culture microenvironment. It is recognized that 
active deformation promote cellular growth and survival, influence metabolic 
processes and gene expression, and governs tissue architecture in various cell 
types9,10,11,12,13. Several technological solutions have already been proposed for 
stretching cultured cells by using elastic membrane. Beside most common 
commercially-available cell-stretching device, developed by Flexcell Corporation 
and largely adopted in many works9,10,14, a number of custom-made solutions 
have been proposed to perform mechanical stimulations on cell cultures in both 
uniaxial and biaxial directions. However, the accurate control in space and time of 
mechanical-induced deformations while observing the cellular behavior at single 
cell level is not straightforward. Moreover, the relative large scale of the existing 
technology hinders to investigate high temporal resolution cell behavior under fast 
cyclic mechanical stimulations and the intrinsic complexity of these systems 
prevents to simultaneously perform multi-parallel experiments analyzing the 
mechanical-associated single cell response in a high-throughput fashion. 
 
2.4.1   Development of a microscale cell-stretching device 
A cell-stretching device was properly designed in order to ensure: i) accurate 
control of mechanical stimulations at single-cell level, ii) high temporal resolution 
of cyclic mechanical stimulations, iii) optical accessibility for in line analysis, iv) 
statistical significance of treated samples, with internal un-stretched control. 
Taking advantage of the microfluidic technology, an ad hoc cell-stretching device 
was designed. It is based on the deformation of a thin PDMS membrane, with 
40µm thickness, through pressurization of a network of microfluidic channels. 
Microfluidic technology, that is recognized to provide highly reproducible and 
well-defined hydrodynamic conditions, was adopted in order to obtain accurate 
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control of pressure-driven mechanical deformation of elastic membrane 
underneath cell culture, in terms of amplitude, temporal profile and frequency of 
bidirectional deformation. Fig. 2.10a shows a schematic representation of how 
cells, cultured on the top of the PDMS membrane, are stretched when 
microfluidic channels are pressurized.  
 
Figure 2.10 (a) Schematic representation of pressure-induced cell stretching through deformation 
of PDMS membrane with underneath microfluidic channels. (b) Deformation of a confluent 
monolayer of an endothelial cell line expressing EGFP. Nuclei are stained in red. Scale bar 20µm. 
(c) Top view of microfluidic cell-stretching device with 32 deformable circular spots (left). The 
device, provided of inlet tubing for gas-pressurization can be integrated into standard multi-well 
plates (right).  
 
Cell deformation following pressure application is shown in Fig. 2.10b for a 
confluent monolayer of endothelial cells. Cell deformation in biaxial directions 
can be appreciated by endogenous expression of fluorescent protein EGFP, 
whereas cells nuclei are stained in red.  
Microscale allows applying accurate cyclic mechanical deformation on several 
micro-regions inside the same culture chamber, both in radial and circumferential 
directions. Microfluidic compartment includes 32 deformable circular spots with 
radius 500 µm. All individual spots are connected through a microfluidic channel 
network with hydraulic symmetry, for each microfluidic path, as shown in Fig. 
2.10c left, in order to apply identical pressure-induced membrane deformation to 
all spots. Moreover, thanks to this configuration, with both stretchable and un-
deformable areas in the same device, an internal un-stimulated control can be used 
in every single experiment. Microfluidic cell-stretching device can be easily 
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integrated in standard multi-well plates (Fig. 2.10c right) or directly coupled with 
an optical microscope for in line analysis. This latter solution requires an 
additional PDMS layer to hold medium up during observation. 
Biaxial mechanical deformation induced on cells was estimated by developing a 
Finite Element Model (FEM) of elastic membrane, assisting microfluidic channel 
configuration design (Appendix E). Computational modeling to fully characterize 
elastic membrane deformation under application of the internal pressure and to 
estimate the level of local strains supported the development of the device. These 
data were adopted in order to accurately calibrate the mechanical bi-directional 
deformation induced on the cells. Typical data from the FEM analysis are shown 
in Fig. 2.11a and 2.11b for a spot with radius of 500 µm and thickness 40 µm, 
showing complete deformation of the spot in both radial and circumferential 
direction respectively.  
 
Figure 2.11 (a-b) Predicted distribution of radial (a) and circumferential (b) deformations of a 
single spot with ΔP equal to 1 bar. (c) Predicted profile and experimental values of the vertical 
displacement in the center of the spot with the applied pressure. (d) Temporal profile of the 
mechanical stimulus at different frequencies, obtained by filling microfluidic channels with a dye 
and recording the absorbance in the center of the membrane at different frequencies.  
 
The derived model was experimentally validated by measuring vertical 
displacements of the membrane in the center of the spot, with different pressures. 
Fig. 2.11c shows the vertical displacement on the top of the PDMS membrane as 
a function of the applied pressure. Theoretical profile obtained by numerical 
solution results in good agreement with the experimental values.  
Microscopic dimensions of microfluidic channels allow manipulation of few 
0 2 4 6 8 10 12 14 16
Time (s)
0
50
100
150
200
250
He
igh
t (r
ela
tiv
e)
0.1 Hz
0.2 Hz
0.5 Hz
1.0 Hz
0 2 4 6 8 10 12 14 16
Time (s)
0
50
100
150
200
250
He
igh
t (r
ela
tiv
e)
0.1 Hz
0.2 Hz
0.5 Hz
1.0 Hz
0 2 4 6 8 10 12 14 16
Time (s)
0
50
100
150
200
250
He
igh
t (r
ela
tiv
e)
0.1 Hz
0.2 Hz
0.5 Hz
1.0 Hz
0 2 4 6 8 10 12 14 16
Time (s)
0
50
100
150
200
250
He
igh
t (r
ela
tiv
e)
0.1 Hz
0.2 Hz
0.5 Hz
1.0 Hz
0 10#82 4 6 12# 14# 16#
Time#[s]#
25 #
200#
15 #
100#
50#
Ab
so
rb
an
ce
#[a
.u
.]#
0.1#Hz# 0.2#Hz# 0.5#Hz# 1#Hz#
Circunferen=al#strain#Radial#strain#
15%#
0%#
15%#
0%#
0#
50#
100#
150#
200#
250#
0# 0.25# 0.5# 0.75# 1# 1.25#
Δh
#[μ
m
]#
ΔP#[bar]#
exp#
num#
Δh 
a b 
d c 
Chapter 2 a 
! 36 
microliters for system pressurization, thus providing fast dynamics of the 
stimulation and uniform spatial and temporal stimulus on cells. In order to assess 
the robustness of the system and the reproducibility of mechanical stimuli during 
cyclic deformations, microfluidic channels were filled with a dye and the 
absorbance of deformed areas during pressurization cycles, was detected at 
different frequency. These values of absorbance can be directly correlated to the 
vertical displacement of the membrane. Fig. 2.11d shows temporal profiles of 
absorbance acquired at different frequencies from 0.1 to 1 Hz and demonstrates 
the efficiency of the system in terms of stability of the mechanical deformation 
and fast dynamics.  
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Chapter 3 
Multi-stage generation of functional hPSCs-
derived cardiac and hepatic cells on a chip 
!
 
HPSCs differentiation into functional tissue-specific cells requires a multi-stage 
process, in which exogenous/endogenous factors balance plays a central role. 
Frequency of medium delivery allows proper factor supply in each of these 
developmental steps, driving hPSCs into functional cardiac and hepatic cells. 
Differentiated cells display mature phenotypes, meaning that differentiated cells 
derived in the microfluidic channels can be directly used for dynamic multi-
parametric and large-scale drug screening or for developing micro-engineered 
human organ models. 
 
3.1   HPSCs expansion and pluripotency maintenance in 
microfluidic platform 
Exogenous and endogenous cell-secreted factors have been demonstrated to play a 
major role in regulating stem cells pluripotency and self renewal, determining cell 
fate1,2. This aspect could be greatly emphasized in a micro-scale environment, 
where, thanks to the high surface/volume ratio, accumulation and local 
concentration of autocrine-paracrine factors are greatly enhanced. 
Intermittent medium delivery with proper frequency of medium change, f, has 
been shown to provide suitable conditions for healthy and homogeneous growth 
of pluripotent stem cells inside microfluidic channels (§2.2.2). Moreover, variable 
f could be used to modulate exogenous/endogenous factors supply, as low f 
promotes higher accumulation of endogenous and depletion of exogenous factors, 
whereas higher f allows sustained supply of endogenous factors to the cells and a 
more frequent wash-out of cell-secreted factors. 
It is reasonable to hypothesize that these factors have a synergic positive effect in 
vitro in promoting transcriptional activity of pluripotency genes, as schematized 
in Fig. 3.1a. The model summarizes relevant phenomena to highlight the effect of 
dynamic changes in extrinsic factors modulated by f, on a hypothetic 
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transcriptional activity. Black arrows in Fig. 3.1a indicate chemical reactions 
involved in the process. In particular, reactions (1) and (2) describe the coupling 
of exogenous, Ex, and endogenous, En, factors to specific membrane receptors, 
which promotes the activation of transcriptional factor, Tr. In addition, Tr is 
activated at a basal level through reaction (3) and induces expression of 
pluripotency-associated genes through reaction (4). Gene transcripts, Gt, in turn, 
produce newly En, as indicated by reaction (5).  
 
Figure 3.1 Pluripotency-associated signaling pathway model in microfluidic stem cell culture. (a) 
Exogenous (Ex) and endogenous (En) factors synergistically contribute to transcriptional activity 
of pluripotency genes transcripts (Gt), through activation of target transcription factors (Tr). (b) 
Model output. Temporal profiles of normalized Ex and En factors concentrations in the 
microfluidic channel at increasing frequencies (up). Gene transcript concentration profiles versus 
transcription factor concentrations during a single cycle of medium perfusion at the same 
increasing frequencies (down). 
 
Mass balances of all species involved consist in a system of ordinary equations, 
which was computationally solved with MATLAB to obtain pseudo-stationary 
profiles of species concentrations, at different f (Fig. 3.1b and Appendix C). These 
computational investigations revealed that frequency of medium delivery strongly 
affects accumulation of exogenous and endogenous factors, thus regulating 
transcriptional activity of target genes. A frequency increase reduces the 
amplitude of temporal fluctuations of both exogenous and endogenous factors 
(Fig. 3.1b), thus maintaining sustained transcriptional activity of the associated 
target genes. However, higher frequencies of medium change produce decreased 
expression of gene transcript, due to continuous wash-out of endogenous secreted 
factors.  
In order to experimentally validate theoretical hypothesis described above, human 
embryonic stem cells were cultured up to 5 days in microfluidic channels with 
different f and pluripotency genes expression was analyzed. The qRT-PCR 
analysis of pluripotency markers Oct-4 and Nanog showed the highest expression 
level by using f=2d-1 (Fig. 3.2a), comparable with standard static conditions in 
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Petri dish. Significant three-fold higher expression compared to lower (f=1d-1) and 
higher frequencies (f=3d-1, f=4d-1 and f=8d-1) was observed. These results are 
consistent with the initial hypothesis that an appropriate optimal balance of 
exogenous molecules and endogenous cell-secreted factors has to be provided. 
 
Figure 3.2 (a) Frequency-dependent pluripotency markers Nanog and Oct-4 expression after 5 
days of culture, compared to standard static culture control and continuous perfusion (CP). (b) 
Significant recovering of Nanog and Oct4 expression in non-optimal frequency conditions, i.e. 
f=8d-1, as in optimal condition (f=2d-1). Data are normalized on GAPDH expression. Student’s t-
test p-value ***P≤0.001. Data are shown as mean ± s.d. (n=3). 
 
In order to demonstrate f=2d-1 is effectively the optimal frequency, which allows 
accumulations of factors essential for pluripotency maintenance in microfluidics, 
conditioned medium containing these factors was used to culture the same stem 
cell line in pro-exogenous not-optimal conditions, i.e. f=8d-1, and looking if  the 
use of this conditioned medium can recover pluripotency markers expression. Fig. 
3.2b shows that accumulated secreted factors can significantly restore markers 
expression as observed in optimal conditions. 
 
3.2   Frequency-driven germ layer commitment 
In order to investigate whether the frequency of medium perfusion could be used 
also for directing early germ layer commitment, according to extrinsic 
endogenous and exogenous factors concentration, hESCs were expanded in 
microfluidic channels and induced to spontaneously differentiate for 4 days at 
different frequencies. Expression levels of early germ layers markers were 
analyzed through qRT-PCR analysis of β-III tubulin, OTX2 (ectoderm), 
Brachyury T, GATA4, aSMA (mesoderm), AFP, EOMES and FOXA2 
(endoderm). Under these conditions, the static culture showed ectoderm and 
mesoderm expression but not endoderm. On the other hand, frequency-dependent 
germ layer enrichment was observed in microfluidic culture (Fig. 3.3).  
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Figure 3.3 Spontaneous differentiation of hESC on-a-chip at different frequencies. The qRT-PCR 
analysis (gene expression normalized on glyceraldehyde 3-phosphate dehydrogenase) of Oct-4, β-
III tubulin, brachyury T and alpha-fetoprotein in hESC spontaneous differentiation on chip, under 
different f. Data are shown as mean ± s.d. (n=3).  
 
Ectoderm resulted highly expressed at lower frequencies (f=1d-1 and f=2d-1) and it 
is completely down regulated at higher frequency (f=8d-1), whereas mesoderm and 
endoderm expression are enhanced at higher frequency (f=8d-1). Interestingly, 
pluripotency markers are down regulated as the frequency increases. These 
experimental observations are consistent with the hypothesis that ectoderm 
differentiation requires high accumulation of extrinsic endogenous factors to be 
induced3,4, whereas strong endoderm enrichment is possible only with specific 
exogenous factors delivery. All together, these results suggest that periodic 
perfusion frequency is an additional player in directing early germ layer 
commitment. 
To verify whether an efficient and selective induction of the three germ layers 
could be achieved, hESCs were induced to ectoderm, mesoderm and endoderm by 
specific differentiation protocols, containing germ layers-induction factors, within 
microfluidic platforms (Fig. 3.4a). Interestingly, a significantly higher expression 
of ectoderm marker β-III tubulin was obtained in microfluidic conditions, 
compared to conventional differentiation in Petri dish. It seems that microfluidic 
environment effectively allows to wash out the endogenous factors that inhibit 
endoderm differentiation, and efficiently delivers the exogenous pro-endoderm 
factors. Immunofluorescence analyses confirmed that highly selective 
commitment for all germ layers, with extremely low contamination from the 
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others, is achievable also at the protein level in each specific differentiation 
protocol (Appendix C). 
 
 
Figure 3.4 (a) Early germ layer induction with specific media. The qRT-PCR analysis of Oct-4, β-
III tubulin, brachyury T and AFP, and comparison between standard static control and microfluidic 
differentiation. Data are shown as mean ± s.d. (n=3). (b) Mesoderm induction optimization. The 
qRT-PCR analysis of Oct-4 and Brachyury T expression in different frequencies of medium 
change for germ layer commitment optimization. brachyury T expression is comparable between 
f=3d-1 and f=2d-1, while there is a significantly lower expression at high and low frequencies. 
Student’s t-test p-values *P≤0.05 **P≤0.01. Data are shown as mean ± s.d. (n=3). 
 
Perfusion frequency can also be adjusted for optimizing germ layer induction 
when specific differentiation protocols are used. As proof of concept, results in 
Fig. 3.4b shows how selective induction of mesoderm can be achieved by 
adjusting frequency of periodic perfusion. A significant 3 fold higher brachyury T 
expression was found at f=2d-1 and f=3d-1, compared to f=1d-1 and almost null 
expression at f=12d-1. 
Collectively, these findings indicate that the frequency of periodic perfusion is an 
additional parameter, which can be adjusted, in order to enhance robustness and 
efficiency of early germ layer specification, even when specific protocols are 
adopted. In particular, it could carry advantages for endoderm differentiation, as it 
requires large quantities of exogenous molecules (e.g. ActivinA) and washing out 
of endogenous inhibiting factors. On the other hand, mesoderm differentiation 
seems to require a proper balance between exogenous and endogenous molecules 
that can be achieved by frequency optimization, although dependent on cell 
culture density and media composition.  
From technological point of view, small-scale microfluidic volume leads to 
extremely reduced medium consumption (few microliter per day per channel) and 
rapid and accurate perturbation of medium composition that is an important 
prerequisite for multi-stage differentiation process. 
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3.3   Functional cardiac and hepatic cells derivation 
Cardiac and hepatic cells, derived from mesoderm and endoderm germ layers, 
respectively, are extremely relevant for organs on a chip applications. Cell 
differentiation was achieved by combining ad hoc hPSCs differentiation stages, 
germ layer commitment and mature differentiation with proper frequencies of 
periodic perfusion and chemical regulation of soluble microenvironment. Detailed 
cardiac and hepatic cell differentiation protocols are reported in Appendix C. 
 
3.3.1   Cardiac tissue derivation 
Cardiac cells on a chip were derived through a frequency-dependent multi-stage 
differentiation protocol, consisting in mesoderm induction, through Wnt up-
regulation, early cardiac commitment, through Wnt inhibition, and functional 
cardiac maturation, through the supply of pro-cardiac factors as shown in Fig. 4.5.  
 
Figure 3.5 Frequency-dependent cardiac differentiation on a chip from hPSCs, with corresponding 
cell morphology changes. Scale bars 200 µm. 
 
Beating cells were obtained in 10-15 days from both hESCs and hiPSCs. 60% of 
total cells resulted positive for cardiac troponin-T staining, showing defined 
cardiac sarcomeric organization. Moreover, these cells showed spontaneous 
calcium transients and excitation contraction coupling. Analyzing calcium 
handling of hPSC-cardiomyocytes in microchannels, cardiomyocytes functional 
response to 0.5 µM Verapamil with reduced calcium release after L-type channel 
inhibition was observed, and response to 10 mM caffeine with cytosolic calcium 
increase after ryanodine channel activation (Appendix C). 
 
3.3.2   Hepatic tissue derivation 
The same multi-stage methodology was applied to derive hepatocytes on a chip, 
consistently with previously endoderm-optimized conditions. Hepatic cells were 
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obtained from both hESCs and hiPSCs by early endoderm commitment, definitive 
endoderm specification and hepatocyte-like cell maturation steps, driven by 
specific periodic medium delivery as shown in Fig. 3.6.  
 
Figure 3.6 Frequency-dependent hepatic differentiation on a chip from hPSCs, with corresponding 
cell morphology changes. Red arrows indicate binucleate cells, typical of hepatic tissue, in the last 
stage.  Scale bars 200 µm. 
 
Characteristic polygonal-shaped hepatocyte-like cells were obtained, with 
presence of bi-nucleate cells at the late stage, showing high expression of the 
specific hepatic markers albumin and cytochrome P450-3A. Moreover, 
quantitative immunofluorescence analysis (count of number of positive cells) of 
late stage marker albumin and CYP-3A in hESCs-derived hepatocytes shows 
higher expression in microfluidic differentiated cells compared to differentiation 
control on Petri dish. The hepatic cells also show metabolic activity by high 
glycogen storage capacity (75% of total cells) and indocyanine green uptake and 
clearance, is extremely relevant for hepatic drug metabolism studies. As expected 
from prior results, compared to static conditions, we obtained a shortening of the 
time required for differentiation (from 16d to 14d) and 40% greater albumin 
secretion rate on the last day of maturation. All results of functional 
differentiation are reported in Appendix C. 
The microfluidic environment together with optimized periodic perfusion 
frequency provides an effective methodology for generating hepatic-like tissues 
on a chip with remarkable functional differentiation also compared to 
conventional cell culture methods.  
These results confirm that it is possible to generate functional cardiac cells on a 
chip and to directly perform dynamic biochemical stimulations taking advantage 
of the microfluidic environment, which allows robust, accurate, fast, and cost-
effective spatial-temporal control of cell microenvironment1. 
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Chapter 4 
Development of disease on a chip assays 
 
 
Mimicking physio-pathologic stimuli that cells experience in vivo allows 
achieving better insights into disease pathogenesis and for testing potential 
therapies. 
In this perspective, two case studies were analyzed. The first one concerns the 
investigation of hypoxia-induced effects on calcium-handling machinery in 
cardiac tissue, whereas the second one is about the role of cyclic mechanical 
stretch on cellular membrane integrity in a Duchenne Muscular Dystrophy in vitro 
model. To this purpose, microfluidic oxygen exchanger and cell strecthing device 
describd in Chapter 2 were employed. 
 
4.1   Calcium dynamics alteration in cardiomyocytes during acute 
hypoxia transient  
Cardiac ischemia occurs when blood supply to part of the organ is suddenly 
reduced or completely interrupted for a discrete amount of time. Ischemic tissues 
undergo rapid changes in cellular environment, such as reduced nutrient supply, 
accumulation of metabolic wastes, drop in oxygen concentration and increase in 
carbon dioxide concentration. In a highly energy demanding tissue, like the 
myocardium, hypoxic conditions that are generated when oxygen demand exceeds 
oxygen supply are reached in very short time1 and lead to irregular ion fluxes with 
generation of arrhythmias2. In particular, hypoxia-induced effects on calcium 
handling and L-type Ca2+ channels activity have been found to occur in these 
conditions. 
The study of early hypoxia-induced effects on cardiac tissue in vitro needs a 
tightly controlled system able to suddenly (within few minutes) reduce oxygen 
partial pressure in the culture medium.  
 
4.1.1   Experimental set-up 
Investigation on calcium transients during hypoxia requires a fine-tuning of 
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oxygen partial pressure in the cell culture medium. To this purpose, a microfluidic 
cell culture system, with integrated cardiac cells, was coupled with the multilayer 
microfluidic gas-exchanger described in §2.3, in order to ensure a fast and 
accurate oxygen concentration control inside the culture chamber and provide a 
precise and repeatable hypoxic stimulus to the cell culture.  
An enriched population of rat cardiomyocytes, constantly stimulated with 
electrical stimuli at 0.7 Hz and 20 V cm-1, to have the same beating rate in all 
cells, was employed in order to test the sensitivity of the assay (Appendix A). 
Hypoxic stimuli on cells have been generated by setting only the oxygen partial 
pressure in the gas phase without perturbing flowing medium. Cellular calcium 
dynamics were analyzed directly on line by a fluorescence confocal microscope. 
An external system for control and data acquisition allowed precisely controlling 
gas phase partial pressures and flow rates, while an uniform medium flow rate 
was maintained during all the experiments (Fig. 4.1).  
 
 
Figure 4.1 Schematic view of experimental set-up. Fast and accurate control of oxygen partial 
pressure inside a microfluidic cell culture chamber is performed by the multilayer microfluidic 
gas-exchanger. Hypoxic stimuli on a cardiomyocytes population are generated by setting gas 
oxygen partial pressure and cells’ calcium dynamics are analyzed in line by a confocal 
microscopy. An external system for control and data acquisition ensures tight regulation of gas 
phase partial pressure and flow rate, whereas a stable medium flow rate is maintained during 
experiments. 
 
The same system could be used with hPSC-derived cardiomyocytes directly 
degenerated inside the microfluidic chip as reported in Chapter 3.  
 
4.1.2   Calcium dynamics analysis in hypoxia 
Experimental set-up, as previously described, allows accurate oxygen partial 
pressure control, while avoiding any perturbations of liquid media. These 
technical improvements make possible to perform long-term confocal acquisitions 
of calcium transients on the same region of interest, using the same cell as its own 
control, continuously acquiring biological data prior and during the hypoxic 
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stimulation. 
In order to rationally study the hypoxia-induced effects on calcium handling 
during excitation-contraction coupling it is important to investigate the duration of 
hypoxic stimulation that could exert a cell physiological response. In this 
perspective, Fig. 4.2a shows a sequence of calcium dynamics recorded in response 
to a fast drop of oxygen partial pressure in the medium, , as a function of time.  
 
Figure 4.2 Hypoxia-induced effects on calcium transients. (a) Calcium transients sequence at 
different time points after hypoxic stimulus to the cell culture. (b) Comparison of single 
normalized calcium transients at different time points after hypoxic stimulus.  
 
A comparison of normalized calcium transient peaks at different time points (Fig. 
4.2b) shows a significant alteration of the fluorescence intensity peak maximum 
after 5 min from hypoxic stimulus. Therefor, all other experiments were 
performed considering this time frame as a minimal value to elicit a hypoxia-
induced physiological response. 
Another question to be addressed is the determination of the hypoxic level at 
which hypoxia-induced effects on calcium handling can be recorded. A multiple 
step experiment was designed by setting GOp 2  at 5 different values from 21% to 0% 
with 5% interval and the resulting LOp 2  step profile is shown in Fig. 4.3a.  
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Figure 4.3 Oxygen level threshold. (A) LOp 2 profile for five different 
G
Op 2  with L =100 µl min
-1. 
Insert shows equilibrium and operating curve obtained by calibration. (B) Calcium transients 
sequence at different LOp 2 measured 7 minutes after
G
Op 2  set-point change. Blue arrows show 
correspondence between GOp 2  set-point and calcium transient sequence (Fig. 5A). (C) Comparison 
of single normalized calcium transients at different oxygen partial pressure. (D) Averaged values 
of normalized calcium transients peak height at different oxygen partial pressure. The histogram is 
based on 5 replicates of same conditions.      
 
Fig. 4.3b shows the corresponding sequence of calcium transients acquired for 6 s 
at different LOp 2  levels measured 7 minutes after the 
G
Op 2  set-point change. The 
fluorescence baseline maintained the same intensity for all the duration of the 
experiment and the effect of hypoxic stimulation emerged with a decrease of the 
maximum of the normalized calcium transient peak (Fig. 4.3b). The analyzed cells 
did not display calcium cycling alterations for GOp 2  > 5% (n=5). At 5% a poor 
significant difference (P<0.05, n=5) decrease was observed, whereas at GOp 2= 0% 
the alteration of calcium transient was observed with higher statistical relevance 
(P<0.01, n=5) (Fig. 4.3c). These data show that the observed effect reveals itself 
only in highly hypoxic nearly anoxic conditions, remaining latent at higher 
oxygen concentrations. 
To test if hypoxia-induced Ca2+ fluxes changes are reversible and, concurrently, 
exclude artifact deriving form long term confocal acquisition such as dye photo-
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bleaching, the cardiomyocyte culture was subjected to a fast drop of LOp 2  and 
maintained in hypoxic conditions for 10 min followed by 10 min of reperfusion 
with normoxic medium. Whole-cell calcium dynamics were acquired every 10 
min and results are reported in Fig. 4.4a.  
 
Figure 4.4 Reversible effect of hypoxia on calcium cycling. (a) Calcium transients sequence 
measured in normoxic, hypoxic ( GOp 2 = 0%) and normoxic conditions. (b) Comparison of single 
normalized calcium transients in normoxic, hypoxic ( GOp 2 = 0%) and normoxic condition. (c) 
Averaged values of normalized calcium transients peak height in normoxic, hypoxic ( GOp 2 = 0%) 
and normoxic condition. The histogram is based on 5 replicates of same conditions.  
 
In response to hypoxic stress a decrease of the maximum calcium transient peak 
was observed (Fig. 4.4b), with no alteration of the fluorescence baseline (n=8). 
After recovering normoxic conditions, cardiomyocytes displayed again the same 
fluorescence intensity, indicating a recovery of calcium cycling towards basal 
conditions. By analyzing the variation of fluo-4 fluorescence after 10 minutes of 
hypoxia and subsequent 10 minutes of reperfusion by means of percentage 
decrease against normoxic fluorescence intensity, a statistically relevant decrease 
(~15%, P<0.01) emerged (Fig. 4.4c). The recovery of normal calcium transients 
after re-establishment of normoxic conditions highlights the reversibility of the 
biological effect and excludes the responsibility of dye photo-bleaching from the 
observed decrease of fluorescence. 
All together, these results show that there is a significant reversible alteration of 
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calcium homeostasis in excitation-contraction coupling during fast hypoxic 
stimuli. This experimental evidence underlines the ability of the cells to sense 
oxygen level and rapidly adapt to normoxic/hypoxic/normoxic transitions by 
regulating either directly or through secondary pathways the molecular machinery 
involved in cardiac Ca2+ homeostasis3.  
Similar calcium peak reductions were recorded using different concentrations of 
L-type voltage-gated calcium channels (VGCC) activity inhibitors (Nifedipine 
and Verapamil) in normoxic conditions (Appendix A). These findings confirm 
that a hypoxia-induced alteration of primary calcium entry through L-type 
VGCCs could turn in a reduced calcium concentration during excitation-
contraction coupling and consequently, in an alteration of the physiological 
activity of cardiomyocytes, also suggesting that a cardioprotective mechanism 
during early phases of acute ischemia takes place through the reduction of calcium 
homeostasis in excitation-contraction coupling.  
In this context, a fully reversible adaptive mechanism of cardiopreservation might 
take place during the early events of ischemic stress through fast alteration in ion 
channel function in response to changes in cellular oxygen. Rational 
understanding of how the cardiomyocyte adapts to acute ischemic stress and 
sustains its survival represents an important challenge because it might help in 
finding novel strategies to enhance cardiomyocytes survival in patients. 
 
4.2   Role of cyclic mechanical stress in dystrophic myotubes 
membrane integrity 
Duchenne Muscular Dystrophy (DMD) is an inherited genetic disease caused by 
mutations in the gene encoding for protein dystrophin, which plays a structural 
and regulatory role in many tissues, especially in skeletal and cardiac muscle, 
preserving cellular membrane integrity and homeostasis4. Mechanical stress 
seems to deeply affect the pathogenesis of muscle fibers, as resulted in many 
studies on mdx, a DMD mouse model. In this context, the effect of dystrophin 
lack in membrane integrity preservation, after prolonged mechanical stimulation, 
was investigated in a human in vitro model.  
 
4.2.1   Mechanical stress-induced membrane damage 
The integrity of membrane proteins complex, including dystrophin, is crucial for 
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the contracting myofiber to withstand the mechanical stress generated by 
sarcomeres and to prevent contraction-induced sarcolemma injuries5. Muscle 
fibers damage is exacerbated during normal muscle contractions and initiates a 
lethal cascade of events that can cause death of the myofiber6 (necrosis) and 
fibrotic tissue formation7. 
Lack of dystrophin in mdx mouse, a DMD mouse model, has been shown to cause 
aberrant mechano-transduction in skeletal muscle fibers8,9, and mechanical stress 
seems to deeply affect the disease pathogenesis by triggering intracellular calcium 
increase, which finally leads to fibers necrosis10,11. 
Conversely, there is broad evidence that muscle fibers from mdx mouse are 
weaker and more permeable to soluble factors and macromolecules when exposed 
to cycles of mechanical stimulations. Moreover, eccentric contractions allow 
soluble cytosolic proteins such as creatine kinase, to leak out of the plasma 
membrane, whereas extracellular proteins, such as albumin and fibronectin can be 
detected inside the muscle12,13. These experimental evidences on mdx mice prove 
that cyclic mechanical stimulation strongly affects the maturation of dystrophic 
muscle phenotype, suggesting a central role also in humans. However, a human in 
vitro study directed at recapitulating physiological mechanical stress-induced 
effects on dystrophic skeletal muscle has never been reported yet. 
For this reason, a human DMD skeletal muscle in vitro model was developed 
through integration of human myotubes derived from healthy and diseased 
patients within cell stretching device described in §2.4, in order to investigate the 
role of cyclic mechanical stress in affecting membrane integrity. 
Microfluidic cell-stretching devices were opportunely functionalized, in order to 
achieve long-term cell attachment during myoblasts differentiation. Human 
myoblasts derived from biopsies of healthy donors and DMD patients were 
seeded at high density and induced to differentiate into fused myotubes, through 
proper factors supply (Appendix E), the day after (Day 1) for 6 days.  
At Day 6 both healthy and dystrophic myotubes express late myogenic marker 
myosin heavy chain, MHC, with defined sarcomere organization, which 
represents the functional unit for muscle contraction, whereas only healthy 
myotubes show dystrophin expression with clear membrane localization 
(Appendix E). 
A membrane impermeant dye, FM 1-43, was used to analyze large molecules 
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membrane permeability induced by mechanical stresses in both healthy and 
diseased cells during physiologic deformation (10-15%). In order to verify the 
efficacy of the probe in the developed system, healthy myotubes were exposed to 
a mechanical overloaded (about 50% deformation) to induce membrane damage. 
When micro-ruptures in the plasma membrane occur the amphiphilic molecule 
FM 1-43, absorbed within plasma membrane, interact with the inner membrane 
layer entering into the cytosol and fluorescence can be observed as shown in Fig. 
4.5. 
 
 
Figure 4.5 30 minutes of cyclic mechanical overload (1Hz) applied to healthy myotubes induce 
micro-ruptures in plasma membrane allowing up-take and fluorescence of dye FM 1-43 into cell 
cytosol. 
 
The developed assay can be used to induce more physiologic stimulations (15%) 
on both healthy and dystrophic, in order to investigate the role of cyclic 
mechanical stretch in affecting membrane integrity of healthy and diseased cells.  
 
4.2.2   Stretch-induced membrane permeability is higher in dystrophic 
myotubes 
Human myotubes were loaded with 4 µM FM 1-43 dye and cyclically stretched 
with 15% physiological deformation for 45 or 90 min at 0.5 Hz. Immediately after 
stimulation, fluorescence intensity due to dye uptake was detected in stretched and 
un-stimulated myotubes in the same device. Fig. 4.6a shows representative 
pictures of dystrophic myotubes after 45 min stimulation, compared to control un-
stretched conditions, with similar uptake of FM1-43 dye.  
Taking advantage of having an internal un-stretched control, fluorescence 
intensity of stretched and control myotubes was analyzed in the same conditions 
and with the same fluorescence background. Fluorescence intensity in the 
cytosolic regions of myotubes was quantified as described in Appendix E and 
FM 1-43 
Plasma 
membrane 
Fig. 3. Myotubes with membrane impermeant dye. 30 min total stretch time, 10 min pressure 
upgrade interval, 5 min acquisition interval.  
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results were represented as intensity mean distribution of region of interests, ROIs 
(N=100). 
 
Figure 4.6 Stretch-induced membrane permeability analysis in dystrophic myotubes after 45min 
cyclic stimulation. (a) Representative pictures of FM 1-43 dye uptake in dystrophic myotubes after 
45 min cyclic stretch (0.5 Hz, 15% deformation), compared to un-stimulated control myotubes. (b) 
Fluorescence intensity distribution of stretched myotubes is not statistically different from the un-
stretched control. 
 
Quantification of fluorescence intensity confirms a non-significant difference 
between the two distributions (Fig. 4.6b).  
The same experiment was repeated for an higher temporal interval, i.e. 90 min and 
in this case cyclic deformation induces a partial increase of dye uptake in healthy 
myotubes, in comparison to un-stretched myotubes, whereas elevated and 
widespread up-take of FM 1-43 dye in cytosolic regions of stretched dystrophic 
myotubes was observed if compared with un-stretched control (Fig. 4.7a).  
Fig. 4.7b shows a non-significant difference between control and stretched 
myotubes distributions (P-value=0.973) for the healthy control; on the other hand, 
stretched dystrophic myotubes resulted in a significant (P-value=0.029) stretch-
induced dye uptake increase in respect to un-stimulated control, as revealed by 
comparing fluorescence intensity distributions (Fig. 4.7c).  
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Figure 4.7 Stretch-induced membrane permeability analysis in dystrophic compared to healthy 
myotubes after 90 min cyclic stimulation. (a) Representative pictures of FM 1-43 dye uptake in 
healthy and dystrophic myotubes after 90 min cyclic stretch (0.5 Hz, 15% deformation), compared 
to un-stimulated control myotubes. (b) Fluorescence intensity distribution of stretched healthy 
myotubes is not statistically different from the un-stretched control. (c) Fluorescence intensity 
distribution of stretched DMD myotubes result statistically different from the un-stretched control. 
  
These results demonstrate that lack of dystrophin strongly affects membrane 
permeability of human myotubes, when subjected to cycles of mechanical stretch 
that closely mimic physiological deformation of muscle fibers. These results also 
validates the hypothesis proposed by Allen et al., that increased permeability in 
dystrophic muscle fibers is likely due to the slow accumulation (about 1 hour) of 
intracellular calcium, which activates stretch-activated ion channels, rather than to 
the formation of membrane tears as a consequence of stimulation-induced 
membrane injury12.   
The developed assay could be used in order to test potential biological 
mechanisms triggering stress-induced membrane-damage, such as activation of 
components proteasome system (calpains), but it could also be used as platform 
for investigate new therapeutic targets or for drug screening investigations. 
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!
Chapter 5 
MicroRNAs as regulators of hPSCs 
differentiation  !
MicroRNAs are non-coding RNAs regulating gene expression at transcriptional level. 
They have the ability to simultaneously target groups of genes determining cell 
phenotype. They possess recognized roles in development and disease, suggesting 
they can be used to drive hPSCs differentiation toward specific developmental stages. 
 
5.1   MicroRNAs biogenesis and targeting 
MicroRNAs are small non-coding RNAs of 20-22 nucleotides, regulating gene 
expression post-transcriptionally. MiRNAs genes are transcribed by either RNA 
polymerase II or RNA polymerase III into primary miRNA transcripts (pri-miRNA), 
which are next cleaved in the nucleus by Drosha/DGCR8 (DiGeorge Critical Region 
8) proteins complex1. Pri-miRNAs are further transferred from the nucleus through 
protein Exportin-5 and processed into cytosol. Mature miRNAs and Argonaute (Ago) 
proteins form the RNA-induced silencing complex (RISC), a ribonucleoprotein 
complex mediating post-transcriptional gene silencing, which pair to the messages of 
protein-coding genes to direct the post-transcriptional repression of these mRNAs2,3.  
This effect generally occurs through direct base-pairing of the mature miRNA to the 
3’-UTR region of partially complementary messenger RNAs. Interaction of the 
miRNA with target mRNAs typically results in either destabilization or suppressed 
translation.  
Like transcription factors, they have the ability to control expression of multiple 
genes in the same time, as they can match several targets RNAs regulating cell 
phenotype through their repression4. These microRNAs have recognized roles in 
several diseases, such as cancer and neurodegenerative disorders, reprogramming of 
somatic cells to hiPSCs and development.  
Several works demonstrated human pluripotent stem cells express a unique pattern of 
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microRNAs, which seem to regulate hPSCs cell cycle and pluripotency maintenance5. 
MiRNAs are also essential for development, as knockout of the RNA-processing 
ribonuclease protein Dicer1and DGCR8 in mice has been shown to disrupt active 
miRNA biogenesis, which is lethal during embryogenesis5. This unique microRNAs 
pattern expression, characterizing pluripotent state, suggests they also regulate germ 
layer specification and differentiation. Indeed, the switch from pluripotent to lineage-
specified cells is accompanied by the up-regulation of many tissue-specific miRNAs4.  
 
5.2   Role of microRNAs in hPSCs differentiation 
The differentiation process from hPSCs to lineage specific cells is associated to a 
defined temporal pattern of microRNAs expressions, which guide stem cells in cell 
cycle exit, germ-layer commitment and tissue specification. 
In this perspective, these microRNAs can be used to drive hPSCs differentiation 
towards specific germ-layers, thanks to their ability to simultaneously regulate 
expression of groups of genes. They could be particularly advantageous in those 
cases in which hPSCs require an high content of expensive and potentially harmful 
exogenous factors to be pushed towards specific lineages. This is the case of hepatic 
differentiation in which the first stage of endoderm commitment requires an elevated 
concentration of exogenous ActivinA and other factors harmful for cell survival, 
leading to low yield of differentiation cells calculated on the total of starting cells. 
In this context, the following approach was adopted: 
1) The main early endoderm markers and transcription factors where identified 
in the literature; 
2) For each of them all corresponding microRNAs were predicted;  
3) Common microRNA where analyzed; 
Table 5.1 shows a list of genes known to be involved in early endoderm commitment 
of hPSCs6,7,8. For each of them targets microRNAs were predicted through the use of 
software Targetscan and all potential candidates, as predicted from the Software, 
were listed. 
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Table 5.1 Genes associated with endoderm development with the corresponding targeting microRNAs 
predicted by TargetScan software. 40% of these genes share a common microRNA cluster, miR-
141/200a (in bold). 
 
Endoderm 
genes 
Targetscan-predicted associated microRNAs 
CXCR4 miR-9/9ab 
SOX17 miR-141/200a; miR-26ab/1297/4465; miR-194 
MIXL1  - 
CER1 miR-4766-3p 
FOXA2 miR-141/200a 
HNF1B 
miR-217; miR-375; miR-24/24ab/24-3p; miR-25/32/92abc/363/363-
3p/367; miR-200bc/429/548a; miR-194; miR-26ab/1297/4465 
LHX1 
miR-182; miR-141/200a; miR-30abcdef/30abe-5p/384-5p; miR-217; 
miR-26ab/1297/4465; miR-139-5p; miR-182; miR-194; miR-
30abcdef/30abe-5p/384-5p; miR-144; miR-128/128ab; miR-
138/138ab; miR-96/507/1271; miR-218/218a 
EOMES 
miR-182; miR-96/507/1271; miR-135ab/135a-5p; miR-
25/32/92abc/363/363-3p/367; miR-96/507/1271; miR-182; miR-
103a/107/107ab 
GATA6 
miR-124/124ab/506; miR-128/128ab; miR-141/200a; miR-375; miR-
196abc; miR-10abc/10a-5p; miR-7/7ab; miR-181abcd/4262; miR-
25/32/92abc/363/363-3p/367 
LEFTY 
miR-93/93a/105/106a/291a-
3p/294/295/302abcde/372/373/428/519a/520be/520acd-
3p/1378/1420ac 
FOXH1 miR-18ab/4735-3p 
PITX2 miR-140/140-5p/876-3p/1244; miR-21/590-5p; miR-141/200a 
JMJD3  
miR-138/138ab; miR-99ab/100; miR-216a; miR-135ab/135a-5p; miR-
29abcd; miR-101/101ab; miR-148ab-3p/152; miR-17/17-
5p/20ab/20b-5p/93/106ab/427/518a-3p/519d; miR-7/7ab; miR-139-
5p; miR-30abcdef/30abe-5p/384-5p; miR-146ac/146b-5p; miR-144 
 
Surprisingly about 40% of analyzed genes show a common target microRNAs 
cluster, miR-141/200a, which was found to be involved in epithelial to mesenchymal 
transition (EMT) process9. This result was used in order to test if repression of these 
two microRNAs, during endoderm differentiation of human pluripotent stem cells, 
can lead to increased expression of endoderm commitment markers, compared to a 
mock control. 
Human embryonic stem cells were transfected with both miR-141 and miR-200a 
inhibitors through FugeneHD (Promega) to induce their repression and, 24h later, 
they were induced to differentiate into endoderm for 5 days, according to protocol 
reported in Appendix D. Efficiency of infection resulted in 67% of transfected cells 
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as analyzed by flow-cytometry analysis, using a fluorophore-labeled miRNA 
inhibitor control. Transfection was repeated after 3 days from the beginning of the 
differentiation protocol in order to maintain miRNAs repression. At day 5 cells were 
collected for total RNAs extraction and analyzed through qPCR analysis for both 
microRNAs and RNAs expression.  
Fig. 5.1a shows expression of miR-302a, which is known to be expressed in 
embryonic stem cells, miR-141 and miR-200a in undifferentiated cells (D0), 
transfected cells at day 5 of differentiation (D5) and the same cells transfected with a 
mock control (D5 ctrl). D5-cells show a significant reduction of expression of both 
miR-141 and miR-200a, compared to the control, meaning that transfection of 
microRNAs inhibitors worked. 
The same samples were further analyzed for RNAs expression of pluripotent gene 
Nanog, mesoderm marker Brachyury-T and four endoderm transcription factors: 
EOMES, GATA6, FOXA2 and Sox17, as shown in Fig. 5.1b.  A significant reduction 
of expression of all the endoderm genes was observed and, interestingly, three of 
these four genes, i.e. GATA6, FOXA2 and Sox17, were predicted targets of the miR-
141/200a cluster. 
 
  MicroRNAs as regulators of hPSCs differentiation  
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Figure 5.1 (a) QPCR analysis of embryonic stage miR-302a and miR-141/200a cluster in 
undifferentiated hESCs (D0), differentiated cell (D5), transfected with miR141/200a inhibitors and 
mock control (D5 ctrl). MiR-141/200a expression reduction in D5 cells proves efficient tranfection. (b) 
QPCR analysis of pluripotency marker Nanog, mesoderm marker Brachyury-T and four endoderm 
transcription factors: EOMES, GATA6, FOXA2 and Sox17in the same samples. A significant increase 
in endoderm markers expression was observed in transfected cells compared to the mock control and 
undifferentiated cells. (2 biological replicates and 3 technical replicates for each analysis were 
performed). 
 
This result, which certainly requires validation at protein level through western blot 
analysis, validates the hypothesis that microRNAs can effectively be used to drive 
differentiation of pluripotent stem cells. 
 
5.3   Future perspectives 
These preliminary results open new perspectives for future investigations on potential 
role of microRNAs in programming hPSCs toward specific developmental stage or 
reprogramming adult somatic cells to other tissue-specific cells. 
This last purpose requires an accurate temporal pattern of overexpression or 
repression of specific microRNAs to guide cells from one phenotype to another one.  
Microscale system described in Chapter 2 could be an efficient tool to regulate and 
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efficiently deliver genetic material to sustain long-term expression and this 
perspective contributes to the development of human tissues on a chip from 
pluripotent stem cells or directly from adult cells. 
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Conclusions 
 
The main goal of this work concerned the development of functional human tissues 
on a chip from pluripotent stem cells, to be used in developing new in vitro disease 
models or drug screening and toxicity assays, more predictive than poor predictive 
animal models, and overcoming issues related to primary cell sources recruitment. 
Specifically, the focus was pointed on cardiac and hepatic tissues, which are 
recognized as the major targets of drug toxicity. Moreover, no human primary cells 
are easily available for these tissues, due to obvious limitations in ex vivo extraction. 
Human pluripotent stem cells (hPSCs), comprising both embryonic and induced 
pluripotent stem cells, were successfully integrated within automatized microfluidic 
platforms, expanded and induced to differentiate into cardiomyocytes or hepatocytes 
through a multistage protocol, resembling embryonic development. 
The different developmental stages required cell niche specification in terms of 
accurate balance between extrinsic and intrinsic cell signaling, through optimal in 
vitro delivery of exogenous factors and removal of endogenous cell-secreted factors. 
In general, continuous medium perfusion resulted to generate soluble factors spatial 
gradients, lead to heterogeneous cells phenotype along the microfluidic channel. On 
the other hand, a discontinuous periodic medium delivery with stage-dependent 
frequency (number of cycles of medium change per day) was proved to represent an 
effective strategy for modulating delivery of growth factors and viral vectors in vitro. 
Indeed, intermittent perfusion with defined frequency of medium delivery allowed 
optimal control of endogenous/exogenous factors balancing in cell microenvironment 
to sustain pluripotency and self-renewal or to selectively induce germ-layer 
commitment with higher specificity, than in standard static conditions in petri dish. 
Cardiac and hepatic cells, derived respectively through mesoderm and endoderm 
induction, and functional maturation, displayed highly differentiated phenotypes and 
ability to respond to external stimuli.  
These functionally differentiated cells on a chip can be directly used for dynamic 
multi-parametric and large-scale drug screening or for developing micro-engineered 
human organ models.  
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The recent generation of adult somatic cells from human induced pluripotent stem 
cells (hiPSCs) provided a new effective tool to obtain patient-specific stem cells and 
potentially screen genetic diversity among cells patients to identify rare responders, 
analyze drug toxicity, or perform ‘clinical trials on a chip’ using hiPSC-derived 
diseased cells.  
In this new perspective, it would be of paramount importance to generate patient-
specific functional-differentiated tissues on a chip and to develop technology for 
assisting in vitro assays for developing new therapeutic strategies or for screening 
among potential clinical cures. In particular, design of proper functional assays to test 
cellular responses to drugs or external stimuli, such as mechanical stress or hypoxia, 
in a physiologic or pathologic context allow investigations of specific disease targets 
and associated therapeutic treatments. 
In this context, the role of acute hypoxia in calcium handling machinery of a 
cardiomyocytes population was investigated, mimicking early effects of ischemia 
characterized by a sudden and rapid depletion of oxygen content in cardiac 
microenvironment. Technological improvements, compared to already developed 
microscale devices for mimicking oxygen gradient, were performed, which led to the 
design of a microfluidic gas exchanger able to accurately reproduce fast temporal 
gradients of oxygen partial pressure in the culture medium. 
Results showed a significant reversible alteration of calcium homeostasis in 
excitation-contraction coupling occurs during fast hypoxic stimuli. This suggests that 
a fully reversible adaptive mechanism of cardio-preservation might take place during 
the early events of ischemic stress through fast alteration in ion channel function, 
specifically L-type voltage-gated calcium channels, in response to changes in cellular 
oxygen content. Rational understanding of how the cardiomyocyte adapts to acute 
ischemic stress and sustains its survival represents an important challenge because it 
might help in finding novel strategies to enhance cardiomyocytes survival in patients. 
Beside this, the role of cyclic mechanical stress, which plays a crucial role in the 
investigation of new physiological and pathological responses to cell culture 
microenvironment, was analyzed in a muscular dystrophy in vitro model.  
Specifically, in Duchenne Muscular Dystrophy (DMD) is an inherited genetic disease 
caused by mutations in the gene encoding for protein dystrophin, which plays a 
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structural and regulatory role in many tissues preserving cellular membrane integrity 
and homeostasis, mechanical stress seems to deeply affect the pathogenesis of muscle 
fibers, as resulted in many studies on mdx, a DMD mouse model. The effect of 
dystrophin lack in membrane integrity preservation, after prolonged mechanical 
stimulation, was investigated in a human in vitro model through evaluation of the up-
take of a fluorescent membrane impermeable compound. 
Development of a microfluidic-based cell-stretching device allowed subjecting cells 
to defined mechanical deformations in biaxial direction with defined frequency and 
having an internal non-stimulated control. After prolonged cyclic deformations 
dystrophic myotubes derived from dystrophic patients biopsies displayed significant 
membrane permeability increase, compared myotubes from healthy patients, probably 
due to their altered phenotype. 
The combination of tissues development on a chip and micro-technology assisting for 
functional assay on a chip opens new and substantial perespective in generating a 
human in vitro model that properly resemble the physio-pathological behaviour of a 
tissues or organs within humna body. As a near future perspective we envisage the 
use of diseased cells and donor-derived cells as healthy control to generate “Disease 
on a chip” models representative of human patho-physiology in vivo. 
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A.1 Abstract 
Heart diseases are the leading cause of mortality in western countries. Apart from 
congenital and anatomical alterations, ischemia is the most common agent causing 
myocardial damage. During ischemia, a sudden decrease in oxygen concentration 
alters cardiomyocyte function and compromises cell survival. The calcium 
handling machinery, which regulates the main functional features of a 
cardiomyocyte, is heavily compromised during acute hypoxic events. Alterations 
in calcium dynamics have been linked to both short- and long-term consequences 
of ischemia, ranging from arrhythmias to heart failure. In this perspective, we 
aimed at investigating the calcium dynamics in functional cardiomyocytes during 
the early phase of a hypoxic event. For this purpose, we developed a microfluidic 
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system specifically designed for controlling fast oxygen-concentration dynamics 
through a gas micro-exchanger allowing in line analysis of intracellular calcium 
concentration by confocal microscopy. Experimental results show that exposure 
of Fluo-4 loaded neonatal rat cardiomyocytes to hypoxic conditions induced 
changes in intracellular Ca2+ transients. Such behavior was reversible and was 
detected for hypoxic levels below 5% of oxygen partial pressure. The observed 
changes in Ca2+ dynamics were mimicked using specific L-type Ca2+ channel 
antagonist, suggesting that alterations in calcium channel function occur at low 
oxygen levels. Reversible alteration in ion channel function, that takes place in 
response to changes in cellular oxygen, might represent an adaptive mechanism of 
cardiopreservation during ischemia. 
 
A.2   Insight, innovation, integration 
Recreating in vitro a low oxygen environment is fundamental for a better 
understanding of the cellular consequences of hypoxia and to screen novel 
therapeutic strategies targeting common ischemic diseases, e.g. coronary heart 
disease. Here, we present a microfluidic platform specifically developed to expose 
cultured cardiomyocytes to acute hypoxic stimuli, allowing robust and high 
quality live confocal imaging. 
Thanks to this novel technology, we were able to observe rapid and reversible 
changes in the electrically-induced cardiomyocyte calcium transients following 
the acute decrease of oxygen partial pressure in the cell environment. Similar 
changes in calcium dynamics were observed upon pharmacological inhibition of 
L-type Ca2+ channels, suggesting a possible target of hypoxia in cardiac cells. 
 
A.3   Introduction 
Cardiovascular diseases are the leading cause of mortality and morbidity in the 
Western countries. Heart diseases due to coronary dysfunction alone were 
responsible for nearly 22% of all deaths in Europe in 2008.1 Cardiac ischemia 
occurs when blood supply to part of the organ is suddenly reduced or completely 
interrupted for a discrete amount of time. Ischemic tissues undergo rapid changes 
in cellular environment such as reduced nutrient supply, accumulation of 
metabolic wastes, drop in oxygen concentration and increase in carbon dioxide 
concentration. In a highly energy demanding tissue, like the myocardium, hypoxic 
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conditions that are generated when oxygen demand exceeds oxygen supply are 
reached in very short time.2 
The time scale of the changes in oxygen concentration has a great importance for 
cell physiology, viability and adaptation to stress conditions. In particular, the 
cellular response to hypoxia depends on its onset kinetics and duration: (i) rapid 
acute hypoxia (seconds or minutes) leads to alterations of the preexisting protein 
pool through post-translational modifications and protein interactions; (ii) 
sustained chronic hypoxia (hours or days) results in whole proteome changes 
through activation of different gene expression patterns.3 
In order to recreate in vitro ischemia pathological models, accurate gas 
concentration dynamics are one of the most difficult parameters to control; for 
instance, in hypoxia studies, gas leakage through liquid-air interface or gas 
permeable materials is extremely difficult to detect and may lead to low 
experimental reproducibility. Studies on chronic hypoxia (lasting hours or days) 
can be easily performed by culturing the cells in airtight chambers in which the 
oxygen concentration control is exerted by tuning the gaseous partial pressure 
inside the chamber. In this steady state experiments, the cell response at desired 
time points is commonly independent from the oxygen dynamics at the initial 
experiment set up.4 On the other hand, observing cellular responses to fast 
hypoxic transients, simulating the early phase of acute ischemic events, is 
essential in understanding how cell biology and physiology are affected by sudden 
changes in oxygen concentrations. However, investigating the immediate effects 
of a rapid drop in oxygen partial pressure requires tight control on the cellular 
environment, a condition hard to achieve with standard culture methods. As such, 
current technological limitations have hindered cellular experiments on hypoxia. 
In this perspective, we aimed to develop a novel tool for in vitro investigation of 
the acute cellular response of cultured cardiomyocytes to fast changes in the 
environmental conditions, including components of the culture medium, drugs 
and oxygen concentration. In this work, we used such approach to investigate the 
effect of acute hypoxic events on Ca2+ homeostasis, through in line confocal 
image acquisition.  
Cardiomyocyte function relays upon proper ion handling during contraction 
cycles, involving both ion channels regulating membrane potential and 
intracellular calcium release. Hypoxia has been proven to modify the activity of 
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most of the molecular components concerned in these features, resulting in 
unbalanced ion fluxes and generation of arrhythmias.5 Rat ventricular 
cardiomyocytes in low pO2 conditions displayed an increase of the late Na+ current 
(INa-L) while the fast Na+ (INa) current appeared reduced.6,7 Effects on potassium 
channels were also described in guinea-pig cardiomyocytes as a decrease in the 
slow component of the delayed rectifier K+ channel (IKs) current, without affection 
of the rapid component (IKr).8 Ca2+ handling, essential in both action potential 
generation and contraction triggering, seems to be influenced by hypoxia as well. 
In particular, the activity of the L-type Ca2+ channel is altered with a decrease of 
basal current (ICa-L) and unchanged current–voltage (I-V) relationship.9,10 
Sensitivity of the channel to β-adrenergic stimulation appears to be increased 
resulting in a pro-arrhythmic substrate during ischemic events.11 The precise 
mechanism through which hypoxia modifies the function of the L-type Ca2+ 
channel is still unclear. Both direct modifications in the C-terminal region of the 
channel12,13 and indirect modulation of its function through mechanisms involving 
mitochondrial ROS formation14 or protein kinases A and C15 have been proposed. 
All these studies clearly show that rapid changes in oxygen concentration affect 
ion handling in cardiac myocytes, but so far no hypoxia-induced effects on 
calcium handling during excitation-contraction coupling were reported, although 
many components of this machinery appear to be altered in ischemia-mimetic 
conditions.16,17 
In this work, we aimed at analyzing calcium dynamics in Fluo-4-loaded functional 
rat cardiomyocytes in response to brief and sudden transients of hypoxia. In 
particular, we focused on the early response to hypoxia induction and re-
oxygenation, by monitoring electrically stimulated Ca2+ changes.  
For this reason, we designed and developed a device enabling confocal 
microscopy analysis while finely tuning the oxygen concentration in the culture 
medium and maintaining proximal cell environment isolated from atmospheric 
conditions. In addition, the device allows exposure of the cells to fast transient 
changes in the environment without perturbing the data acquisition process. 
Particular care has been placed to avoid, manipulation of the liquid phase that 
could generate pressure waves in the cell culture chamber and cause loss of focal 
plane leading to artifactual changes in fluorescence signals.  
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As mentioned above, conventional humidified chambers or incubators with a 
controlled pO2 in the gas phase show equilibration time of the order of hours,19 due 
to the great volumes involved and the low oxygen diffusion coefficient in the 
culture medium (2.1 × 10-5 cm2 s-1).18 Such characteristic time can only be slightly 
decreased using particular expedients like gas-permeable membrane-based 
dishes20 or by forcing gas exchange through bubbling of gas mixtures in 
chemostats or flasks.  
In this perspective, technology developed at the microscale level can be an 
effective practical solution for obtaining a system able to accurately control 
oxygen partial pressure for two main reasons: 
   (i) at microscale liquid flow regime is typically laminar, allowing to accurately 
control the delivery of nutrients, soluble species and gas in the culture medium;21-
23  
   (ii) the time scale of diffusive mass transport phenomena are related to the 
characteristic length of the system and scaling down the system highly accelerates 
the gas exchange dynamics. 
For this reason, many microfluidic bioreactors were developed to provide solely 
moderate to long-term control of the cellular environment, including dissolved gas 
concentrations.24-27 Some miniaturized devices include gas-microexchangers that 
generate spatial gradients of oxygen partial pressure by on-chip gas mixing and 
allow to study the influence of the oxygen concentration on the cell growth.28-30 
However, only few microfluidic devices for rapid generation of hypoxic 
conditions in cell culture were designed, due to the difficulty in obtaining fast 
oxygen concentration transients from a saturated level to a very low partial 
pressure, without perturbing the cell culture environment and the data acquisition 
system. For instance, Oppergard et al. have developed a microfabricated insert 
that nests into a standard multiwell plate and serves as a passive microfluidic gas 
network with a permeable membrane aimed to modulate oxygen delivery to 
adherent cell with an equilibration time on the order of few minutes,31 however no 
in-line analysis can be made with such device. Other groups have developed an ad 
hoc system to rapidly set the oxygen partial pressure in the cell culture and study 
particular cellular responses under hypoxic conditions.32,33 
The complexity of the devices previously described induces to find out a 
structurally simpler microfluidic platform able to perform and control fast oxygen 
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concentration dynamics and that could be coupled with any other miniaturized 
bioreactor or culture chamber. Unlike other works, we are aimed to engineer a 
new oxygen micro-exchanger to carry out on line analysis on the cell culture, for 
example using confocal microscopy, during an oxygen shift in the culture 
medium, and acquire particular cellular responses without any perturbation of the 
detection system. 
 
A.4   Experimental methods 
A.4.1   Experimental set up 
Our investigation on calcium transient requires a fine tuning of oxygen partial 
pressure inside a microfluidic cell culture chamber by a multilayer microfluidic 
gas-exchanger. The device has to ensure a fast and accurate oxygen concentration 
control inside the culture chamber in order to provide a precise and repeatable 
hypoxic stimulus to the cell culture. Hypoxic stimuli on a cardiomyocyte 
population are generated by setting only the oxygen partial pressure in the gas 
phase without perturbing flowing medium. Cellular calcium dynamics were 
analyzed directly on line by a fluorescence confocal microscope. An external 
system for control and data acquisition allowed to precisely set gas phase partial 
pressures and flow rates, while an uniform medium flow rate was maintained 
during all the experiments (Fig.1).  
 
 
Figure 1. Schematic view of experimental set up. Fast and accurate control of oxygen partial 
pressure inside a microfluidic cell culture chamber is performed by a multilayer microfluidic gas-
exchanger. Hypoxic stimuli on a cardiomyocytes population are generated by setting gas oxygen 
partial pressure and cells’ calcium dynamics are analyzed in line by a confocal microscopy. An 
external system for control and data acquisition ensures fine tuning of gas phase partial pressure 
and flow rate, whereas a stable medium flow rate is maintained during experiments. 
 
A.4.2   Microfluidic gas exchanger fabrication 
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Fig. 2A shows a schematic view of the multilayer microfluidic gas exchanger. The 
oxygen exchange process between the gas and liquid compartments takes place 
through a thin, non-porous, permeable membrane. Microfluidic gas exchanger 
consists in a three-layer structure: a fluidic layer containing cell culture medium, a 
gas chamber for gas flow with defined oxygen partial pressure and an oxygen 
permeable membrane. The fluidic layer is formed by a network of microfluidic 
channels in an oxygen non-permeable glass substrate to achieve complete gas 
sealing. The micrometric thickness of the gas permeable membrane ensures low 
oxygen diffusion resistance. The gas domain is a milliliter rectangular chamber 
that allows high gas flow rate and, consequently, almost uniform oxygen partial 
pressure within the gas chamber. 
 
!
Figure 2. Microfluidic gas exchanger. (A) Schematic representation of the three-layered 
microfluidic system; inlet/outlet flow rates and oxygen partial pressure are shown for both gas, G, 
and liquid, L, phase. (B) Top view of the fluidic layer channel network (all dimensional values are 
in µm). (C) Image of glass-etched microfluidic channels network obtained by wet-etching 
technique and observed under inverted optical microscope. (D) Schematic view of the three 
different layer of the gas exchanger. Red and blue arrows show gas and liquid phase inlet and 
outlet inside the platform. (E) Image of the gas-exchanger with inlet/outlet connections for liquid 
and gas phase perfusion. The microfluidic channels are perfused with 1 mM fluorescein solution. 
 
In the fluidic layer, the flow channels network is characterized by a series of gas 
exchanger unit and each unit is formed by 8 parallel microchannels 100 µm wide 
(Fig. 2B). This modular design allows to add series of units, up to obtain the total 
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length required for a given exchange efficiency. The imprinting of microchannels 
in the glass slide was achieved by wet-etching technique. A borosilicate glass 
slide 50 × 75 mm was cleaned using MICRO90 Cleaning Solution (Sigma-
Aldrich, USA), placed in an oven for 1 h at 403 K, cooled at 303 K and silanized 
with hexamethyldisilazane, HDMS, (Sigma-Aldrich, USA) for 3 minutes at 403 
K. The glass slide was spin-coated with 5 g of SPR220-7.0 positive photoresist 
(Rohm&Haas, Dow, USA), to obtain an homogeneous film with a thickness of 15 
µm and subsequently photolithografically patterned using standard procedures.34 
The glass slide was immersed in an aqueous 40% fluoridric acid solution (HF, 
Sigma-Aldrich, USA) at 298 K and only exposed areas were etched. After 
patterning, the slide was washed with distilled water, deep into an aqueous 98% 
sulfuric acid solution (H2SO4, Sigma-Aldrich, USA) to remove etching-reaction 
byproducts and rinsed with distilled water. The protective photoresist layer was 
removed with 1-methyl-2-pyrrolidone (Sigma-Aldrich, USA) and the patterned 
glass slide was cleaned in piranha solution (H2SO4:H2O2, 3:1). Fig. 2C shows an 
image of the etched microchannels on glass under an inverted microscope (Leica, 
Germany).  
Channels section shape and depth were analyzed with a profilometer (Alpha Step 
IQ surface profiler, KLA Tencor, USA). Rounded cross-section shape was 
observed, while channels depth resulted etching-time dependent; depths of 40, 70 
and 100 µm were obtained with an immersion time in HF solution of 2.5, 5 and 
7.5 min, respectively. 
A thin polydimethylsiloxane, PDMS, permeable membrane with defined and 
homogenous thickness was obtained by spinning the unpolimerized solution on a 
silicon wafer. A premixed 10:1 ratio of PDMS prepolymer and curing agent 
(Sylgard 184 kit, Dow Corning, USA) was spin-coated on a previously silanized 5 
in Si wafer at 1400 rpm for 1 min to obtain a thickness of 40 ± 5 µm and cured on 
a hotplate at 353 K for 1 h.  
The gas layer consists in a 5 cm3 PDMS chamber in which gas phase flows at 
defined flow rate and pO2. Residence time is only of few seconds to maintain an 
uniform oxygen partial pressure during steady-state experiments. 
PDMS layers were punched with a 22G stainless steel needle (Small Parts Inc, 
USA) to obtain gas and liquid inlet/outlet holes. A 50 × 75 mm glass cover slide, 
gas chamber, PDMS membrane and fluidic layer were assembled and sealed by 
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plasma bonding (Plasma Cleaner, Harrick Plasma, USA). All fluidic connections 
to the microfluidic device were made using PTFE microtubing (Cole Parmer, 
USA). Fig. 2D shows a schematic view of the assembled layers. The red arrows 
indicate gas inlet/outlet, whereas blue lines show the liquid track inside the 
platform.  
Different liquid flow rates through the fluidic microchannels were obtained by a 
syringe pump (Harvard Pump, Harvard Apparatus, USA). A constant gas flow 
rate and oxygen composition were maintained in the gas chamber using air and 
nitrogen mass flow meters (Bronkhorst, The Netherlands), controlled through 
software FlowDDE32.  
 
A.4.3   Oxygen measurement 
A 100 µM solution of tris(4,7-diphenyl-1,10-phenanthroline)-ruthenium(II)-
dichloride, Ru(ddp), (Sigma-Aldrich, USA) in a 30% ethanol in PBS 1X 
(Invitrogen, USA) solution was used to measure oxygen partial pressure inside the 
microfluidic channels. Fluorescence of Ru(ddp) was detected by an inverted 
fluorescence microscope LeicaDMI6000B equipped with a mercury short-arc 
reflector lamp (Leica, Germany) excited at BP 450-490 nm and acquired at LP 
590 (Fig. 2E). 
Oxygen partial pressure was also continuously monitored with a fiber optic 
oxygen sensor (OceanOptics, USA) at the microchannel outlet. Fluorescence 
intensity is linearly correlated to the oxygen partial pressure in the sample. Both 
sensors are based on fluorescence quenching that increases with the oxygen 
partial pressure. The degree of quenching can be correlated to the oxygen partial 
pressure of the sample by Stern-Volmer equation:  
2
10 OkpI
I
+=
                                                                                                          (1)  
where I0 is the fluorescence intensity at zero partial pressure of oxygen, I is the 
fluorescence intensity at a particular 
2O
p  and k is the Stern-Volmer constant which 
depends on the chemical composition of the sensor and on the temperature. 
Calibration of the sensor at 298 K was achieved using five liquid standards, 
obtained by bubbling a gas mixture with a partial pressure of 0%, 5%, 10%, 15% 
and 21%. Complete oxygen removal was achieved with 8 hours of humidified 
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argon bubbling (Rivoira, Italy). Stern-Volmer constant value was obtained by 
correlating experimental data. 
 
A.4.4   Microfluidic cell culture chamber  
Microfluidic cell culture chamber was made by standard soft-litography 
technique.34 Briefly, design shown in Fig. 3A was produced by CAD program and 
patterned in a silicon substrate using negative photoresist SU8-2100 (Microchem, 
Germany). After silanization with HDMS under vacuum for 1 h, 10:1 ratio of 
PDMS prepolymer and curing agent was casted and cured for 2 h at 343 K in an 
oven. Through a 27 mm punch, PDMS mold was extracted. In order to ensure an 
electrical stimulation to the cell culture, a platinum wire was inserted in the 
PDMS mold and wired to an electrical stimulator. The glass slide hosting the cell 
culture was located in a standard microscopy aluminum holder (20 mm diameter 
hole), covered by the PDMS mold and pressure sealed by a teflon cover (Fig. 3B).  
 
!
Figure 3. Cell culture chamber and calcium dynamic acquisition. (A) Microfluidic cell culture 
chamber top view. The chamber is characterized by 1 inlet and 2 outlets and by 2 platinum wires 
placed in the lateral walls to electrically stimulate cells. (B) Assembly of the microfluidic chamber 
within microscope holder to perform on line detection. (C) Confocal image and calcium dynamic 
of a cardiomyocyte under electrical stimulation. Line scan (yellow line) is placed between nucleus 
and sarcolemma of the cell and calcium transient are continuously detected as a function of time.     
!
The perfusion culture chamber was connected to the  microfluidic exchanger 
through silica tubings in order to avoid external oxygen infiltrations. All the 
experiments were performed with a 100 µl min-1 flow rate using syringe pumps 
(Harvard Pump, Harvard Apparatus, USA) allowing fast exchange of medium 
without any apparent change in cellular calcium dynamics. 
 
!
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A.4.5   Cardiomyocytes isolation and culture 
Neonatal rat cardiomyocytes were obtained from Sprague-Dawley pups 1-3 days 
old. The cells were plated on 20 µg/ml laminin-coated (BD Bioscience, USA) 
glass coverslips in Day1 medium: 25 mM Hepes Dulbecco’s Modified Eagle’s 
Medium (Gibco, USA), 17% Medium M199 (Gibco, USA) 10% Horse Serum 
(Gibco, USA), 5% Newborn Calf Serum (Gibco, USA), 2 mM L-Glutammine 
(Gibco, USA), Penicillin-Streptomycin (EuroClone, Italy). After 24 hours, the 
Day1 medium was replaced with Day2 medium: Day1 medium with 5% Horse 
Serum and 0.5% Newborn Calf Serum. Experiments were performed 4 days after 
plating. The animals were housed and operated at the Animal Colony of the 
Venetian Institute of Molecular Institute. All experiments with animals were 
approved by Padova University’s Institutional Animal Care Committee (Comitato 
Etico di Ateneo per la Sperimentazione Animale). 
 
A.4.6   Calcium dynamic acquisition and analysis  
Confocal Calcium measurements were performed as reported in Fig. 3C. 
Cardiomyocytes were loaded in serum-free D-MEM (Gibco, USA) supplemented 
with 3 µM fluorescent calcium dye fluo-4 AM (Invitrogen, USA) for 20 minutes 
at 310 K in presence of 2 µM Pluronic F-127 (Invitrogen, USA) and 20 µM 
sulfinpyrazone (Sigma-Aldrich, USA), then incubated for additional 10 minutes at 
310 K in Fluo-4-free D-MEM to allow complete de-esterification of the dye, and 
added with 0.2 µM di-8-ANEPPS (Invitrogen, USA). After loading, the coverslips 
were transferred to the microfluidic chamber and perfused with recording 
solution: NaCl 125 mM, KCl 5 mM, Na3PO4 1 mM, MgSO4 1 mM, Hepes 20 
mM, CaCl2 2 mM, Glucose 5.5 mM, to pH 7.4 with NaOH. Line scan was 
acquired with Leica TCS SP5 confocal microscope equipped with a 63×, 1.4 NA 
oil immersion objective, with 488 nm Ar laser line as excitation source, 700 Hz 
acquisition frequency. To reduce dye photo-bleaching and photo-toxic effects on 
the analyzed cells, the laser power was set at minimum possible. During all the 
experiments, the culture was constantly filed-stimulated with electrical pulses at 
0.7 Hz, 20 V cm-1, to overcome spontaneous beating activity allowing acquisition 
at the same beating rate in all cells. Nifedipine and Verapamil (Sigma-Aldrich, 
USA) were dissolved in DMSO (Sigma-Aldrich, USA) or deionized H2O, 
respectively, at a 10 mM starting concentration and diluted to the desired 
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concentration in recording solution immediately prior to the experiments. All data 
analysis were performed with ImageJ and Origin7 software. 
Data are presented as means of percentage decrease normalized on the reference 
conditions ± standard error of mean (SEM). The effects of different oxygen 
concentrations on calcium transients were compared by a one way ANOVA 
followed by Bonferroni's mean comparison. We considered P < 0.01 to be 
statistically significant.  
 
A.4.7   Mathematical modeling 
The oxygen concentration profile, and consequently the oxygen partial pressure, 
within the liquid phase domain of the microfluidic gas exchanger was described 
by simplified analytical model and by computational solution of the species mass 
balance. The simplified model was validated with computational analysis and 
used for a proper gas exchanger design. 
Mass transfer was assumed to be governed by convective transport in the gas 
phase, diffusive resistance in the permeable membrane and convective-diffuse 
regime in the liquid phase. The concentration in the gas phase was assumed 
constant along spatial coordinates because, according to the high gas flow rate, the 
permanence time in the gas chamber is much smaller than the characteristic time 
of the membrane oxygen exchange process. 
On the other hand, the oxygen concentration in the liquid phase changes from the 
inlet (x = 0) to the outlet (x = CL) of the microfluidic gas exchanger. For this 
reason, in order to describe oxygen concentration profile along y-coordinate 
(height of the microfluidic channel), both hydrodynamic and mass transport 
models should be solved simultaneously. Due to the low Reynolds numbers 
(1÷10) an analytical solution of fully developed hydrodynamic profile between 
flat planes was assumed.35 Considering that Péclet number (convection/diffusion 
ratio) is much greater than 1 for all experimental conditions tested in this work, 
we assumed that diffusive flux is relevant only in the y-direction, whereas 
convective flux occurs in the x-direction. Moreover, we define hL as the 
equivalent channel height, which is obtained as the area of the cross-section 
divided by the width of the channel. 
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Under these assumptions and considering all mass transfer resistances localized at 
the interfaces, the steady-state mass balance equation in the liquid domain takes 
the following form: 
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where LOp 2   is the oxygen partial pressure of the liquid phase, u is the axial 
velocity, H is the Henry’s constant of oxygen solubility in water at experimental 
temperature condition, ( )LyO hyxN =,,2  is the total oxygen flux at liquid-
membrane interface along x-coordinate and INLOp
,
2
 is the boundary condition at 
channel inlet. The total oxygen flux at liquid-membrane interface, ( )LyO hyxN =,,2 , 
can be expressed as the product of the overall mass transfer resistance and the 
total driving force:  
( ) ( ) apxpKhyxN GOLOGLyO )(, 222 , −>=<= !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(3) 
G
Op 2  is the constant oxygen partial pressure in gas phase, a is specific surface, 
which corresponds to the inverse of the equivalent channel height hL, whereas 
>< GK  is the averaged overall mass transfer coefficient. The analytical 
expression of >< GK  is derived by equating oxygen fluxes for the three different 
domains and its general form can be expressed as follows: 
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kG and kL are the mass transfer coefficients in the gas and liquid phase 
respectively, p the oxygen permeability in PDMS and s the membrane thickness. 
Integration of equation (2) from the inlet to the outlet of the channel leads to the 
following relation: 
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Equation (5) relates the oxygen partial pressure in the microchannel to the length 
and geometry of the channel, operative conditions and mass transfer properties. 
This relation is used to calculate the minimal channel length necessary to ensure a 
defined oxygen concentration at the outlet of the system.  
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The solution of equation (5) requires a proper estimation of the mean overall mass 
transfer coefficient by equation (4). Due to the high oxygen diffusivity in the gas 
phase compared to those in the liquid and solid phase, the first resistance term in 
equation (4) results negligible.  
The mass transfer coefficient in the liquid phase, kL, can be evaluated from 
empirical correlations for laminar flow which relate together dimensionless 
groups (Péclet, Reynolds and Sherwood numbers). In the developing diffusive 
concentration profile and for boundary layers which are extremely thin relative to 
the channel width, the following relation has been proposed:36 
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where D is the oxygen diffusion coefficient in the liquid phase. c1 and c2 are 
constant values that can be evaluated by computationally solving oxygen mass 
balance equations for the system shows in Fig. 2A.   
The numerical solution of the convective-diffusion equation for the fluidic domain 
and the diffusive equation for the solid domain were obtained with the support of 
the software COMSOL Multiphysics 3.4 at different operative conditions. 
Boundary and initial conditions were set as follows: the top of the membrane 
domain is taken to be at a constant concentration in equilibrium with the adjacent 
gas phase, whereas oxygen concentration at the bottom surface is equilibrated 
with that in the fluidic domain. In the inlet section of the fluidic domain it was set 
a constant concentration, whereas at the outlet section it was considered only a 
convective flux. The remaining walls were assumed to be impermeable to oxygen. 
All values for the parameters used for the simulations are listed in Table 1. 
 
Table 1. Summary of physical properties. 
Property U.M. Value       Ref. 
D, oxygen diffusion in PBS m2 s-1 2.1×10-9 37 
p, oxygen permeability in PDMS (10-10 cm3(STP) × cm/cm2 × s × cmHg) 800 38 
O2 solubility in PBS at 1 atm and 
298K 
mol m-3 1.045 39 
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A.5   Results and discussion 
A.5.1   Microfluidic platform validation 
Fig. 4A shows the oxygen concentration distribution in the microfluidic channel 
obtained by computational simulation of oxygen mass balance equations. 
Boundary conditions were set as follows: inlet oxygen partial pressure, INLOp
,
2
, was 
set to 21%, whereas oxygen partial pressure in the gas phase, GOp 2 , is assumed to 
be constant at 0%. Oxygen flux through the PDMS membrane is directed from the 
liquid phase to the gas compartment according to the oxygen partial pressure 
gradient. Oxygen flux at the membrane interface decreases along the x-coordinate 
due to the progressive reduction of the gradient for 1 mm channel length as shown 
in Fig. 4B.  
 
Figure 4. Mass transport model development and validation. (A) 2D representation of oxygen 
concentration obtained by computational solution of mass balance equations in the microfluidic 
channel longitudinal cross-section. Empty arrows show oxygen flux directed from liquid phase to 
the gas one, in which oxygen partial pressure is assumed to be 0%. Full arrows show y-direction 
velocity profile. (B) Profile of the oxygen flux normal to the PDMS membrane interface along x-
coordinate. (C) Comparison of computational and analytical solution in term of adimensional 
numbers according to Eq. 6. (D) Oxygen partial pressure profile obtained from analytical solution 
given by Eq. 5 as a function of x-coordinate, parametric in liquid flow rate, L , and channel height, 
hL. Red line shows design target value of 2%. (E) Fluorescence imaging of fluidic layer filled with 
Ru(ddp) solution, using L =100 µl/min and hL=40 µm. White mark shows the region of interest for 
fluorescence quantification reported in Fig. 4F (values of x-coordinate are in cm). (F) Comparison 
of LOp 2 experimental profile inside the fluidic layer and the analytical solution obtained by Eq. 5. 
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In order to properly design the gas exchanger, the application of computational 
simulation to a larger portion or overall microfluidic channel could be time 
consuming and computational intensive. For this reason a simplified analytical 
theory to fairly describe mass transport inside the microfluidic device was 
derived. The mass balance analytical expression (Eq. 5) can describe oxygen 
profile inside the channel as a function of all operative parameters that affect mass 
transfer process and of the mean overall mass transfer coefficient (<KG>) and, in 
particular, liquid mass transfer coefficient (kL).  In this work, we adopt the model 
proposed by Vollmer and coworkers 36 to our system using computational results 
to estimate model parameters. We found out that c1 and c2 constant values of Eq 6 
are 0.10 and 2.62 respectively. Fig. 4C shows a comparison between 
computational simulation and modified analytical model (Eq. 6) in terms of 
adimensional numbers. This analytical model allows to fairly estimate the liquid 
mass transfer coefficient for several experimental conditions, in particular for 
different liquid flow rates )(L  and channel heights (hL).  
On the other hand, the minimal channel length for achieving a target LOp 2  
reduction using specific liquid flow rate and channel height can be easily 
estimated by Eq. 5. Fig. 4D shows LOp 2  profiles as a function of x-coordinate, 
obtained by varying both L  and hL. 
In order to experimentally validate the developed theory we mapped fluorescence 
intensity of the oxygen sensitive dye in the overall fluidic layer of the oxygen 
exchanger (Fig. 4E). Fig. 4E shows a fluorescence intensity increase along x-
coordinate from the inlet to the outlet according to LOp 2 . Fig. 4F shows a 
comparison of experimental LOp 2  measured at different x-coordinate values 
(reported in Fig. 4E) and analytical solution obtained from Eq. 4. Very good 
agreement between profiles within the experimental uncertainty has been 
observed. Finally, using the simplified analytical theory, we designed a gas 
exchanger that is able to perform a LOp 2  reduction of 95% with a steady state flow 
rate of 100 µl min-1. The gas exchanger configuration consists in 8 exchanger 
units in series formed by 8 parallel channels with 80 mm total length, 40 µm 
height and 100 µm width. 
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A.5.2   Calcium dynamics in hypoxia 
The microfluidic cell culture chamber and gas exchanger must preserve 
cardiomyocytes physiological characteristics while providing fast transient 
biochemical stimulation. The cell culture chamber was properly designed to 
obtain a uniform laminar flow avoiding unpaired velocity profile, back flow and 
stagnant dead volumes. This ideal condition was experimentally verified by 
observing the dynamic of a pulse of fluorescein in the cell culture chamber at 
different flow rates (data not shown). In addition, before each experiment, the 
culture was maintained in perfusion for 1 hour in normoxic solution while 
recording calcium dynamics. The cardiomyocytes displayed normal calcium 
dynamics during electrical stimulation. In order to test the time course of 
substance delivery to the microfluidic chamber, we injected a 50 µl bolus of 10 
mM caffeine solution in the perfusion line. The caffeine stimulated Ca2+ release 
from sarcoplasmic reticulum (SR) had a rapid onset and resulted in the change in 
fluorescence intensity. Such effect lasted 45 s, after which the calcium transients 
amplitude returned to normal indicating complete caffeine wash out (Fig. 5A). 
This time is consistent with the estimated permanence time of caffeine within the 
microfluidic chamber, as evaluated through fluorescence dye experiments. 
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Figure 5. Effect of hypoxia on calcium transients. (A) Calcium dynamic in a cardiomyocyte 
under electrical stimulation revealed through fluo-4 in the microfluidic culture chamber during 
perfusion of 50 µl of 10 mM caffeine solution; cardiomyocyte displays normal Ca2+ transients and 
response to caffeine with full recovery after wash out. (B,C) Liquid phase oxygen dynamic during 
step impulse of the oxygen partial pressure in the gas phase monitored by Ru(ddp) with three 
different flowrates (B) and by optic fiber sensor with L  = 200 µl min
-1 (C) at exchanger outlet. 
(D) Calcium transients sequence at different time points after hypoxic stimulus to the cell culture. 
(E) Comparison of single normalized calcium transients at different time points after hypoxic 
stimulus.  
!
In order to analyze the early effect of hypoxic events on cardiac physiology it is 
fundamental to fully characterize the oxygen partial pressure dynamics after set 
point variations. For this reasons, oxygen partial pressure at the outlet of the gas 
exchanger were measured by continuously detecting intensity fluorescence of 
oxygen sensitive dye during a GOp 2  set point change from 21% to 0% at three 
different flow rates: 50, 100 and 200 µl min-1 (Fig. 5B). The LOp 2  half decay value 
of 10 s for all different flow rates ensures fast oxygen dynamics. Different 
hypoxic steady state levels ( LOp 2 < 5%) can be achieved by varying medium flow 
rate (Fig. 5B). In order to exclude gas leakage between the gas exchanger and the 
culture chamber, oxygen partial pressure values, LOp 2 , were continuously 
monitored at cell culture chamber inlet by fiber optic probe. Fig. 5C shows LOp 2  
steady state values (black line) reached after two GOp 2  set point variations (red 
line): 21% to 0% and 0% to 21%. Consistent measurements reported in Fig. 5B-C 
confirms an efficient gas insulation.  
All together, these results show that the microfluidic experimental set up (as 
reported in Fig. 1) is able to accurately control oxygen partial pressure on cell 
culture in terms of steady state levels and rapid set point variations. It is worth to 
underline that oxygen partial pressure control is achieved without any 
perturbations on liquid media, allowing long term confocal acquisitions on same 
region of interest. These technical improvements make possible to perform 
experimental investigations using the same cell as its own control, continuously 
acquiring biological data prior and during the hypoxic stimulation. 
In order to rationally study the hypoxia-induced effects on calcium handling 
during excitation-contraction coupling it is important to investigate the duration of 
hypoxic stimulation that could exert a cell physiological response.  
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In this context, Fig. 5D shows a sequence of calcium dynamics in response to fast 
L
Op 2  drop as a function of time. A comparison of normalized calcium transient 
peaks at different time points (Fig. 5E) shows a significant alteration of the 
fluorescence intensity peak maximum after 5 min from hypoxic stimulus. All 
other experiments were performed considering this time frame as a minimal value 
to elicit a hypoxia-induced physiological response. 
We then sought to determine the hypoxic level at which hypoxia-induced effects 
on calcium handling during excitation-contraction coupling can be recorded. A 
multiple step experiment was designed by setting GOp 2  at 5 different values from 
21% to 0% with 5% interval and the resulting LOp 2  step profile is shown in Fig. 6A. 
Corresponding values of LOp 2  and 
G
Op 2  were correlated to obtain operating curve 
shown in Fig. 6A insert. Interestingly, the operating curve differs slightly from the 
equilibrium curve within the accuracy used in the gas exchanger design ( LOp 2 = 2% 
as target value (Fig. 4D), corresponding to 95% reduction from normoxic 
conditions). 
!
Figure 6. Oxygen level threshold. (A) LOp 2 profile for five different 
G
Op 2  with L =100 µl min
-1. 
Insert shows equilibrium and operating curve obtained by calibration. (B) Calcium transients 
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sequence at different LOp 2 measured 7 minutes after
G
Op 2  set-point change. Blue arrows show 
correspondence between GOp 2  set-point and calcium transient sequence (Fig. 5A). (C) Comparison 
of single normalized calcium transients at different oxygen partial pressure. (D) Averaged values 
of normalized calcium transients peak height at different oxygen partial pressure. The histogram is 
based on 5 replicates of same conditions.      
!
Fig. 6B shows the corresponding sequence of calcium transients acquired for 6 s 
at different LOp 2  levels measured 7 minutes after the 
G
Op 2  set-point change. Blue 
arrows show correspondence between GOp 2  set-point values and calcium transients. 
The baseline fluorescence maintained the same intensity for all the duration of the 
experiment and the effect of hypoxic stimulation emerged with a decrease of the 
maximum of the normalized calcium transient peak (Fig. 6C). The analyzed cells 
did not display calcium cycling alterations for GOp 2  > 5% (n=5). At 5% a poor 
significant difference (P<0.05, n=5) decrease was observed, whereas at GOp 2 = 0% 
the alteration of calcium transient was observed with high statistical relevance 
(P<0.01, n=5) (Fig. 6D). These data show that the observed effect reveals itself 
only in highly hypoxic nearly anoxic conditions, remaining latent at higher 
oxygen concentrations. 
To test the reversibility of the hypoxia induced Ca2+ changes and, concurrently, 
exclude artifact deriving form long term confocal acquisition such as dye photo-
bleaching, the cardiomyocyte culture was subjected to a fast drop of LOp 2  and 
maintained in hypoxic conditions for 10 min followed by 10 min of reperfusion 
with normoxic medium (Fig. 7A).  
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Figure 7. Reversible effect of hypoxia on calcium cycling. (A) Calcium transients sequence 
measured in normoxic, hypoxic ( GOp 2 = 0%) and normoxic conditions. (B) Comparison of single 
normalized calcium transients in normoxic, hypoxic ( GOp 2 = 0%) and normoxic condition. (C) 
Averaged values of normalized calcium transients peak height in normoxic, hypoxic ( GOp 2= 0%) 
and normoxic condition. The histogram is based on 5 replicates of same conditions. (D,E) 
Normalized calcium transients for different concentrations of L-type Ca2+ channel antagonist 
Verapamil (D) and Nifedipine (E). 
 
Whole-cell calcium dynamics were acquired every 10 min. In response to hypoxic 
stress we observed a decrease of the maximum calcium transient peak (Fig. 7B) 
with no alteration of the baseline fluorescence (n=8). After recovering the 
normoxic conditions, the cardiomyocytes displayed again the same fluorescence 
intensity, indicating a recovery of calcium cycling towards basal conditions. By 
analyzing the variation of fluo-4 fluorescence after 10 minutes of hypoxia and 
subsequent 10 minutes of reperfusion by means of percentage decrease against 
normoxic fluorescence intensity, a statistically relevant decrease (~15%, P<0.01) 
emerged (Fig. 7C). The recovery of normal calcium transients after the return to 
normoxic conditions highlights the reversibility of the biological effect and 
excludes the responsibility of dye photo-bleaching from the observed decrease of 
fluorescence. 
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All together, these results show that there is a significant reversible alteration of 
calcium homeostasis in excitation-contraction coupling during fast hypoxic 
stimuli. This experimental evidence underlines the ability of the cell to sense 
oxygen level and rapidly adapt to normoxic/hypoxic/normoxic transitions by 
regulating either directly or through secondary pathways the molecular machinery 
involved in cardiac Ca2+ homeostasis.3 In addition to direct channel sensing or 
specifically target protein modification (such as phosphorylation and cysteine 
reduction), hypoxia may also alter the regulation of these channels via indirect 
bulk mechanisms, such as changes in cell redox state by action of ROS.3 
However, all these hypoxia-induced phenomena affect membrane depolarization 
and concurrently alter of L-type voltage-gated calcium channels (VGCC) 
function, which provide the main entry pathway for extracellular Ca2+ into 
cardiomyocytes and are a major component of excitation-contraction coupling 
machinery. L–type VGCCs trigger the calcium-induced calcium release (CICR) 
process through extracellular calcium influx; calcium entry through VGCCs, 
which are topologically associated to calcium-release channels (ryanodine 
receptors) in the sarcoplasmic reticulum (SR) membrane, cause further calcium 
SR release within cytosol compartment. These secondary calcium dynamics can 
be easily measured as reported in this study. 
In this context, the alterations in excitation-contraction coupling under hypoxia 
could be related to impaired CICR for hypoxia-dependent desensitization of L-
type VGCCs. 
In order to explore this hypothesis, experimental investigation of calcium 
transients upon inhibition of the L-type Ca2+ channel with two antagonists was 
performed. Fig. 7D and 7E show normalized calcium transient at different 
concentrations of channel blocker ranging from 1 nm to 1000 nM in normoxic 
conditions. Similar calcium peak reductions recorded for hypoxia below 5% LOp 2  
were observed with 100nM of Verapamil and 10 nM of Nifedipine Fig. 7D and 
Fig. 7E, respectively. 
These findings confirm that a hypoxia-induced alteration of primary calcium entry 
through L-type VGCCs could turn in a reduced calcium concentration during 
excitation-contraction coupling and consequently, in an alteration of the 
physiological activity of cardiomyocytes. 
Our results suggest that a cardioprotective mechanism during early phases of 
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acute ischemia takes place through the reduction of calcium homeostasis in 
excitation-contraction coupling.  
A reversible adaptation of myocardium after short ischemic stress (5 min and 15 
min ischemia/reperfusion) in vivo was first observed by Heyndrickx and co-
workers.40 They demonstrated that a fully reversible dysfunction of the ischemic 
heart is prolonged after hypoxic stress, named “myocardial stunning”. The 
molecular basis behind this physiological behavior is still unclear. Myocardial 
stunning results from different adaptive mechanisms such as down-regulation of 
myocardial metabolism, and leads to activation of long-term cardioprotective 
responses including activation of cell survival pathways resulting in changes in 
gene and protein expression.41 
In this context, we first show that a fully reversible adaptive mechanisms of 
cardiopreservation might take place during the early events of ischemic stress 
through fast alteration in ion channel function in response to changes in cellular 
oxygen. 
 
A.6   Conclusions 
A microfluidic gas exchanger was designed to accurately and very quickly 
regulate LOp 2  without perturbing medium flux and consequently on line 
acquisition. By developing an ad hoc mass transfer theory, supported by 
computational simulations, we were able to predict LOp 2  inside cell culture 
chamber as a function of operative parameters (liquid flow rate). Experimental 
validation of LOp 2  profile inside the gas-exchanger microchannels confirmed that 
both constructive method and analytical model were valid.  
With the support of the developed technological system we observed a significant 
calcium handling alteration in a neonatal rat cardiomyocyte population after an 
exposure to 5 min of hypoxic conditions. Thanks to accuracy in tuning oxygen 
level in our system we found a threshold value of 5% 
L
Op 2 , above which no 
significant calcium transients peak decreases were observed. 
The recovery of normal calcium transients after the return to normoxic conditions 
highlights the reversibility of the biological effect and excludes the responsibility 
of sample damaging phenomena like dye photo-bleaching from the observed 
decrease of fluorescence. 
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We also explored the hypothesis that calcium-handling alteration in hypoxia could 
be affected by the desensitization of voltage gated calcium channels. In order to 
support our hypothesis we compared calcium transients peak obtained during a 
hypoxic stimulus and those obtained under effect of L-type calcium antagonist, 
Verapamil and Nifedipine. 
Rational understanding of how the cardiomyocyte adapts to acute ischemic stress 
and sustains its survival represents an important challenge because it might help in 
finding novel strategies to enhance cardiomyocytes survival in patients. 
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B.1   Abstract 
Adenoviruses are commonly used in vitro as gene transfer vectors in multiple 
applications. Nevertheless, issues such as low infection efficiency and toxicity 
effects on host cells have not been resolved yet. This work aims at developing a 
new versatile tool to enhance the expression of transduced genes while working at 
low viral doses in sequential manner. 
We developed a microfluidic platform with automatically controlled sequential 
perfusion stages, which includes 10 independent channels. In addition, we built a 
stochastic mathematical model, accounting for the discrete nature of cells and 
viruses, to predict not only the percentage of infected cells, but also the associated 
infecting-virus distribution in the cell population. 
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Microfluidic system and mathematical model were coupled to define an efficient 
experimental strategy. We used human foreskin fibroblasts, infected by 
replication-incompetent adenoviruses carrying EGFP gene, as the testing system. 
Cell characterization was performed through fluorescence microscopy, followed 
by image analysis. We explored the effect of different aspects: perfusion, 
multiplicity of infection, and temporal patterns of infection.  
We demonstrated feasibility of performing efficient viral transduction at low 
doses, by repeated pulses of cell-virus contact. This procedure also enhanced the 
exogenous gene expression in the sequential microfluidic infection system 
compared to a single infection at a higher, non-toxic, viral dose. 
 
B.2   Introduction 
The precise control of in vitro viral transduction is highly desirable in several 
applications, like the optimization of gene therapies (1-3), RNA interference 
experiments (4), induced pluripotent stem (iPS) cell production (5), or for 
promoting stem cell differentiation (6). Non-replicating adenoviral vectors 
(AdVs) are increasingly used for such purposes, because they introduce 
transgenes into cells without uncontrollable random integrations in host DNA and 
minimizing other perturbations of cell homeostasis (7). In addition, they are easy 
to manufacture and have the ability to infect also quiescent cells (8). On the other 
hand, transduction by AdVs suffers from low efficiency (9), and using high viral 
doses to achieve sufficient transduction induces cytotoxicity, as previously 
demonstrated not only in vivo (7, 10), but also in vitro (7, 11-14), using different 
types of primary cells and cell lines. Cytotoxicity is dose-dependent, and in vitro 
studies do not show significant effects on the cells at low multiplicities of 
infection (MOIs) (11, 12). MOI is defined as the number of viral particles per cell. 
Chuck and Palsson used convective flow conditions to enhance virus-cell contact 
and increase the probability of virus entrance into the cells (15). Furthermore, 
microfluidics can improve the control over virus-mediated gene delivery even at 
very low MOIs. In fact microfluidic devices overcome some of the limitations of 
conventional bench-top systems, taking advantage not only of their high surface-
to-volume ratio but also of laminar flow in the microfluidic channels (16). 
Microfluidics has already been used in applications involving viral particles, 
especially in the field of biosensors, for example for infectious virus detection 
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(17, 18). However, some devices were also developed for novel interesting 
applications: to measure virus infectivity and antiviral drug efficacy (19), for 
efficiently studying virus inactivation (20), and for virus-blood cell separation 
(21). Furthermore, a microfluidic bioreactor for virus production (22), and a 
device for protein production generating virus concentration gradients (23) were 
designed. 
The highly-defined environment in a microfluidic system, coupled with the 
possibility of easily automating its control, makes simple to explore a huge range 
of experimental conditions, also for viral transduction. However, a precise 
understanding of the physical and biological phenomena involved is needed for a 
rational experimental design. Multiple mathematical models describing viral 
infection have been developed on different scales. Efforts to quantitatively 
describe viral dynamics in vivo have been reviewed by Perelson (24). More 
detailed computational models, based on in vitro viral infection data, include 
works describing virus transport to the cell surface (25, 26), virus-cell interaction 
(25, 27, 28), and intracellular viral trafficking (29, 30). Tayi et al developed a very 
exhaustive deterministic mathematical model including the steps from virus 
transport in the extra-cellular medium to viral transgene expression (31). 
Although computationally more requiring, a stochastic approach in modeling 
virus transduction dynamics is more appropriate, as both viruses and cells are 
discrete particles. Seisenberger et al experimentally showed that viruses move 
within the culture medium by Brownian motion and, once they get to a cell 
surface, they have a certain probability of penetration through the membrane (26). 
Some of the models mentioned above partly adopted a probabilistic approach, but 
including only the discrete nature of viruses and not of cells (25, 27-29). Thus, 
they could not calculate how viruses distribute within the cell population without 
further assumptions, such as the approximation of a Poisson distribution for the 
fraction of cells infected by a given number of viruses (31). 
In this work, we developed a useful methodology for the accurate control of time-
dependent gene delivery by AdVs, by integrating experimental and theoretical 
analyses. We realized a microfluidic platform to perform up to ten parallel 
independent experiments in a single miniaturized chip, with accurate control of 
perfusion stages. Given this setup, multiple operating conditions, in terms of mass 
transport parameters and temporal profiles of virus delivery, could be easily 
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tested. Enhanced green fluorescent protein (EGFP) was used as a reporter of cell 
infection for online detection of the temporal evolution of the experiment. In 
parallel, we developed a stochastic simulation algorithm to theoretically study the 
viral transduction process. The model accounts for the discrete nature of both cells 
and viruses in a three-dimensional space. The computational simulations show not 
only the percentage of infected cells, but also the distribution of viral particles in 
the cell population. With these tools, we studied the feasibility of performing 
efficient AdV transduction experiments at low viral dose, by performing multiple 
sequential pulses of viral transduction. 
 
B.3   Materials and methods 
B.3.1   Cell culture 
Human foreskin fibroblasts (HFF) were expanded in gelatin-coated 75-mL flasks 
with high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM 41965, 
Invitrogen, USA), supplemented with 10% fetal bovine serum (Invitrogen) and 
1% penicillin/streptomycin (Invitrogen). At 90% confluency cells were 
trypsinized with trypsin-EDTA 0.25% (Invitrogen), centrifugated at 1200 rpm for 
5 minutes and re-suspended in growth medium for seeding.  
 
B.3.2   Adenoviral Vectors 
Replication-incompetent adenoviral vectors (AdVs) based on the Ad5 genome 
and lacking the E1 and E3 regions were constructed by homologous 
recombination in E. coli using AdEasy vector system (Qbiogene, Carlsbad, CA). 
In these vectors, human cytomegalovirus promoter was used to drive expression 
of EGFP. Transgenic adenoviral vectors were propagated in E1-complementing 
HEK 293 cells, purified by cesium chloride density centrifugation, and titrated by 
TCID50 cpe endpoint assay according to the AdEasy production protocol. Viral 
vector stocks were stored at 2·108 pfu/mL concentration in 10% glycerol at -80°C 
until use.  
 
B.3.3   Microfluidic device 
The microfluidic platform contains 10 independent channels for cell culture, each 
connected to a built-in medium reservoir of ~70 µL, and to a syringe pump system 
a  Appendix B 
! 99 
for fluid handling. A schematic representation of the microfluidic system is shown 
in Fig. 1A, and its dimensions are reported in Fig. 1B. 
 
 
Figure 1 Microfluidic experimental setup. (A) 3-D graphical representation of the microfluidic 
platform composed of 10 parallel independent channels. (B) Lateral section of one channel 
indicating its geometrical dimensions. White arrow indicates flow direction. (C) Overview of the 
whole system: the microfluidic platform (top view on the left) is placed in a biological incubator 
during experiments, and medium perfusion (from left to right) in every channel is provided by a 
set of syringe pumps, whose temporal pattern of flow rate is automatically controlled. (D) Images 
of the whole microfluidic channel taken with a fluorescence microscope to detect EGFP+ cells and 
cell nuclei. 
 
The microfluidic chip was fabricated by common soft-lithographic techniques 
(32). The master was photolitographically patterned by using SU8-2100 negative 
photoresist (Microchem, USA) to obtain a final thickness of 200 µm, according to 
manufacturer’s indications. A PDMS mold was obtained by casting a premixed 
10:1 ratio prepolimer and curing agent solution (Sylgard 184 kit, Dow Corning, 
USA) on the silicon wafer. After curing at 70°C for 2 h, the PDMS mold was cut, 
peeled off and punched with a 21G stainless steel needle (Small Part Inc, USA) to 
obtain inlet/outlet holes. The PDMS mold was assembled and sealed to a 50×75 
mm cleaned glass slide by plasma bonding. 10 independent medium reservoirs, 
one for each channel, were obtained by sealing an additional PDMS block to the 
top of the device by plasma bonding. The assembled device was cleaned with 
isopropanol (Sigma-Aldrich, USA) and sterilized in autoclave. A syringe pump 
with a 10-syringe rack (Harvard Pump, Harvard Apparatus, USA) was used to 
control the medium flow rate from the reservoirs into the microfluidic channels. 
0.5 ID Tygon tubings (Cole Parmer, USA) and 21G stainless-steel needles with 
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polypropylene luer (Microtest, Taiwan) were used to connect the microfluidic 
chip to the syringes. The entire experimental setup is shown in Fig. 1C. 
 
B.3.4   Viral transduction experiments 
Before cell seeding, the microfluidic channels were coated with gelatin 0.6% and 
incubated at 37°C and 5% CO2 atmosphere for 24 h. The cell suspension was 
injected into each channel and the microfluidic chip was incubated overnight at 
37°C and 5% CO2 atmosphere without perfusion. We used a proper cell seeding 
concentration in order to achieve confluent cell culture (corresponding to a final 
cell density of 150 cell/mm2) at 24 h after seeding. Then, discontinuous medium 
refill was achieved by automatically controlling the multichannel syringe pump 
through Labview 8.2 (National Instruments Corp., USA), without further manual 
intervention. The pump was programmed to run every 3 h for 4 min with a flow 
rate of 3 µL/min for medium change.  
24 h after cell seeding, AdV transduction was performed. The viral stock solution 
was thawed and diluted with culture medium to the final concentration. Medium 
perfusion into the micro-channels was performed with different dynamics through 
the automated syringe pump that aspirates medium from the channels. Each 
experimental condition was tested in at least two microfluidic channels in parallel. 
Parallel control experiments were performed in micro-channels supplied with 
AdV-free medium during viral transduction. 
The conventional bench-top system used as a reference is a 24-well tissue culture 
plate (Becton Dickinson, USA). Cells were seeded and cultured for 24 h in 1-mL 
medium. Then, medium was replaced with 200-µL AdV-containing medium at 
different concentrations. After incubation for 90ft =  min at 37°C and 5% CO2, 
medium was changed again with 1-mL virus-free medium that was kept until the 
end of the experiment. Each experimental condition was tested in at least three 
wells in parallel. Three wells were used as controls in every experiment and were 
supplied with medium without AdVs during viral transduction. 
 
B.3.5   Cell characterization 
Cell count and EGFP expression were detected in situ by fluorescence microscopy 
(Leica DMI 6000-B, Leica Microsystems, Italy). Cell nuclei were stained by 
incubating live cells with 2 µg/mL Hoechst 33342 dye (Invitrogen) in culture 
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medium for 30 min. Bright field and fluorescence images were taken at 10X 
magnification, with exposure, gain and intensity parameters equal to the 
respective control in each culture system. Every channel was entirely captured for 
the microfluidic system (Fig. 1D), and three randomly chosen positions in every 
well were acquired for the multi-well plate. 
The cell density and the percentage of EGFP+ cells were quantified by image 
analysis, using MATLAB (The MathWorks, Natick, MA), as previously described 
(16). We performed this image analysis using different values for the threshold of 
fluorescence intensity, f , that discriminates between EGFP positive and negative 
cells. In this way we could quantify, besides the number of EGFP+ cells, also the 
number of cells expressing EGFP at different levels. 
 
B.3.6   Stochastic simulation algorithm 
The mathematical model developed includes the extra-cellular virus transport in 
the culture medium (by diffusion and convection) and the entrance of viruses into 
the cells. Convective transport, present only in the microfluidic channels during 
filling and emptying, occurs in the x -direction (Fig. 2A) with a parabolic velocity 
profile, ( )xv y . 
 
Figure 2 Stochastic model processes and parameter fitting. (A) Graphical representation of the 
phenomena included in the stochastic model: medium convection with parabolic velocity profile, 
virus brownian motion in 3-D space, virus entering a cell with a certain probability when it gets on 
its surface. Plane xz represents the bottom surface of the channel where cells are randomly 
distributed within a regular square grid. (B) Results of model parameter fitting. Experimentally, 
transduction was performed in a 24-well plate using 200 µL of virus-containing medium for 90 
min. Cell concentration was 130 cell/mm2. The percentage of cells expressing EGFP 24 h after 
AdV transduction is shown as a function of virus concentration by red error bars, which represent 
mean ± standard deviation values obtained in independent experiments, each performed in double 
or triple. Simulations by the stochastic model reproduce the experimental conditions. In the model, 
EGFP+ cells are given by cells infected by at least one virus. The model outcome is shown as 
black dots, each obtained from one simulation at the given virus concentration. 100 simulations 
were performed at each condition. Black solid line indicates simulation mean results. 
 
The geometry simulated includes the whole culture channel for the microfluidic 
system. While for the conventional multi-well plate a representative sub-volume 
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of the well (1.73-mm2 bottom area), having the same height as the medium during 
viral transduction ( 1H =  mm), was simulated. 
Choosing a time step tΔ  for the simulation, the position ( , , )i i ix y z  of the i -th 
virus at time t t+Δ , given that at time t , was computed according to the Euler 
scheme of discretization for the Smoluchowski stochastic differential equation, as 
follows: 
,
,
,
( ) ( ) ( ) 2
( ) ( ) 2
( ) ( ) 2
i i x x i
i i y i
i i z i
x t t x t v y t D t
y t t y t D t
z t t z t D t
ξ
ξ
ξ
" + Δ = + ⋅Δ + ⋅ ⋅Δ ⋅
%%
+ Δ = + ⋅ ⋅Δ ⋅&
%
+ Δ = + ⋅ ⋅Δ ⋅%'
                                                       (1) 
where D  is the diffusion coefficient of the virus in medium, and ,x iξ , ,y iξ , and ,z iξ  
are normally distributed random variables with zero mean and unit variance. The 
model was solved in MATLAB. 
In both systems, cells were randomly distributed at the bottom within a regular 
square grid (Fig. 2A), to have the same density as in the experiments. The grid 
size was equal to 65.7celld =  µm, in order to have squares of the same cell surface 
area as that experimentally measured (4300±560 µm2). We neglected cell division 
because contact inhibition prevails at the cell seeding density used, as we verified 
during the experiments (Supporting Material). 
In the simulated sub-domain of the multi-well plate, at time 0t =  viruses were 
randomly placed within the three-dimensional medium volume to match the 
experimental concentration. Instead, in simulating the microfluidic system, virus 
concentration was null at time 0t = , and then viruses progressively entered with 
the flowing medium, at the appropriate concentration, distributed randomly on the 
inlet section surface. 
Virus entrance into the cells was described in the model as a partially adsorbing 
boundary condition at 0y = , because not all cell-virus contacts are successful for 
introducing the virus into the cell (26). Formally, the probability that the i -th 
virus enters a cell in the time span tΔ  is given by 1P tΔ , if the virus has 
( ) 0iy t t+Δ ≤ , where 1P  is a model parameter; or 
[ ]1 exp ( ) ( ) / ( )i iP t y t y t t D tΔ ⋅ − ⋅ +Δ ⋅Δ , otherwise. More details on this boundary 
condition are provided in the Supporting Material and in (33). The other boundary 
conditions were set as reflection, a part for the open boundaries at medium inlet 
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and outlet of the channel. We assumed that cells infected by at least one virus, 
then express EGFP.  
 
B.3.7   Model parameter values 
The model parameter values are summarized in Table I. The parameters related to 
system geometries and operative variables were fixed to match the experimental 
conditions. The value of the diffusion coefficient (D ) was taken from the 
literature (34).  
 
Table I. Parameter values of the model. 
Parameter Value 
Cell equivalent size ( )celld  65.7 mµ  
Culture volume height ( )H  1000 mµ
 (multi-well) 
200 mµ  (microfluidics) 
Culture volume length ( )L  
1314 mµ  (multi-well) 
317 10 mµ⋅  (microfluidics) 
Culture volume width ( )W  1314 mµ
 (multi-well) 
1500 mµ  (microfluidics) 
Virus diffusion coefficient ( )D  23.67 /m sµ  
AdV-cell interaction constant ( )1P  0.50.0079 s−  
Cell seeding density ( )cellρ  2130 150 /cell mm−  
AdV transduction duration ( )ft  90 min  
Simulated time step ( )tΔ  0.16 s  
 
 
Parameter 1P  was derived by fitting the experimental data obtained in the multi-
well plate under static conditions. Specifically, we minimized the following cost 
function, ϕ : 
( )
( )
2
2
mod exp
i i
i exp
i
x x
ϕ
σ
−
=∑ ,                                                                                           (2) 
where superscripts mod  and exp  refer to model and experimental values, 
respectively; and ix  and iσ  are the mean and standard deviation of the percentage 
of EGFP+ cells, obtained at the i -th virus concentration. Parameter fitting results 
are shown in Fig. 2B, in terms of both mean and standard deviation due to 
experimental uncertainty and model stochasticity. 
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B.4   Results and discussion 
B.4.1   Spatial heterogeneity in microfluidics 
To perform transduction experiments in a microfluidic channel, virus-containing 
medium needs to be perfused over the cells. As medium flows from inlet to outlet, 
it gets depleted of the viruses that enter the cells in between; hence, cells located 
in the downstream part of the channel are exposed to a lower MOI than those near 
the inlet. We computationally investigated how relevant is spatial heterogeneity in 
a perfused channel.  
First, we simulated a channel perfused with a constant flow rate of 0.1 µL/min 
(Peclet number equal to 300). The medium entering the system had a virus 
concentration corresponding to an instantaneous MOI of 20 in the system, given a 
cell density of 130 cell/mm2. We defined the MOI as instantaneous because it 
represents the number of viruses per cell within the channel at a given time. On 
the other hand, a global MOI can be defined by considering the total number of 
viruses entering the system during the whole time span of infection. The time of 
perfusion was set to 90 minutes, because it is the time ( ft ) required for a viral 
particle to travel a distance 200s = µm (the channel height) by Brownian motion, 
calculated from the Einstein's relation: 
2
f 2
st
D
=
⋅
                                                                                                                (3) 
where D  is the diffusion coefficient of the virus in medium. 100 stochastic 
simulations were performed. We verified that the whole channel was perfused by 
calculating that, at the flow rate simulated, 90 min correspond to 1.7 residence 
times. 
The length of the channel was divided in ten sectors and in each sector the 
percentage of EGFP+ cells, i.e. of cells infected by at least one virus, was 
calculated. The results are shown in Fig. 3A (top) and C. The percentage of 
positive cells in the last sector, near the outlet, is about 20% less than that in the 
first sector, at the inlet. Thus, spatial heterogeneity can be a relevant phenomenon 
introduced by perfusion that affects the quality of the resulting cell population. 
We also studied this aspect at different MOIs in the Supporting Material. 
Although at high MOI all the cells are infected, we verified that heterogeneity is 
still present in terms of virus distribution within the cell population, producing a 
gradient of infection level along the channel (Fig. 3A (bottom)). 
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Figure 3 Computational study of spatial heterogeneity in the microfluidic system. (A, C) Results 
of stochastic simulations of continuous channel perfusion with a flow rate of 0.1 µL/min for 90 
min. (B, D) Results of simulations of discontinuous perfusion: 2 min of inflow at 6 µL/min,  90 
min without perfusion, and 2 min of outflow at 6 µL/min. (A, B) Bottom of a microfluidic 
channel: the EGFP+ cells (top) and the number of virus/cell (bottom) are shown, color meaning is 
explained in color bars in (A). The black arrow indicates flow direction. (C, D) Percentage of 
EGFP+ cells in each of the 10 equal sectors of the channel indicated by the dotted lines. Error bars 
indicate mean ± standard deviation of 100 simulations. (A-D) Cell concentration is 130 cell/mm2, 
instantaneous MOI is 20. 
 
To avoid this issue, we developed a different strategy for providing virus-
containing medium to the cells, based on discontinuous perfusion. Keeping the 
same system geometry, cell density, and virus concentration as in the previous 
case, we simulated a perfusion of 2 min at a flow rate of 6 µL/min, 90 min 
without perfusion, and then 2 min of outflow. We verified that the shear stress 
occurring at 6 µL/min, approximately 6.8 mPa, is well below the threshold of cell 
damage (35), and can be effectively used during biological experiments. As 
shown in Fig. 3B and D, by performing the infection under these discontinuous 
conditions, spatial heterogeneity is within the stochastic noise of the system. 
EGFP+ cells are homogeneously distributed along the channel, because the 2 min 
of inflow and outflow negligibly affect the overall outcome. The whole channel is 
filled in less than a minute at this flow rate and virus adsorption does not occur 
fast enough to produce a gradient in the infection level along the channel. On the 
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contrary, in the previous case, channel filling took about 50 min, a time of the 
same order of magnitude of the characteristic time of adsorption. Other conditions 
of flow were simulated confirming this hypothesis, whose results are presented in 
the Supporting Material. Furthermore, it is worth to underline that perfusion 
conditions may also affect the overall cell quality by changing the accumulation 
of endogenous factors in cell microenvironment, as recently reported (36). A 
discontinuous flow protocol better preserves cell microenvironment while 
ensuring a homogenous transfection along the microfluidic channel. 
The homogeneity of transfection was confirmed also by experimental 
observations in our microfluidic system, as shown in the Supporting Material. All 
the results presented in the next sections, both computational and experimental, 
are obtained applying a discontinuous flow. 
 
B.4.2   Effect of MOI after Single Viral Infection 
We computationally investigated the effect of MOI on the percentage of  EGFP+ 
cells and the infecting-viruses distribution. We simulated the transduction process 
in a microfluidic channel for a cell density of 150 cell/mm2 at four different 
MOIs: 20 (equal to a concentration of 15000 pfu/µL), 10 (7500 pfu/µL), 5 (3750 
pfu/µL), and 1 (750 pfu/µL). Fig. 4 shows the resulting probability and 
complementary cumulative distributions of the percentage of cells infected with 
different numbers of viruses, as calculated by the model. Despite the spatial 
homogeneity performing AdV transduction in microfluidics under discontinuous 
flow (Fig. 3), the discrete nature of cells and viruses and how they are randomly 
distributed on the bottom surface and in the medium volume, respectively, can 
still generate a heterogeneous cell population as for the number of viruses 
infecting each cell. At MOI 1 almost all the cells infected have only 1 virus, but at 
higher MOIs heterogeneity is visible in the cell population (Fig. 4). Furthermore, 
the effective mean number of viruses per cell is much lower than the theoretical 
one, given by the MOI, confirming previous work (37). For example, at MOI 20 
the mean number of viruses per cell is only between 3 and 4 (Fig. 4D). Fig. 4 
shows also the percentage of cells infected by at least one virus, i.e. of EGFP+ 
cells, according to the hypotheses described in Materials and Methods section. As 
expected, the efficiency of the infection process increases at higher MOIs. 
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Figure 4 Computational study of viral transduction at different MOIs. Results of 100 stochastic 
simulations at MOI 1 (A), 5 (B), 10 (C), and 20 (D), in a microfluidic channel under discontinuous 
flow conditions, at a cell concentration of 150 cell/mm2. Bar plots represent the percentage of 
EGFP+ cells infected by n  viruses. Black lines show the corresponding complementary 
cumulative distribution. In each plot the percentage of EGFP+ cells (i.e. cells infected by at least 1 
virus) is also indicated. Error bars indicate mean ± standard deviation of the 100 simulations. 
 
Experimentally, given the very great surface-to-volume ratio of microfluidic 
systems, we first verified that there were not substantial AdV losses due to 
binding on the surfaces of the channels. The results are reported in the Supporting 
Material. Then, we performed experiments of viral transduction in the 
microfluidic platform under the same conditions simulated above and 
characterized the cell population at 24 h after the beginning of infection. We 
assumed that this period of time is sufficient for infected cells to express EGFP 
protein, as reported previously (38). The very good agreement between the 
percentages of EGFP+ cells obtained from experimental data and predicted by the 
model (Fig. 5A), shows the stochastic model fairly describes the overall infection 
process within the microfluidic platform. This result is particularly relevant 
considering that all extra and intra-cellular biological phenomena of viral 
infection (excluding those related to extra-cellular viral particle mass transport) 
are lumped in an overall limiting step, whose parameter was obtained by 
experimental data collected under static conditions in a multi-well plate. 
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Figure 5 Experimental study of viral transduction in the microfluidic platform at different MOIs. 
(A) Comparison of experimental (subscript exp) and simulated (subscript mod) percentage of 
EGFP+ cells. Marker colors are defined by legend in (B). (B) Complementary cumulative 
distribution of the percentage of EGFP+ cells showing a fluorescence intensity > f (see Cell 
Characterization section). (C) Probability distribution of the percentage of EGFP+ cells showing a 
fluorescence intensity f at MOI 1, 5, 10, and 20 (from left to right). (A-C) The percentage of cells 
expressing EGFP was detected 24 h after AdV transduction. Cell concentration was 150 cell/mm2. 
Error bars represent mean ± standard deviation values obtained in independent experiments, each 
performed in double or triple. 
 
We investigated the experimental heterogeneity of the cell population as for the 
EGFP produced at the single-cell level. We quantified the intensity of 
fluorescence, f , of each cell by image analysis, as described in Materials and 
Methods section. The results are shown in Fig. 5B and C, in terms of 
complementary cumulative distribution and of probability distribution, 
respectively. Besides increasing the percentage of cells expressing EGFP, AdV 
transduction performed at higher MOIs enhances the amount of exogenous RNA 
and consequently the amount of EGFP produced by single cells. This could be 
related to the increase in the number of viruses infecting each cell, as explored 
computationally (Fig. 4). However, multiple other processes overlap (such as, 
virus intracellular transport, cell cycle, regulation of transcription and translation), 
and a straight correlation between the two variables, number of virus per cell and 
intensity of cell fluorescence, is not possible. 
 
B.4.3   Multiple Pulses of Viral Transduction 
Thanks to the developed technology, the same efficiency of infection of cell 
culture could be obtained by infecting cells several times at low MOI, thus 
preventing any cytotoxic effect due to external viral particles. For this reason, we 
explored the possibility of performing multiple sequential pulses of infection at 
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low viral doses in order to increase protein expression over time and also avoiding 
the cell toxicity of high MOIs. We compared the outcome of a single viral 
transduction at MOI 20 (still low enough not to be toxic) with that of two 
infections at MOI 10, and of 4 infections at MOI 5. The total number of viruses 
entering the system was thus the same, but three different regular temporal 
sequences were used (Fig. 6). We simulated these three scenarios with the 
stochastic model, and found that theoretically the same outcome is achievable 
with a multi-pulse strategy, in terms of percentage of EGFP+ cells and of the 
distribution of the number of viruses per cell (Fig. 6).  
 
Figure 6 Multiple viral transductions strategy and computational results. Repeated 90-min AdV 
infections with MOI 20 (A), 10 (B), and 5 (C), at the time points indicated. Insets show model 
predictions of the percentage of EGFP+ cells infected by n  viruses at the end of each pulse of 
infection. Cell concentration was 150 cell/mm2. Error bars indicate mean ± standard deviation of 
100 simulations at each condition. 
 
Taking advantage of the precise automation of flow rate control in the 
microfluidic platform, we performed the experiment corresponding to the 
theoretical simulations described above. We infected the cells at time 0 and the 
other time points given in the three protocols, using a discontinuous flow strategy, 
i.e. 2 min of virus-containing medium flow (or virus-free medium in the channels 
not to be infected), 90 min of infection under static conditions, and 2 min of virus-
free medium flow. We monitored the level of cell EGFP expression 24 h after 
each infection, i.e. at the following time points: 24, 36, 48, and 60 h after the first 
infection. The results are presented in Fig. 7, in terms of probability and 
complementary cumulative distributions. Fig. 7D shows a comparable EGFP gene 
expression with the three protocols after 48 h, while at 60 h channels treated with 
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multi-pulse viral transduction at lower MOIs show a higher percentage of cells 
being more fluorescent (Fig. 7D). 
 
Figure 7 Results from experiments of multiple viral transductions within the microfluidic 
platform. AdV transduction timing followed the strategy shown in Figure 6: one infection at MOI 
20 (A and blue line in D), two infections at MOI 10 (B and red line in D), and 4 at MOI 5 (C and 
green line in D). EGFP+ cell fluorescence intensity, f, was measured at 24, 36, 48, and 60 h after 
the first infection. Cell concentration was 150 cell/mm2. Error bars indicate mean ± standard 
deviation of experiments repeated twice. (A-C) Probability distribution of the percentage of 
EGFP+ cells showing a fluorescence intensity f, and (D) associated complementary cumulative 
distribution. 
 
In this experiment, the maximum MOI used was 20. As previously verified, this is 
below the threshold of cytotoxicity, identified approximately at MOI 50 (11, 12). 
These conditions, coupled with a constant cell density due to contact inhibition, 
are useful to detect the effect of a sequential infection strategy at net of cell 
division and death phenomena, which are also not included in the stochastic 
model. Overall, a comparison between the percentage of EGFP+ cells (Fig. 7D) 
shows the feasibility of performing sequential viral transduction experiments 
without loss of efficiency, and highlights the importance of the multi-pulse 
infection strategy in cases when cytotoxicity is a concern. We performed 
sequential transduction experiments also at very high MOIs, as reported in the 
Supporting Material, and the results strongly support the reduction in cytotoxicity 
achievable. 
Furthermore, the higher EGFP expression achieved after repeated infections at 
MOI 5 than after a single one at MOI 20, confirms the complexity of gene 
expression regulation, which is not linearly dependent on the amount of 
exogenous DNA inserted. Thus, the sequential infection strategy may be a useful 
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means also to study complex dynamics of gene expression in a highly controlled 
system. 
 
B.5   Conclusions 
Viral vectors are increasingly used to insert exogenous genetic material in cells. 
Low efficiency of infection at low MOIs and cytotoxicity at high MOIs are two 
critical limitations affecting the process. In this work, we showed the feasibility of 
performing sequential infections at low viral dose with high efficiency, taking 
advantage of microfluidic technology to provide a highly-defined temporal 
control over the cell culture environment. 
We coupled the experiments with a theoretical analysis through a stochastic 
model to follow the dynamics of virus entrance into the cells under continuous 
and discontinuous flow conditions. In particular, being discrete in its description 
of viruses and cells, the model can recapitulate also the heterogeneity in the cell 
population without further assumptions. 
Under the simplifying hypotheses of the model, one infection at high viral dose 
and multiple at low doses, using the same overall amount of viruses, should give 
the same outcome in terms of distribution of viruses in the infected cell 
population. However, we also found experimentally that, compared to a single 
infection at high MOI, performing multiple low-dose infections affects the gene 
expression profile of the resulting cell population. Thus, the strategy developed to 
perform time-controlled multi-pulse infections, besides reducing viral toxicity, 
could be a powerful tool to investigate the dynamic complexity of the expression 
of exogenous genes using a highly controlled system. 
 
Supporting material is available at: 
http://www.biophysj.org/biophysj/supplemental/S0006-3495(13)00038-6 
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C.1    Summary 
Key cellular decisions, such as proliferation or growth arrest, typically occur at 
spatially-defined locations within tissues. Loss of this spatial control is a hallmark 
of many diseases, including cancer. Yet, how these patterns are established is 
incompletely understood. Here we report that physical and architectural features 
of a multicellular sheet inform cells about their proliferative capacity through 
mechanical regulation of YAP and TAZ, known mediators of Hippo signaling and 
organ growth. YAP/TAZ activity is confined to cells exposed to mechanical 
stresses, such as stretching, location at edges/curvatures contouring an epithelial 
sheet, or stiffness of the surrounding extracellular matrix. We identify the F-actin 
capping/severing proteins Cofilin, CapZ and Gelsolin as essential gatekeepers that 
limit YAP/TAZ activity in cells experiencing low mechanical stresses, including 
contact inhibition of proliferation. We propose that mechanical forces are 
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overarching regulators of YAP/TAZ in multicellular contexts, setting 
responsiveness to Hippo, WNT and GPCR signaling.  
 
C.2   Introduction 
Spatially restricted patterns of cell proliferation shape embryonic development 
and maintain adult epithelial tissues. How these local growth patterns are 
established remains unclear. In the past decades, major emphasis has been placed 
on graded distribution of soluble growth factors or their restricted activity in 
“niches”. This view, however, does not fully explain how the microenvironment 
can robustly template cell behavior in time and space, with micrometer accuracy 
(Discher et al., 2009; Huang and Ingber, 1999). Moreover, soluble factors alone 
can hardly account for some remarkable examples of ordered proliferation, 
differentiation and self-organization of entire organs emerging in vitro from naïve 
cells cultured in media saturated of mitogens and growth factors (Sasai, 2013). 
This suggests that tissues are somehow endowed with the capacity to inform 
individual cells on their proliferative competence, likely including the 
responsiveness to soluble cues. Although the molecular nature of these 
informational systems is uncertain, an intriguing model is that the architectural 
form of the tissue - its shape and three-dimensional geometry - serves as template 
to initiate and self-sustain asymmetric patterns of cell proliferation (Nelson and 
Bissell, 2006; Nelson et al., 2005). Key elements of such architectural signal are 
cell shape, cell geometry and deformation generated by the pulling forces of the 
extracellular matrix (ECM) and of neighboring cells, and the associated changes 
in cytoskeletal organization and tension (Berrier and Yamada, 2007; Miranti and 
Brugge, 2002; Schwartz, 2010; Vogel and Sheetz, 2006). In this model, a specific 
tissue conformation would translate into a pattern of mechanical forces potentially 
targeting individual cells with exquisite detail. Supporting this “biomechanical” 
perspective, the physical properties of the microenvironment are increasingly 
recognized as potent and pervasive regulators of cell behavior, such as 
proliferation and differentiation (Halder et al., 2012). A critical step forward in 
understanding these processes has been the discovery that mechanical signals are 
transduced by two related transcriptional coactivators, YAP and TAZ (Dupont et 
al., 2011). These are powerful regulators of cell proliferation and survival, playing 
critical roles in organ growth (Pan, 2010; Zeng and Hong, 2008). A number of 
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human cancers hijack these properties to foster their own growth, including 
induction of cancer stem cells and metastatic colonization (Cordenonsi et al., 
2011; Harvey et al., 2013). YAP and TAZ shuttle between the cytoplasm and the 
nucleus, where they interact with TEAD transcription factors to regulate 
transcription. Classically, the Hippo cascade has been regarded as the major 
regulatory input upstream of YAP/TAZ (Pan, 2010). Very recently, WNT and 
GPCR signaling pathways have also been recognized as important regulators of 
YAP/TAZ (Azzolin et al., 2012; Yu et al., 2012). Thinking along the connections 
between tissue architecture, cell mechanics and YAP/TAZ biology, we asked: is 
the mechanical regulation of YAP and TAZ translating spatial force distribution 
into patterned growth within multicellular layers? If so, how is positional 
information transmitted to YAP/TAZ? Are the different inputs feeding on 
YAP/TAZ (e.g. mechanical stimulation, Hippo, WNT or GPCR signaling) parallel 
or interdependent regulations? Here we started to shed light on these issues by 
discovering that cell proliferation in an epithelial monolayer is profoundly 
influenced by a mechanical and cytoskeletal checkpoint that regulates YAP and 
TAZ. This tissue-level checkpoint is enforced by the F-actin capping and severing 
proteins CapZ, Cofilin and Gelsolin. These factors inhibit YAP and TAZ in cells 
that, within a monolayer, are located at sites of low mechanical stress. 
Conversely, YAP/TAZ-mediated proliferative competence occurs in cells that 
exhibit higher contractility in response to stretching forces, depending on the 
shape of the epithelial sheet or on the rigidity of the surrounding ECM. We 
propose that mechanical stresses are overarching regulators of YAP/TAZ in 
multicellular contexts, also setting cell responsiveness to Hippo, WNT and GPCR 
signaling.  
 
C.3   Results 
C.3.1   Mechanical regulation of cell proliferation through YAP/TAZ  
A classic paradigm on the control of proliferation in multicellular aggregates is 
contact inhibition of proliferation (CIP), a process by which cultured cells stop 
dividing when they become confluent occupying the entire space allotted to them. 
This behavior recapitulates the proliferative arrest of most epithelia typically 
leading to cell differentiation or death. Interestingly, loss of CIP is considered a 
hallmark of cancer (McClatchey and Yap, 2012; Zeng and Hong, 2008). In CIP, a 
Appendix C          a 
! 118 
unifying theme is the regulation of YAP and TAZ, that tend to remain nuclear in 
cells growing at low density and relocate in the cytoplasm in confluent cultures 
(Zhao et al., 2007). CIP is associated with phosphorylation of YAP and TAZ, 
indicating the activation of the Hippo pathway kinases (Zhao et al., 2007). 
However, the regulation of YAP/TAZ by contact inhibition appears more 
complex. For example, recent data show that, at least in MEFs or keratinocytes, 
the mammalian Hippo homologue MST1/2 and LATS1/2 are dispensable for CIP 
(Schlegelmilch et al., 2011; Zhou et al., 2009). Here we decided to explore a 
different scenario, in which CIP incorporates a mechanical regulation of YAP and 
TAZ. To test this, we compared immortalized human mammary epithelial cells 
(MEC) plated at different densities (3000, 15000, 75000 cells⁄cm2) (Figure 1A). 
At the lowest plating density (hereafter called “sparse”), cells exhibited no or 
minimal contact between neighboring cells. At the intermediate plating density 
(“confluent”), cells were confluent with all-around cell-cell contacts, while, at the 
highest density (“dense”), space constraints caused cells to form a densely packed 
monolayer. Using anti-E-Cadherin immunofluorescence to identify cell borders, 
we quantified that the projected cell area dropped more than ten folds with 
increasing density, from 1400 µm2 in sparse cells, to 700 µm2 in confluent cells 
and down to 130 µm2 in dense cells (Figure 1A). As measured by BrdU 
incorporation, confluent cultures displayed about a 30% reduction of S-phase 
entry when compared to sparse cultures (Figure 1B). This degree of proliferative 
inhibition is in agreement with the expected contribution of cell-cell contact and 
E-Cadherin engagement to CIP (Kim et al., 2011), and was paralleled by a partial 
YAP/TAZ cytoplasmic relocalization (Figure 1C). That said, both nuclear 
YAP/TAZ levels and proliferation remained clearly evident in confluent cultures 
(Figures 1B and 1C), with YAP/TAZ activity being causal for S-phase entry 
(Figure 1B). This suggests that cell-cell contact per se is not sufficient to induce 
either post-confluence inhibition of proliferation, or robust YAP/TAZ 
inactivation. This is in contrast to the cells seeded at high density (dense), which 
are overtly growth arrested and exhibit largely cytoplasmic, transcriptionally 
inactive YAP/TAZ (Figures 1B, 1C, S1A). CIP is reversible, as inducing a 
“wound” in the monolayer by scraping away a stripe of cells caused the cells 
lying within a few cell diameters from the edge of the wound to stretch without 
losing cell-cell contacts, re-localize YAP/TAZ to the nuclei and proliferate 
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(Figure S1B and data not shown). Similar results were observed by using 
immortalized human HaCaT keratinocytes (Figures S1C-F and data not shown). 
YAP/TAZ inactivation in the course of CIP has been associated with activation of 
cell-cell adhesion machinery and activation of the Hippo pathway (Zhao et al., 
2007). We thus asked if the distinct degrees of YAP/TAZ inactivation observed in 
confluent and dense cultures, were dependent on catenins and LATS. Consistently 
with previous reports (Kim et al., 2011; Schlegelmilch et al., 2011), knockdown 
of α-catenin, p120-catenin or LATS1/2 rescued YAP/TAZ transcriptional activity 
in confluent cultures, as measured by the expression of YAP/TAZ target genes 
CTGF, CYR61 and ANKRD1 (Figures S1G-I and data not shown). Surprisingly, 
however, the same depletions had marginal effects on YAP/TAZ signaling in 
dense cultures (Figures S1G-I). The above results suggest that, beside cell-cell 
contacts, the main determinant for YAP/TAZ inhibition and post-confluent 
growth arrest is actually to attain a small cell size - intended as adhesion to a small 
ECM substrate area (Figure 1A). Indeed, cells attaching to a small area are known 
to experience low mechanical stresses, as they display decreased integrin-
mediated focal adhesions, reduced actin stress fibers, and blunted cell contractility 
(Berrier and Yamada, 2007; Schwartz, 2010; Vogel and Sheetz, 2006). 
Importantly, these mechanical cues have recently been shown to be essential for 
YAP/TAZ nuclear localization and activity (Dupont et al., 2011; Wada et al., 
2011). In this perspective, CIP would represent the response to a mechanical 
constraint: as cell crowding progressively boxes individual cells into smaller 
areas, these would be subjected to the same YAP/TAZ-regulating 
mechanotransduction pathways that affect isolated cells plated on small ECM 
islands. In line with this view, MEC plated as single cells on micropatterned 
fibronectin islands of defined areas displayed strong inhibition of YAP/TAZ 
nuclear levels and BrdU incorporation when individual cell-size dropped below 
300 µm2 (Figures 1D and 1E), independently of cell-cell contacts. Similarly, 
decreasing mechanical cues by culturing cells on soft substrates (i.e., fibronectin-
coated acrylamide hydrogels) also caused cell rounding, YAP/TAZ nuclear 
exclusion and proliferative inhibition (Figures 1F, 1G and S1J).  
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Figure 1: High Cell Density, Small Cell Geometry, and Soft ECM All Lead to Restriction of Cell 
Area, YAP/TAZ Relocalization, and Growth Arrest (A) Cells plated at different densities display 
increasingly smaller cell-substrate adhesion areas. MECs were seeded to obtain sparse cells and 
confluent or dense monolayers. After 2 days, cells were fixed for immunofluorescence with anti- 
E-cadherin antibody (anti-E-CAD) to visualize formation of cell-cell contacts by confocal 
microscopy. TOTO3 is a nuclear counterstain. Scale bar, 20 mm. (Right) Average cell area in the 
three seeding conditions. Similar results were obtained with HaCaT keratinocytes (Figure S1C). 
(B) MECs were plated as in (A); after 2 days, cells were incubated for 1 hr with a pulse of BrdU to 
label cells undergoing DNA duplication. Cells were fixed and processed for anti-BrdU immuno-
fluorescence (aBRDU). (Right) Quantitation of proliferation measured as the percentage of BrdU-
positive cells. Similar results were obtained with HaCaT keratinocytes (Figure S1D). Note 
minimal residual proliferation in dense cells, even after YAP/TAZ depletion, suggesting that cell 
proliferation in culture may not be totally dependent on YAP/TAZ. (C) MECs were plated as in 
(A) and stained for immunofluorescence with anti-YAP/TAZ antibody (aYAP/TAZ). TOTO3 is a 
nuclear counterstain. Scale bar, 20 µm. (Right) Proportion of cells dis- playing preferential nuclear 
YAP/TAZ localization (N, black), even distribution of YAP/TAZ in nucleus and cytoplasm (N/C, 
gray), or cytoplasmic YAP/ TAZ (C, white). Similar results were obtained with HaCaT 
keratinocytes (Figure S1E) and with an in- dependent anti-YAP antibody (not shown). (D and E). 
Restricting cell-substrate adhesion area to levels comparable to those of dense cells is sufficient to 
cause YAP/TAZ nuclear exclusion and inhibition of proliferation. MECs were seeded as 
individual cells plated on fibronectin-coated glass (large) or on square microprinted fibronectin 
islands of 300 mm2 (small). In (D), cells were fixed after 1 day for immunofluorescence with anti-
YAP/ TAZ antibody (aYAP/TAZ). DAPI is a nuclear counterstain. Scale bar, 20 µm. (Right) 
YAP/TAZ nucleo/cytoplasmic localization was scored as in (C). In (E), cells were processed for 
BrdU incorporation as in (B). (F and G) Effects of a soft ECM substrate on epithelial proliferation. 
Confocal immunofluorescence images of YAP/TAZ of MECs plated on fibronectin-coated stiff 
(plastic) and soft (acrylamide hydrogels of 0.7 kPa) substrates. TOTO3 is a nuclear counterstain. 
Scale bar, 20 mm. On the right: YAP/TAZ nucleo/cytoplasmic localization was scored as in (C). 
In (G) cells were processed for BrdU incorporation as in (B). Similar results were obtained using 
acrylamide hydrogels of 40 kPa or plastics (Dupont et al., 2011 and data not shown). Data are 
mean and SD. Experiments were per- formed at least three times with three biological replicates 
each time. Quantitations were carried out by scoring at least 2,000 cells for each sample. Pictures 
show representative results. See also Table S1 for siRNA sequences and Figure S1. 
 
The remarkable phenotypic similarities between cells cultured in small, soft or 
dense conditions clearly suggest that these apparently different modalities to 
regulate YAP/TAZ may actually all correspond to the control of YAP/TAZ by 
mechanical cues. To address more directly the notion that in a multicellular layer 
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the control of YAP/TAZ activity and cell proliferation occurs through mechanical 
cues, we developed a microdevice that reproduces some of the mechanical 
challenges experienced by tissues, such as stretching (Figure 2A and S2A-C). 
This microdevice was built by fabricating into polydimethylsiloxane silicone 
(PDMS) a microfluidic network of hollow channels connecting larger “chambers” 
filled with saline solution. The surface of PDMS was coated with ECM 
(fibronectin) to allow cell attachment. MECs were seeded on this surface at high 
cell density causing cells to exclude YAP/TAZ from nuclei and undergo CIP. 
Next, we slowly applied computer-controlled pressure to the system, imposing 
cells to radially stretch as the PDMS membrane overlaying each chamber inflated 
(Figure 2A). This applied strain increased the cell adhesive surface to 150%, as 
quantified from measurements of the cell-projected area (Figure 2B). This was 
associated to a remodeling of the F-actin cytoskeleton with appearance of 
phalloidin-positive actin bundles in stretched cells (Figure S2D). Remarkably, 
stretched cells rapidly reactivated YAP/TAZ, as monitored by nuclear 
localization, and re-entered S-phase (Figure 2C and 2D). Based on these 
experiments we conclude that mechanical forces acting on specific areas of an 
epithelial sheet reflect into changes of shape and mechanics of the individual 
cells, and act as spatially localized determinants of cell proliferation through 
YAP/TAZ regulation.  
 
 
 
Figure 2: Stretching of an Epithelial Monolayer Overcomes YAP/TAZ Inhibition and Growth 
Arrest in Contact-Inhibited Cells (A) A monolayer stretching device. Cells were seeded on the 
upper surface of a PDMS substrate to obtain a dense monolayer (see also Figure S2A). Underneath 
the PDMS is a chamber filled of fluid (white space between the PDMS and glass). At atmospheric 
pressure (dense, p = 0), the cell monolayer remains flat; when pressure is applied to the fluid 
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inside the chamber (stretched, p = 0), the increase of the chamber volume causes a corresponding 
increase of the surface to which the monolayer is attached. (B) MECs stably expressing 
membrane-bound EGFP (Mb-EGFP) and nuclear-localized mCherry (NLS-Cherry) were seeded at 
dense conditions as in Figure 1A on top of the stretching device. After 2 days, cells were imaged 
under the epifluorescent microscope before (Co.) and immediately after stretching. Pressure was 
then maintained constant during observation. Projected cell area was measured in the two 
conditions (dashed lines in the lower pictures indicate the cell boundaries before and after 
stretching). The graph shows the average quantitation of cell area. The ramping of pressure 
increase was set in order to avoid destruction of cell-cell contacts (as monitored with Mb-EGFP; 
data not shown). Scale bar, 20 mm. (C) MECs were plated on the stretching device as in (B). After 
2 days, cells were subjected to 6 hr of static stretching, fixed with the device still under pressure, 
and then processed for immunofluorescence with anti-YAP/TAZ antibody (aYAP/TAZ). DAPI is 
a nuclear counterstain. Scale bar, 20 mm. (Right) Proportion of cells displaying preferential 
nuclear YAP/TAZ localization (N, black), even distribution of YAP/TAZ between the nucleus and 
the cytoplasm (N/C, gray), or prevalently cytoplasmic YAP/TAZ (C, white). Similar results were 
obtained after 3 hr of stretching (not shown). (D) MECs were plated on the stretching device as 
described in (B). After 2 days, cells were subjected to 6 hr of static stretching in the presence of 
BrdU to label cells undergoing DNA duplication. Scale bar, 20 mm. (Right) Quantitation of 
proliferation measured as the percentage of BrdU-positive cells. Throughout the panels, data are 
mean and SD. Experiments were performed at least three times with at least three biological 
replicates each time. Quantitations were carried out by scoring at least 2,000 cells for each sample. 
Pictures show representative results. See also Figure S2. 
 
C.3.2   F-actin-capping and -severing proteins are YAP/TAZ inhibitors 
We next sought to identify molecular players involved in YAP/TAZ regulation by 
mechanical cues. F-actin regulatory proteins appeared as ideal candidates: 
treatments that disrupt F-actin or cytoskeletal contractility oppose YAP/TAZ 
function (Dupont et al., 2011; Wada et al., 2011; Zhao et al., 2012); then, it is 
recognized that cells respond to external mechanical cues by adjusting the tension 
and overall organization of their actin cytoskeleton by engaging a plethora of 
actin-binding proteins (Berrier and Yamada, 2007). Finally, cells plated on small 
ECM islands, on soft ECM or in a dense monolayer are characterized by similar 
F-actin organization, as they retain cortical F-actin, but all display reduced or 
absent F-actin bundles (Figure S2D and data not shown). We thus reasoned that 
knockdown of endogenous negative regulators of F-actin should restore 
cytoskeletal structures required for YAP/TAZ activity in inhibitory mechanical 
conditions. We selected a total of 62 genes identified as F-actin inhibitors in a 
genome-wide screen (Rohn et al., 2011). In order to specifically identify genes 
relevant for YAP/TAZ regulation by mechanical cues, we screened them using an 
unambiguous mechanotransduction assay, that is, the rescue of YAP/TAZ-
dependent transcription on soft ECM substrates. MECs were transfected with two 
pairs of siRNAs for each F-actin inhibitor and seeded on soft hydrogels 
(approximating an elastic modulus of 0.7 kPa). Cells were harvested after 48 
hours and analysed by qPCR for CTGF mRNA expression as read-out of 
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YAP/TAZ activity (Figure 3A). Although most siRNAs were ineffective, few 
siRNAs reactivated CTGF expression to levels comparable to, or higher than, 
those of cells growing on a stiff matrix (Figure 3B). These candidates were then 
validated by using individual siRNAs and testing their effectiveness at activating 
multiple YAP/TAZ endogenous targets (CTGF, ANKRD1, CYR61); among the 
candidates, Cofilin1/2, Capzb and Gelsolin, well-established organizers of F-actin 
distribution and dynamics (Pollard and Cooper, 2009), stood out as potent 
YAP/TAZ inhibitors (Figure 3C and S3A and data not shown). Cofilin and 
Gelsolin (also known as Actin Depolymerizing Factors) increase the turnover of 
F-actin by severing microfilaments; after severing, Gelsolin remains attached to 
the newly formed barbed end, preventing filament annealing and polymerization. 
CapZ (also known as β-actinin or Capping Protein) shares with Gelsolin such 
actin-capping function (Pollard and Cooper, 2009). Most of what we know about 
Cofilin, Gelsolin and CapZ in mammalian cells is based on cell migration studies, 
particularly in the context of dynamic cell protrusions, or from in vitro studies 
(Pollard and Cooper, 2009), while little data is available on their role in other 
relevant biological processes. In sparse MECs, depletion of Cofilin, CapZ and 
Gelsolin caused a general increase in F-actin staining, with particularly thickened 
stress-fibers, and increased peripheral protrusions resembling filopodia and 
lamellipodia (Figure 3D and S3B). Supporting the notion that F-actin capping and 
severing proteins do work through F-actin modification to regulate YAP/TAZ, we 
found that CapZ depletion could not increase YAP/TAZ activity in cells treated 
with LatrunculinA, an F-actin inhibitory drug (Figure S3C). To further dissect 
which subset of the F-actin networks is relevant for YAP/TAZ activity we treated 
cells with chemical inhibitors of formins (SMIFH2) or ARP2/3 (CK666; CK869; 
see Supplemental Information for details): these compounds preferentially inhibit 
formation of F-actin bundles (formin-dependent), or of F-actin branched networks 
that sustain lamellipodia formation (ARP-dependent). qPCR for CTGF indicated 
that YAP/TAZ activity mostly depends on F-actin bundles (Figure 3E). Taken 
together, the results link mechanical regulation of YAP/TAZ activity to F-actin 
capping/severing proteins and formation of stress fibers. We next used F-actin 
capping/severing proteins as tools to further query the nature of YAP/TAZ 
inhibition by cell density. Depletion of Cofilin, CapZ or Gelsolin rescued 
formation of stress fibers as well as YAP/TAZ nuclear localization, TAZ protein 
Appendix C          a 
! 124 
stability and YAP/TAZ-dependent gene expression in dense cells (Figures 4A-C, 
S4A and S4B). These findings support the notion that control of YAP/TAZ by 
high cell density entails a mechanical and cytoskeletal regulation.  
 
 
Figure 3: CapZ, Cofilin, and Gelsolin Inhibit YAP/TAZ Activity (A and B) siRNA screen for 
negative regulators of the F-actin cytoskeleton impinging on YAP/TAZ activity. (A) Schematic 
overview of the screening procedure. MECs were transfected with two independent couples of 
siRNAs against each gene (siRNA 1+2 or siRNA 3+4). The day after transfection, cells were 
replated as single cells on a soft ECM hydrogel (0.7 kPa) and harvested after 2 more days for 
qPCR analysis. (B) Results of the screening, where each point of the purple line corresponds to a 
single siRNA/gene. The orange diamonds indicate the effects of controls and of selected siRNAs 
that were further validated (see text). Cfl, Cofilin; Gsn, Gelsolin. The dotted line represents CTGF 
levels in cells transfected with siControl (siCo.) but plated on a stiff ECM substrate. Here and 
throughout the figures, CTGF levels are relative to GAPDH expression. (C) Loss of capping and 
severing proteins rescues YAP/TAZ inhibition on soft ECM. CTGF (purple) and ANKRD1 
(violet) expression in MECs are independent readouts of YAP/TAZ transcriptional activity. Cells 
were transfected with single siRNA against each gene (A, B, or C). Stiff (white column) is a stiff 
ECM substrate; soft (colored columns) is a 0.7 kPa ECM hydrogel. See Figure S3A for 
knockdown efficiencies on endogenous proteins. (D) Loss of Capzb, Cfl1, and Gsn induces 
formation of thicker actin bundles. Close-up confocal immunofluorescence of MECs transfected 
with the indicated siRNA and stained for F-actin with phalloidin (green) and nuclei (TOTO3, red). 
Scale bar, 20 µm. See Figure S3B for increased filopodia and lamellipodia after Capzb, Cfl1, and 
Gsn knockdown. Consistent results were obtained with independent siRNAs (not shown). (E) 
Regulation of F-actin dynamic and assembly by formin proteins is required for YAP/TAZ activity. 
MECs were plated on a stiff ECM substrate and treated for 24 hr with increasing doses of the 
inhibitor of formin-homology 2 domains SMIFH2 (used at 5, 15, 30 µM) or of the Arp2/3 
inhibitors CK666 (5, 10, 50 mM) and CK869 (5, 10, 50 µM). Data are mean and SD. Experiments 
were performed three times with at least three biological replicates each time. See also Figure S3 
and Tables S1 and S2. 
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C.3.3   Role of YAP/TAZ and F-actin inhibitors in mechanical patterning of 
cell proliferation 
Next, we wondered whether YAP/TAZ reactivation by depletion of F-actin 
capping and severing proteins is also paralleled by a rescue of CIP. To address 
this question, we employed microfabrication methods to stamp fibronectin-coated 
substrates of defined shape and area. This set-up allows studying how patterns of 
mechanical forces generate patterned growth within a monolayer: cells located at 
the borders of the island experience higher mechanical stress than cells located in 
the center (Nelson et al., 2005). MECs were uniformly seeded at high density on 
circular islands and, after 48 hours, cell proliferation rate was assayed by BrdU 
incorporation (Figure S4C). As shown in Figure 4D, the number of cells in S-
phase greatly decreased in the center of the island but persisted at the border, 
matching the distribution of physical forces (Nelson et al., 2005). Knockdown of 
YAP and TAZ revealed that proliferation at the border was YAP/TAZ dependent 
(Figure 4D). This growth pattern - as previously noticed (Nelson et al., 2005) - 
was driven by tensional forces, since inhibition of non-muscle myosin II with 
blebbistatin, or of myosin light chain kinase with ML-7, greatly reduced 
proliferation at the culture borders, phenocopying attenuation of YAP/TAZ 
(Figure 4D). Strikingly, depletion of CapZ and Cofilin clearly prevented CIP in 
center cells. Importantly, this occurred without increasing the growth of cells at 
the border, thus partially leveling the growth differentials within the epithelial 
sheet (Figure 4D). The restoration of proliferation by depletion of capping and 
severing proteins was dependent on YAP and TAZ (Figure 4D). We obtained 
similar results by seeding cells on square-shaped islands, where YAP/TAZ-
dependent proliferation was concentrated at corners and edges (Figures S4D, S4E 
and data not shown). The above results suggest that the form of an epithelial 
monolayer generates patterns of tensional forces that translate into differentials of 
YAP/TAZ activity, whose establishment requires F-actin inhibitors. Yet, in vivo, 
distinct tissues not only exhibit specific shapes, but also their ECM composition 
varies greatly, due to the content, crosslinking and topology of collagen fibers 
(Butcher et al., 2009).  
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Figure 4: Knockdown of F-Actin-Capping and -Severing Factors Rescues Contact Inhibition of 
Proliferation (A) Loss of Capzb, Cfl1, or Gsn rescues YAP/TAZ nuclear localization in dense 
monolayers. MECs were transfected with the indicated siRNA and were seeded to obtain sparse 
cells or a dense mono- layer. After 2 days, cells were fixed for immunofluorescence with anti-
YAP/TAZ antibody (aYAP/ TAZ). DAPI is a nuclear counterstain. Scale bar, 20 µm. (Right) 
Proportion of cells displaying preferential nuclear YAP/TAZ localization (N, black); even 
distribution of YAP/TAZ between the nucleus and the cytoplasm (N/C, gray); or cytoplasmic 
YAP/ TAZ (C, white). Consistent results were obtained with independent siRNAs (not shown). 
(B) CTGF expression in MECs transfected and seeded as in (A). Loss of Capzb, Cfl1, and Gsn 
rescues YAP/TAZ transcriptional activity in dense monolayers. (C) Western blotting for TAZ and 
YAP in MECs transfected and seeded as in (A). GAPDH is a loading control. (D) Panels show 
colorimetric stacked images of BrdU incorporation, used to visualize spatial variations of 
proliferation in cell monolayers of defined shape and dimensions. MECs were plated as 
monolayers on large microprinted fibronectin islands (diameter, 350 µm ) and processed as 
described in the text and as in the Figure S4C legend. The color scale indicates the extent of cell 
proliferation in a given position of the monolayers. The proliferation rate decreases to nearly 
undetectable levels at the center of the circle due to CIP (black/blue color), whereas cells continue 
proliferating along the border of the cellular sheet (green/ red color). Cultures were treated with 
blebbistatin (Blebbi, 50 µM) or myosin light-chain kinase inhibitor (ML-7, 10 µM) overnight 
before the BrdU pulse. For experiments with siRNAs, cells were first transfected with the 
indicated siRNA and were re- plated after 1 day. Similar results were obtained on islands of square 
shape (Figures S4D and S4E). Data are mean and SD. Experiments were per- formed at least twice 
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with biological replicates each time. Quantitations were carried out by scoring at least 2,000 cells 
for each sample. Pictures show representative results. See also Figure S4 and Table S1.  
 
To mimic such integration, we investigated the roles of YAP/TAZ, and F-actin 
capping and severing proteins, on the behavior of MECs growing in three 
dimensions (3D). For this, we used reconstituted ECM containing a mix of 
basement membrane (BM; Matrigel) and collagenI (COL), whose concentration 
can be changed to obtain soft and stiff BM/COL gels (COL 1.2 mg/ml or 3 
mg/ml, respectively) (Paszek et al., 2005) (see Figure S5A for validation of these 
gel compositions as mechano-regulators of YAP/TAZ). After 8 days in culture, 
MECs growing embedded in soft BM/COL gels formed growth-arrested acini 
(Figure 5A). When collagen concentration was increased, we observed the 
formation of larger spheroids, actively growing tubules and organoid-like 
structures (Figure 5A). By immunofluorescence, YAP/TAZ were predominantly 
evenly distributed in cells cultured in soft ECMs, but were clearly nuclear in cells 
embedded in the stiffer ECM (Figure 5B). Transcriptional activation of YAP/TAZ 
by increased ECM stiffness in 3D cultures was confirmed by induction of 
endogenous markers, such as CTGF, CYR61 and ANKRD1 mRNAs (Figure 
S5B). siRNA-mediated knockdown of YAP and TAZ caused severe reduction of 
the overall number and size of the 3D colonies, that in no case expanded beyond 
small aggregates, regardless of substrate rigidity (data not shown). We next 
sustained endogenous YAP/TAZ activity in cells embedded in the soft ECM 
through siRNA-mediated knockdown of Cofilin or Gelsolin. Strikingly, this 
induced the formation of bigger acini and caused the appearance of elongated or 
branched structures (Figure 5C) and was paralleled by YAP/TAZ-dependent 
induction of CTGF and CYR61 mRNAs (Figure 5D). Using phospho-histone-3 as 
proliferation marker, acini transfected with control-siRNA were mainly growth 
arrested, while Cofilin or Gelsolin-depleted spheroids retained proliferative 
activity (Figure 5E). We conclude that YAP/TAZ regulation by F-actin capping 
and severing proteins plays a critical role in regulating the growth of epithelial 
cells in a 3D reconstituted ECM.  
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Figure 5: 3D Matrix Stiffness Regulates Growth and Morphogenesis of Mammary Epithelial Cells 
through YAP/TAZ (A) Mammary epithelial cells (MECs) were embedded as a single cell in a 
matrix formed of a different mixture of Matrigel and CollagenI (see Experimental Procedures). 
Soft matrix contained 1.2 mg/ml CollagenI, whereas stiff matrix contained 3 mg/ml CollagenI 
(Paszek et al., 2005). After 8 days, cells were fixed and stained for phalloidin to help visualize the 
morphology of multicellular structures. TOTO3 is a nuclear counterstain. Scale bar, 100 µm. 
Bottom panels show bright fields at lower magnification. (B) 3D matrix density regulates 
YAP/TAZ localization, as assayed by confocal immunofluorescence with anti-YAP/TAZ antibody 
(aYAP/TAZ). MECs were plated as in (A) and were fixed after 6 days. TOTO3 is a nuclear 
counterstain. Scale bar, 100 µm. (C) Loss of Cfl1 and Gsn promotes the formation of tubule-like 
structures in soft 3D matrix. MECs were transfected with the indicated siRNAs and then 
embedded in soft matrix as in (A). After 8 days, acini were fixed and stained for phalloidin. 
TOTO3 is a nuclear counterstain. Scale bar, 100 µm. (D) Loss of Cfl1 and Gsn increases 
YAP/TAZ transcriptional activity in soft 3D matrix. MECs were treated as in (C) and were 
harvested for qPCR of the YAP/TAZ target genes CTGF and CYR61. (E) Loss of Cfl1 and Gsn 
promotes proliferation of cells embedded in 3D soft matrix. MECs were treated as in (C) and were 
stained with anti-pH3 antibody to mark mitotic cells. pH3 signal is shown merged with the 
TOTO3 nuclear counterstaining. Scale bar, 100 µm. (Right) Quantitation of cell mitosis 
normalized to the volume of the multicellular structures, as calculated from 3D z stacks 
reconstructions. Data are mean and SD obtained from at least 20 structures per condition. Data are 
mean and SD. Experiments were performed at least twice with biological replicates each time. 
Pictures show representative results. See also Figure S5 and Table S1. 
 
C.3.4   Cytoskeletal regulation of YAP/TAZ dominates over Hippo signaling 
We next sought to investigate the intersections between the control of YAP/TAZ 
activity by cytoskeletal cues and the classical Hippo cascade, centered on the 
activity of two kinases, MST1/2 (Hippo in Drosophila) and LATS1/2, the latter 
directly phosphorylating YAP/TAZ and causing their inhibition (Pan, 2010). CIP 
has been associated to increased YAP/TAZ phosphorylation mediated by 
LATS1/2 (Zhao et al., 2007); similar phosphorylation occurs in cells rounded 
a Appendix Ca 
! 129 
after placing them in suspension, or upon disruption of the F-actin cytoskeleton 
(Kim et al., 2013; Wada et al., 2011; Zhao et al., 2012). Fully confirming these 
associations, we also found increased YAP/TAZ phosphorylation in cells treated 
with LatrunculinA, an F-actin inhibitory drug (Figure 6A). YAP/TAZ 
phosphorylation, however, may not automatically surrogate for biological 
function, and no previous studies supported this biochemical observation with 
functional evidence (Halder et al., 2012). To investigate the functional role of 
LATS, we used independent pairs of validated siRNAs targeting both LATS1 and 
LATS2. We first controlled the efficacy of LATS-depletion by reconstituting NF2 
expression, a bona fide upstream regulator of the Hippo cascade, in the NF2-null 
breast cancer cell line MDA-MB-231 (Dupont et al., 2011). NF2 re-expression 
caused a dramatic inhibition of TEAD luciferase reporter and LATS1/2 
inactivation completely abolished this effect, confirming the efficacy of our 
siRNAs (Figure 6B). Similarly, NF2 re-expression was completely ineffective in 
cells expressing only a LATS-insensitive, phosphorylation mutant form of YAP 
or TAZ (Figure S6A and data not shown). Next, we wondered if LATS1/2 were 
downstream of mechanical cues. If this were the case, as in the above NF2 
paradigm, loss-of-LATS1/2, or loss-of-YAP/TAZ phosphorylation, should also 
rescue YAP/TAZ activity in cells on soft ECM or dense cultures. In stark contrast 
to this hypothesis, the results for mechanical regulation were different: depletion 
of LATS1/2 could not rescue YAP/TAZ inhibition by a soft environment (Figures 
6C), indicating that F-actin and mechanical regulation affect YAP/TAZ activity 
independently from their phosphorylation by LATS. In line, cells expressing only 
LATS-insensitive YAP or TAZ mutants (5SA-YAP, 4SA-TAZ) did not escape 
mechanical inhibition when cultured on soft hydrogels (Figure S6B and S6C). 
Using CapZ inactivation as paradigm of cytoskeletal remodeling, we also found 
that cells expressing 4SA-TAZ were still responding to depletion of CapZ (Figure 
S6D). Finally, knockdown of CapZ left the YAP/TAZ phosphorylation levels 
completely unchanged, as shown by Phos-TAG analysis (Figure 6D); collectively, 
the results strongly suggest that YAP/TAZ control by the F-actin cytoskeleton and 
Hippo signaling represent formally distinct regulations. An unexpected discovery 
came when we simultaneously inactivated CapZ together with LATS1/2 in MECs 
cultured in soft or dense conditions. The results actually showed that LATS1/2 are 
effective inhibitors of YAP/TAZ only in the context of a mechanically competent 
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F-actin cytoskeleton. Several results support this conclusion: (i) combined 
depletion of CapZ and LATS1/2 cooperated to fully induce nuclear localization of 
YAP and TAZ in cells seeded on soft hydrogels and dense conditions (Figure 6E 
and 6F); (ii) LATS1/2 depletion in either soft or dense MEC cultures was 
inconsequential per se but potently synergized with CapZ depletion to maximize 
YAP/TAZ transcriptional activity (Figure 6G and 6H); (iii) in large square (or 
round) fibronectin-coated islands, LATS1/2 depletion alone could not rescue CIP 
(Figure 6I, S6E, S6F), and left proliferation of cells at the border still sensitive to 
inhibitors of cytoskeletal tension (Figure S6E). However, combined depletion of 
CapZ and LATS1/2 fully rescued the blockade of S-phase entry in cells located at 
the center of the epithelial sheets triggering unabated proliferation evenly 
throughout the island (Figure 6I and S6F). We next tested how loss of YAP/TAZ 
regulation by the Hippo kinases impacted on MECs growing in 3D within a soft 
or stiff ECM. To this end, we compared MECs stably expressing near to 
endogenous levels of wild-type TAZ, and LATS phosphorylation-insensitive 
4SA-TAZ. As shown in Figure 6J, wild-type TAZ expressing cells behaved 
similarly to their parental counterparts. 4SA-TAZ expressing cells displayed 
increased protrusive activity in soft ECM, yet retained a spheroid structure. 
Notably, in the more rigid ECM, 4SA-TAZ expressing cells did not form tubular 
structures and invaded the matrix as single cells. As TAZ overexpression has been 
shown to induce Epithelial-to-Mesenchymal Transition in cells cultured on plastic 
in 2D (Lei et al., 2008), this 3D phenotype likely reflects fully unleashed TAZ 
activity. Finally, we asked if the permissive effect of the cytoskeleton is specific 
for the Hippo pathway or also applies to other regulatory inputs. To this end, we 
used two inducers of YAP/TAZ, WNT and GPCR signaling (Azzolin et al., 2012; 
Yu et al., 2012), and monitored their efficacy in soft vs. stiff extracellular 
conditions. As shown in Figure 6K, knockdown of APC (mimicking WNT 
signaling by inactivation of the APC/Axin/GSK3 TAZ destruction complex 
(Azzolin et al., 2012)) caused robust upregulation of YAP/TAZ-dependent 
transcription in cells cultured on stiff substrates, but had minimal effect in cells 
seeded on a soft matrix. Similarly, addition of TRAP6, a positive inducer of 
YAP/TAZ activity through GPCR-signaling, could operate only in cells cultured 
on stiff, but not on soft matrices (Figure 6L). Remarkably, depletion of capping 
and severing proteins re-empowered YAP/TAZ activation by WNT and GPCR 
a Appendix Ca 
! 131 
signaling (Figures 6K, 6L and data not shown). Collectively, the results suggest 
that mechanical and physical properties of the environment control not just Hippo 
signaling but also YAP/TAZ responsiveness to signaling cascades initiated by 
soluble growth factors.  
 
 
Figure 6: Cytoskeletal Mechanics Is a Dominant Input for YAP/TAZ Activity. (A) Disruption of 
the F-actin cytoskeleton induces YAP phosphorylation. Phos-TAG SDS-PAGE analysis of MECs 
plated as confluent monolayer and treated with LatrunculinA (Lat.A, 100 µM) for 3 hr. Black and 
white arrowheads indicate hyperphosphorylated or nonphosphorylated YAP, respectively. Identity 
of YAP isoforms was defined based on extracts from cells transfected with YAP siRNA and on l-
phosphatase treatment (not shown). (B) LATS1/2 knockdown completely rescues YAP/ TAZ 
inhibition by NF2/Merlin. Luciferase reporter assay (8XGTIIC) in MDA-MB-231 transfected with 
the indicated siRNA and without (Co.) or with NF2 expression plasmid. See Figure S6A for 
similar results obtained with LATS-insensitive 5SA-YAP mutant. Similar results were obtained in 
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HeLa cells (not shown). (C) LATS1/2 knockdown does not rescue YAP/ TAZ inhibition by soft 
ECM. Luciferase reporter assay (8XGTIIC) in MDA-MB-231 cells transfected with the indicated 
siRNA and replated on stiff or soft ECM substrates. See Figure S6B for similar results obtained 
with LATS-insensitive 5SA-YAP mutant. Similar results were obtained in HeLa cells (not shown). 
Of note, inhibition of LATS by constitutive-activation of PI3K or AKT (Fan et al., 2013), known 
for being downstream of integrin signaling, could not rescue YAP/TAZ inhibition by soft ECM; 
and inhibition of PI3K, AKT, and mTOR by small-molecule inhibitors had no effect on a stiff 
ECM (data not shown). (D) Capzb knockdown does not result in a decrease of YAP 
phosphorylation. Phos-TAG SDS-PAGE analysis of MECs transfected with the indicated siRNAs 
and plated as confluent mono- layers. Black and white arrowheads indicate hyperphosphorylated 
or nonphosphorylated YAP, respectively. (E) MECs were transfected with the indicated siRNAs 
and were plated on soft ECM substrates. After 2 days, cells were fixed for immunofluorescence 
with anti-YAP/TAZ antibody. Scale bar, 10 µm. (Below the pictures) Proportion of cells 
displaying preferential nuclear YAP/TAZ localization (N, black), even distribution of YAP/TAZ 
between the nucleus and the cytoplasm (N/C, gray), or prevalently cytoplasmic YAP/TAZ (C, 
white). Transfection of LATS1/2 siRNA alone had no significant effects on YAP localization (not 
shown). Consistent results were obtained with independent siRNAs (not shown). (F) MECs were 
transfected with the indicated siRNAs and were seeded to obtain a dense monolayer. After 2 days, 
cells were fixed for immunofluorescence with anti-YAP/TAZ antibody. Scale bar, 20 µm. (Below 
the pictures) Proportion of cells displaying preferential nuclear YAP/TAZ localization (N, black), 
even distribution of YAP/ TAZ between the nucleus and the cytoplasm (N/C, gray), or prevalently 
cytoplasmic YAP/TAZ (C, white). (G) MECs were transfected with the indicated siRNAs and 
were plated on stiff (white column) or soft (colored columns) ECM substrates. After 2 days, cells 
were harvested for qPCR analysis. LATS knockdown has no effects on a soft ECM but potently 
enhances CTGF transcription upon combined depletion of Capzb. Similar results were obtained 
with ANKRD1 and CYR61. (H) MECs were transfected with the indicated siRNAs and plated as 
sparse cells (white column) or dense monolayers (colored columns). After 2 days, cells were 
harvested for qPCR analysis. Similar results were obtained with ANKRD1 and CYR61. (I) 
Combined depletion of LATS1/2 and Capzb completely rescues contact inhibition of proliferation. 
Panels show colorimetric stacked images of BrdU incor- poration in MECs transfected with the 
indicated siRNAs and seeded on top of microprinted square fibronectin islands (side, 500 µm). 
The synergistic effect of LATS and Capzb depletion is indicated by the stark increase of red-
stained areas (indicating higher proliferation) compared to the other conditions. Similar results 
were obtained with circular microprinted fibronectin islands (see Figure S6F). (J) MECs were 
transfected with YAP/TAZ siRNA (to avoid interference from endogenous proteins) and 
reconstituted with siRNA-insensitive mouse TAZ (mTAZ). TAZ add-back was carried out with 
both WT and LATS-insensitive 4SA mTAZ. Cells expressing empty vector and transfected with 
control siRNA serve as controls. Cells were embedded as a single cell in a matrix formed of a 
different mixture of Matrigel and CollagenI to obtain softer and stiffer gels (see legend to Figure 
5A and Experimental Procedures). After 6 days, cells were fixed and stained for phalloidin to help 
visualize the morphology of multicellular structures. Scale bar, 100 µm. (K and L) WNT and 
GPRC signaling efficiently promote YAP/TAZ-dependent transcription on soft substrates only 
after Capzb depletion. (K) MECs were transfected with control siRNA (siCo.), APC siRNA 
(siAPC) to activate WNT signaling, or with Capzb siRNA (siCapzb). Cells were plated on stiff or 
soft ECM substrates and were harvested after 2 days for qPCR of YAP/TAZ target genes (CTGF 
and ANKRD1). (L) MECs were transfected with the indicated siRNAs and were plated on stiff or 
soft ECM substrates. After 1 day, cells were serum starved overnight and were subsequently left 
untreated or treated with 2 µM TRAP6 for 3 hr. Data are mean and SD. Experiments were 
performed at least twice with biological replicates each time. Quantitations were carried out by 
scoring at least 2,000 cells for each sample. Pictures show representative results. See also Figure 
S6 and Table S1. 
 
C.4 Discussion 
How cell shape and tissue form connect with tissue function, growth and 
patterning is one of the most fascinating and least understood aspects of biology. 
Here we provide evidence that tissue shape and three-dimensional ECM 
compliance pattern the proliferative competence of an epithelial sheet. These 
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inputs localize YAP/TAZ activity at sites of high mechanical stresses, and inhibit 
it where mechanical forces are minimal. Thus, YAP and TAZ regulation serves as 
link between tissue architecture and a key cellular function, that is, proliferation. 
YAP/TAZ inhibition entails a remodeling of the F-actin cytoskeleton mediated by 
F-actin capping and severing proteins, for which we reveal an essential role as 
proliferative checkpoints in mammalian epithelial sheets through YAP/TAZ 
regulation. The presently described connections appear to hold a number of 
implications for the biology of epithelial cells. For organ size control, tissue 
regeneration and homeostasis cells must be constantly informed of the size and 
shape of the whole organ (Discher et al., 2009; Huang and Ingber, 1999; Nelson 
and Bissell, 2006). This suggests that cells are able to perceive what happens 
many cell diameters away and respond to it with great spatial accuracy. 
Mechanical forces are ideally suited to serve as messenger of this global control, 
as it has been recently shown that forces display long-range and broad scale 
effects (Halder et al., 2012; Guo et al., 2012). Using monolayers of defined shape 
and size, here we show that patterns of mechanical stresses locally control 
YAP/TAZ activity. At sites of low mechanical forces, that is, in contact-inhibited 
center cells, YAP/TAZ are inhibited by F-actin capping and severing proteins, as 
loss-of-CapZ or Cofilin potently rescues YAP/TAZ nuclear localization, 
transcriptional activity and proliferation. In contrast, cells at edges and corners of 
the same multicellular sheets display YAP/TAZ dependent proliferation induced 
by cytoskeletal contractility and, here, loss-of-CapZ or Cofilin has marginal 
effects.  
Inactivation of capping and severing proteins is accompanied by reappearance of 
F-actin stress fibers. Conversely, YAP/TAZ inactivation is phenocopied by 
inhibiting formin and myosin, which by themselves are essential for stress fibers 
formation and cellular contractility. These data collectively suggest that 
mechanical forces promote YAP/TAZ activity at least in part by inhibiting 
capping and severing proteins. However, this does not exclude a different 
scenario, one in which YAP/TAZ are regulated independently by mechanical 
forces and capping/severing proteins; the latters may operate to unbalance the 
distribution of microfilaments to different, perhaps competing, F-actin pools (e.g. 
cortical F-actin, stress fibers and nuclear actin) endowed with different YAP/TAZ 
activating capacities. In other words, while this study unambiguously identifies 
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endogenous F-actin capping and severing proteins as YAP/TAZ inhibitors, a more 
detailed picture of their function will necessarily require the unraveling of the 
precise mechanisms by which F-actin affects YAP/TAZ-dependent transcription 
as well as a more comprehensive understanding of cellular rigidity sensing. 
Classical experiments using transformed mammary epithelial cells grown as 
spheroids in three-dimensional ECM of distinct rigidities and compositions 
unequivocally showed that the physical properties of the matrix could lead to 
tumor cells “reversion” to a near normal phenotype, overriding oncogenic 
aberrations (Nelson and Bissell, 2006). Conversely, ECM stiffening, and ensuing 
cytoskeletal tension, cooperate with oncogenes, and may even initiate aberrant 
proliferation (Butcher et al., 2009). Yet, how the microenvironment intercepts the 
malignant phenotype at the level of gene-expression is a major question in cancer 
biology. Here we show that transformed mammary epithelial cells grown in low-
collagen 3D environments display low levels of YAP/TAZ activity, while 
collagen-rich matrices induce YAP/TAZ nuclear localization, YAP/TAZ target 
genes and YAP/TAZ dependent proliferation. These observations are consistent 
with the positive correlations between collagen content and tissue stiffness (as 
determined by mammographic density) with breast cancer risk and metastasis 
(Butcher et al., 2009). Here we show that F-actin capping and severing proteins 
are instrumental for the effects of a soft ECM, as their depletion induces 
YAP/TAZ activation and proliferation, phenocopying the attributes of a more 
rigid ECM environment. This work also provides a unifying principle for how 
contact inhibition of proliferation is realized. We propose a two-step model of this 
classic phenomenon (McClatchey and Yap, 2012). As cells engage in cell-cell 
adhesion - starting from a situation of unrestricted adhesive areas with fully 
nuclear YAP/TAZ - the E-cadherin/catenins system triggers LATS activation and 
YAP/TAZ phosphorylation, as previously reported (Kim et al., 2011; Zeng and 
Hong, 2008), but this is insufficient for overt growth arrest. Then, as proliferation 
continues, cell crowding causes reduction of cell size and low mechanical stress, 
now leading to a more effective contact inhibition. We show that the regulation of 
YAP/TAZ by cell mechanics is not only distinct from Hippo pathway-induced 
YAP/TAZ phosphorylation and inhibition, but in fact dominates over it. 
Remarkably, LATS1/2 inactivation is per se inconsequential in cells experiencing 
a low mechanical stress. Moreover, depletion of F-actin capping/severing proteins 
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sustains YAP/TAZ activity without affecting their phosphorylation. In fact, 
LATS-mediated inhibition of YAP/TAZ requires a mechanically competent 
cytoskeleton, as the effect of LATS knockdown becomes manifest only in the 
absence of F-actin capping/severing proteins. Our finding that LATS and F-actin 
organization act independently to regulate YAP/TAZ is also supported by genetic 
evidence in Drosophila (Fernández et al., 2011; Sansores-Garcia et al., 2011). In 
fly wing development, inactivation of the CapZ homologue induces organ 
overgrowth similarly to Hippo mutations, and the extent of this phenotype can be 
either counteracted or amplified, respectively by overexpression or inactivation of 
LATS, altogether making unlikely an epistatic relationship between the two 
inputs. Our data further suggest that the scale of activation of YAP/TAZ may be 
particularly broad, depending on the relative intensity and duration of cytoskeletal 
and Hippo controls. There is ample genetic evidence for the Hippo pathway as an 
intrinsic regulator of organ size; for example, inactivation of the upstream Hippo 
kinase MST1/2, or of its cofactor Salvador/WW45, causes remarkable tissue 
overgrowth in several organs, including liver, intestine and skin (Ramos and 
Camargo, 2012). According to our findings, the effect of a Hippo pathway 
mutation should not indiscriminately affect all cells, but preferentially expand the 
cell populations experiencing a mechanical stress. The existence of a second 
control layer for YAP/TAZ activity overseeing the effects of an Hippo mutation is 
supported by in vivo observations: in the liver, YAP/TAZ hyperactivation by 
Hippo deficiencies generates a functional and histologically well-organized organ 
(Ramos and Camargo, 2012; Zhou et al., 2009), a finding incompatible with 
global and uncontrolled cell proliferation. Similarly, in the α-catenin knockout 
mouse model, YAP activation remains spatially restricted to the basal layer of the 
skin, where YAP protein is normally confined (Schlegelmilch et al., 2011), 
suggesting that cell attachment to the appropriate ECM is instrumental to locally 
sustain normal as well as aberrant YAP activation. Finally, the idea that the 
cytoskeleton is a key input for YAP/TAZ in vivo is supported by recent genetic 
evidence: kidney development requires YAP activation by the CDC42 Rho-
GTPase, well known promoter of F-actin polymerization (Reginensi et al., 2013).  
Besides the Hippo pathway, mechanical cues also dominate the cellular response 
to soluble cues positively affecting YAP and TAZ activity. We show that 
YAP/TAZ activation by WNT or GPCR signaling requires a mechanically 
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stressed cytoskeleton, or, in cells experiencing a soft ECM, inactivation of F-actin 
capping and severing proteins. In the same line of thought, the fact that YAP/TAZ 
are stabilized and act in stem and progenitor cells, typically lodged in specific 
tissue-niches (Ramos and Camargo, 2012), is an enticing argument that the status 
of the ECM, the cell’s cytoskeletal organization and tension may impart a 
“physical” competence for stemness and differentiation.  
 
C.5   Experimental procedures 
C.5.1   Plasmids  
siRNA-insensitive FLAG-hYAP1 WT and 5SA were generated by PCR and 
subcloned in pcDNA3. pXJ40-HA-Merlin/NF2 S518A is Addgene# 19701. 
8xGTIIC-lux (Dupont et al., 2011) is Addgene# 34615.  
 
C.5.2   Cell cultures and Transfections  
MCF10A and MII cells were used with equal results, except for experiments 
shown in Figure 3 and 5 where we used only MII cells. Micropatterned glass 
slides were from Cytoo. Fibronectin-coated hydrogels were as previously 
described (Dupont et al., 2011). The monolayer stretching-device was fabricated 
by using standard soft-lithography techniques. For 3D assays, cells were 
embedded into mixes of Growth Factor Reduced Matrigel (BD Biosciences) and 
CollagenI (TREVIGEN CULTUREX 3D Culture Matrix Rat CollagenI). For 
assays on large square and circular fibronectin-coated islands, 1.000.000 cells 
were plated in a 35mm dish containing a single Cytoo glass slide. siRNA 
transfections were done with Lipofectamine RNAi-MAX (Life technologies). 
Sequences of siRNA are provided in Table S1 and S2. DNA transfections were 
done with TransitLT1 (Mirus Bio). siRNA and DNA transfection were performed 
on sparse cells plated on tissue culture plastics before replating on the various 
ECM substrates and islands. For Retroviral infections see (Azzolin et al., 2012).  
 
C.5.3   Antibodies and Bioassays  
Antibodies: anti-YAP/TAZ (sc101199), anti-CAPZB (sc81804), anti-COFILIN1 
(Epitomics 6663-1), anti-GELSOLIN (sc57509), anti-GAPDH (Millipore 
mAb374), anti-LATS1 (CST) and anti-LATS2 (Abcam), anti-E-Cadherin (BD 
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Biosciences). For microscopy, luciferase, proliferation and real-time PCR assays 
see Extended Experimental Procedures.  
 
Supplemental Information includes Extended Experimental Procedures, six 
figures, and two tables and can be found with this article online at 
http://dx.doi.org/10.1016/j.cell.2013.07.042 
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D.1   Abstract 
Micro-engineering human tissues and “organs-on-chips” remains an open 
challenge from both scientific and technological points of view. Here, we describe 
a robust and efficient microfluidic-based approach for the differentiation of 
human pluripotent stem cells into functional cells. Specific frequency of periodic 
medium perfusion enhances the selectiveness of early germ layer differentiation 
and cell commitment through extrinsic microfluidic signal perturbations. Human 
cardiomyocytes and hepatocytes generated on chip from human pluripotent stem 
cells through multi-stage approach show functional differentiation, which opens a 
new perspective for multi-parametric and large scale human organ-based 
screening assays. 
 
D.2   Results 
The development of human organs-on-chips, in which the microscale engineering 
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technologies are combined with cultured human cells to recapitulate whole living 
organ microenvironment, offers a unique opportunity to study human physiology 
and pathophysiology in an organ-specific context1,2,3. This technological 
perspective could provide an effective solution to the limitations of conventional 
cell culture models that fail to recapitulate complex, organ-level disease processes 
in humans and it could overcome the use of costly and time-consuming animal 
testing, which often shows poor predictive power of human physiology. 
Moreover, the scientific community, the major pharmaceutical companies and the 
government agencies are recognizing the paramount importance of developing 
new technologies, which allow to perform cost effective and multi-parametric 
assay for ad hoc studies in development, disease and pathogenesis, or for 
screening specific therapeutic strategies. 
Recently, successful examples of organs-on-chips development have been 
provided4,5,6,7, however, they were obtained from primary animal cells and, in few 
cases, from primary human cells. The possibility of developing direct 
organogenesis-on-chip from human pluripotent stem cells (hPSCs) could 
overcome the limited availability of human primary cells, such as human 
hepatocytes or cardiomyocytes. Human embryonic stem cells (hESCs) and 
induced pluripotent stem cells (hiPSCs) grown in culture have the potential to 
give rise to any fetal and adult cell type, but they also show intrinsic and 
unexpected levels of emergent self-organization for generating highly ordered 
structures and tissues8,9,10, thus opening a wide perspective for multi-organ 
generation on a chip.  
Organogenesis and tissue generation are complex developmental processes 
starting from germ layer specification and phenotypic differentiation to tissue 
morphogenesis. Biomimetic scale down of this multi-stage developmental process 
could take advantage of the intrinsic properties of micro-technologies and 
microfluidics that allow accurate control of cell culture microenvironment, of 
temporal evolution of chemical gradients and of mechanical features, which 
support specific tissue differentiation11,12,13. Few studies reported on mouse 
embryonic stem cell cultures using microfluidic systems and highlight the 
importance of accurate soluble microenvironment regulation to maintain 
pluripotency and self-renewal14,15,16. We reported for the first time on hESCs 
culture on a chip17 and few other works dealt with hESCs modulating flow 
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perfusion, mainly for maintaining pluripotency18,19. Integrated functional hPSC 
differentiation on a chip, which certainly requires step-by-step control of hPSCs 
programming for resembling early stages of organogenesis, has not yet been 
developed. 
Here, we explored whether we can control stem cell expansion, selective germ 
layer commitment and derive functional tissue-specific cells on a chip from both 
hESCs and hiPSCs through a multi-stage microfluidic-based technology. The 
different developmental stages required cell niche specification in terms of 
accurate balance between extrinsic and intrinsic cell signaling, through optimal in 
vitro delivery of exogenous factors and removal of endogenous cell-secreted 
factors. Continuous microfluidic flow perfusion has been recently shown to 
generate soluble factor spatial gradients along the microfluidic channel that lead 
to heterogeneous cell phenotype. Here, we showed that a discontinuous periodic 
medium delivery with stage-dependent frequency (number of cycles of medium 
change per day) is an effective strategy for modulating stem cell niche 
specification in vitro. 
Identification of the essential role of extrinsic autocrine-paracrine factors in 
pluripotency and self-renewal and germ layer commitment20, suggests a synergic 
mechanism of specific exogenous and endogenous factors in promoting 
transcriptional activity of pluripotency genes (Fig. 1a). The computational 
investigations on extrinsic signaling model (Supplementary Methods for model 
details) revealed that frequency of periodic medium delivery strongly affects 
accumulation of exogenous and endogenous factors, thus regulating 
transcriptional activity of target genes. A frequency increase reduces the 
amplitude of temporal fluctuations of both exogenous and endogenous factors 
(Fig. 1b), thus maintaining sustained transcriptional activity of the associated 
target genes. However, higher frequencies of medium change produce decreased 
expression of gene transcript, due to continuous endogenous secreted factors 
wash-out. This simple schematic modeling reveals high correlation between 
frequency of medium change and extrinsic signaling regulation.  
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Figure 1 Pluripotent stem cell culture on-a-chip. (a) Pluripotency signaling model in microfluidic 
stem cell culture.  Both exogenous (Ex) and endogenous (En) factors contribute to transcriptional 
activity of pluripotency genes through activation of target transcription factors (Tr). (b) Signaling 
model output. Temporal profiles of normalized Ex and En factor concentrations in the microfluidic 
channel at increasing frequencies (up). Gene transcript (Gt) concentration profile plotted versus 
corresponding Transcription factor (Tr) variation during a single medium perfusion at increasing 
frequencies. (c) Experimental set-up. Periodic medium delivery in microfluidic channels (200 µm 
high, 1.5 mm width, 1.8 mm length and 6 µL volume) is controlled through a multi-port delivery 
system. Different frequencies sequences are automatically programmed through Labview software. 
(d) Microfluidic hPSCs culture. Half channel views showing hESCs and hiPSCs expanded for 6 
days in microfluidic conditions with f=2d-1. Insets show typical morphology of stem cells colonies. 
Scale bar 50 µm. (e) Immunofluorescence analysis of pluripotency markers Oct-4, Sox2, Tra-1-60 
and Tra-1-81 for hESCs and hiPSCs after 6 days in microfluidic channels. (f) Frequency-
dependent Oct4 expression. QRT-PCR analysis of pluripotency marker Oct-4 expression of hESCs 
at different frequencies, f, compared to standard static culture control and continuous perfusion 
(CP). Student’s t-test p-value ***P≤0.001. Data are shown as mean ± s.d. (n=3). 
 
First, we investigated the best condition for both hESC line hES2 and hiPSC line 
ADHF#1 expansion in microfluidic channels to maintain high stemness and 
homogeneous morphology among colonies at different regions along the channels. 
HPSCs were injected into multiple microfluidic platforms, each containing 8 
independent channels and connected to a multi-port syringe pump (Fig. 1c), were 
cultured with different frequencies up to 6 days (Fig. 1d). Immunofluorescence 
staining revealed that both hESCs and hiPSCs homogeneously express 
pluripotency markers such as Oct-4, Sox2, Tra-1-60 and Tra-1-81 (Fig. 1e). We 
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optimized the hESC microfluidic culture to maintain high pluripotency in the 
channels, comparable to standard static conditions. The qRT-PCR analysis of 
pluripotency marker Oct-4 after 6 days of culture, showed an optimal frequency 
of f=2d-1 (Fig. 1f). Significant three-fold higher expression compared to lower 
(f=1d-1) and higher frequencies (f=4d-1 and f=8d-1) was observed. These results are 
consistent with the initial hypothesis that an appropriate balance of exogenous 
molecules and endogenous cell-secreted factors has to be provided. The presented 
data show a crucial effect of medium change frequency on hPSCs pluripotency 
maintenance and homogeneity in microfluidics, to allow proper factor supply, 
while avoiding up-downstream effects throughout the channels (Supplementary 
Fig. S1). 
We next investigated whether the frequency of periodic perfusion could be used 
for directing early germ layer commitment according to extrinsic endogenous and 
exogenous factors concentration (as schematized in Fig. 2a). HES2 cells were 
expanded for 3 days and differentiated for 4 days at different frequencies in 
spontaneous differentiating conditions (Supplementary Methods). Expression 
levels of early germ layers markers were analyzed through qRT-PCR analysis of 
β-III tubulin (ectoderm), brachyury T (mesoderm) and alpha-fetoprotein 
(endoderm). Under these conditions, the static culture showed ectoderm and 
mesoderm expression but not endoderm. On the other hand, frequency-dependent 
germ layer enrichment was observed in microfluidic culture (Fig. 2a). Ectoderm 
resulted highly expressed at lower frequencies (f=1d-1 and f=2d-1) and it is 
completely down regulated at higher frequency (f=8d-1) whereas mesoderm and 
endoderm expression are enhanced at higher frequency (f=8d-1). Interestingly, 
pluripotency markers are down regulated as the frequency increases. Gene 
expression is associated with cell morphology changes (Fig. 2a). These 
experimental observations are consistent with the hypothesis that ectoderm 
differentiation requires high accumulation of extrinsic endogenous factors14,20, 
whereas strong endoderm enrichment is only possible with specific exogenous 
factor delivery. All together, these results suggest that periodic perfusion 
frequency is an additional player in directing early germ layer commitment. 
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Figure 2 | Early germ layer induction of hESC on-a-chip. (a) Frequency-dependent differentiation. 
Schematic of frequency, f, relation to En and Ex factors balance (up). The qRT-PCR analysis (gene 
expression normalized on glyceraldehyde 3-phosphate dehydrogenase) of Oct-4, β-III tubulin, 
brachyury T and alpha-fetoprotein in hESC spontaneous differentiation on chip, under different f. 
Cell morphology in phase contrast for each differentiation condition. Scale bar 50 µm. Data are 
shown as mean ± s.d. (n=3). (b) Early germ layer induction with specific media. The qRT-PCR 
analysis of Oct-4, β-III tubulin, brachyury T and AFP, and comparison between standard static 
control and microfluidic differentiation. Data are shown as mean ± s.d. (n=3). (c) Specific 
differentiation marker expression. Differentiation protocols applied on hESC line cultured on 
matrigel-coated channels. Immunofluorescence analysis of each differentiation protocol, with high 
expression of β-III tubulin in ectoderm, brachyury T in mesoderm and AFP in endoderm. Scale bar 
50 µm. (d) Mesoderm optimization. The qRT-PCR analysis of Oct-4 and brachyury T expression 
in different frequencies of medium change for germ layer commitment optimization. brachyury T 
expression is comparable between f=3d-1 and f=2d-1, while there is a significantly lower expression 
at high and low frequencies. Student’s t-test p-values *P≤0.05 **P≤0.01. Data are shown as mean 
± s.d. (n=3). 
 
To verify whether an efficient and selective induction of the three germ layers 
could be achieved, hES2 cells were induced to ectoderm, mesoderm and 
endoderm by specific differentiation media and with ad hoc frequency (Fig. 2b). 
Particularly, according to previous results, f=1d-1 was used for ectoderm 
specification whereas f=2d-1 and f=3d-1 for mesoderm and endoderm, respectively. 
Selective germ layer commitment was successfully obtained as reported by qRT-
PCR analysis, which showed high expression of specific germ layer genes for 
each differentiation protocol. All other non-specific germ layer genes are strongly 
down regulated. Interestingly, endoderm is significantly higher expressed in 
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microfluidic condition, compared to conventional differentiation in Petri dish. It 
seems that microfluidic environment effectively washed out the endogenous 
factors that inhibit endoderm differentiation, and efficiently delivered the 
exogenous pro-endoderm factors. Immunofluorescence analyses (Fig. 2c) 
confirmed that highly selective commitment for all germ layers, with extremely 
low contamination from the others, is achievable also at the protein level in each 
specific differentiation protocol. 
Next, we examined if perfusion frequency can be further adjusted for optimizing 
germ layer microfluidic induction when specific differentiation protocols are used. 
As proof of concept, results in Fig. 2d showed how selective induction of 
mesoderm was achieved by adjusting frequency of periodic perfusion. In 
particular, we found a 3 fold higher brachyury T expression at f=2d-1 and 3d-1, 
compared to f=1d-1 and almost null expression at f=12d-1. 
Collectively, our findings indicate that the frequency of periodic perfusion is an 
additional parameter to enhance robustness and efficiency of early germ layer 
specification, even when specific protocols are adopted. In particular, we found 
major advantages for endoderm differentiation, because it requires large quantities 
of exogenous molecules (e.g. activin A) and washing out of endogenous inhibiting 
factors. On the other hand, mesoderm differentiation seems to require a proper 
balance between exogenous and endogenous molecules that can be achieved by 
frequency optimization, although dependent on cell culture density and media 
composition. Ectoderm commitment is mainly driven by endogenous stimulations 
and microfluidic differentiation can reproduce the results obtained with 
conventional cell culture methods. From technological point of view, small-scale 
microfluidic volume leads to extremely reduced medium consumption (few 
microliter per day per channel) and rapid and accurate perturbation of medium 
composition that is an important prerequisite for multi-stage differentiation 
process. 
Therefore, we then demonstrated whether functional tissue-specific cell 
generation on chip could be achieved. We focused on cardiac and hepatic cells 
that are derived from mesoderm and endoderm germ layers, respectively, and are 
extremely relevant for organ-on-a-chip applications. Cell differentiation was 
achieved by combining ad hoc hPSCs differentiation stages, germ layer 
specification and mature differentiation with proper frequencies of periodic 
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perfusion and chemical regulation of soluble microenvironment. Cardiac and 
hepatic cell differentiation protocols are described in Supplementary Methods. 
We first showed how cardiac cells on chip were derived after 15 days of 
frequency-dependent multi-stage differentiation protocol (Fig. 3a), consisting on 
mesoderm induction (by Wnt induction), early cardiac commitment (by Wnt 
inhibition) and functional cardiac maturation (by pro-cardiac factors supply). 
Typically 5 to 10 thousands cells per channel were obtained. We robustly 
achieved spontaneous contractile activity from both hES2 and ADHF#1-derived 
cardiomyocytes, 60% of cardiac troponin-T positive cells showing defined cardiac 
sarcomeric organization (Fig. 3b). HPSC-derived cardiomyocytes show 
spontaneous calcium transients and excitation contraction coupling (Fig. 3c). In 
the line scan magnification in Fig. 3c both calcium transients and spark-like 
spontaneous activity are presented. Analyzing calcium handling of hPSC-
cardiomyocytes in microchannels, we observed cardiomyocyte functional 
response to 0.5 µM Verapamil with reduced calcium release after L-type channel 
inhibition, and response to 10 mM caffeine with cytosolic calcium increase after 
ryanodine channel activation (Fig. 3d). We successfully showed that it is possible 
to generate functional cardiac cells on chip and to directly perform dynamic 
biochemical stimulations taking advantage of the microfluidic environment, 
which allows robust, accurate, fast, and cost-effective spatio-temporal control of 
cell microenvironment11. 
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Figure 3 | Cardiac and hepatic functional differentiation on-a-chip from both hESCs and hiPSCs. 
(a) Microfluidic cardiomyocyte differentiation protocol and morphology changes from pluripotent 
state to differentiated cell type. Scale bars 200 µm. (b) Immunofluorescence analysis of hES-
derived CM showing F-actin and cardiac troponin-t organization. Scale bars 20 µm (c) 
Microfluidic calcium dynamics. Spontaneous calcium transients in hPSC-cardiomyocytes recorded 
with Fluo-4 indicator. (d) Functional cardiomyocytes response to 0.5 µM verapamil with reduction 
in calcium release, and to 10 mM caffeine with increase in cytosolic calcium. (e) Hepatic 
differentiation protocol and cell morphology change up to hepatocyte-like cells. Red arrows 
indicate binucleate cells in late stages.  Scale bars 200 µm. (f) Immunofluorescence analysis of 
hepatocyte-like markers albumin and cytochrome P450 3A from hESCs. Scale bars 30 µm. (g) 
Quantification of immunofluorescence markers. Microfluidic hepatic cells show significant higher 
expression of albumin and CYP-3A compared to static control. Data are shown as mean ± s.d. 
(n=10). (h) PAS staining of hepatic cells derived on chip; nuclei are stained in blue, pink-violet 
colored cells show glycogen storage. Indocyanine green staining of live hepatic cells; colorant is 
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absorbed and metabolized in 6 h by functional hepatocyte-like cells. Scale bars 100 µm. (i) ELISA 
albumin secretion quantification. Microfluidic-derived hepatocyte-like cells secrete 40% more 
albumin compared to static control at the last day of differentiation (albumin production rate is 
expressed as ng/mL/day/2x10^5 cells). Student’s t-test p-values *P≤0.05 **P≤0.01. Data are 
shown as mean ± s.d. (n=3). (j) Comparison of Albumin production at Day 14 for different hiPSC 
lines differentiated in hepatocytes-like cells. Levels of albumin production comparable to hES2 
hESC line derived hepatocytes were obtained for hiPSCs lines ADHF#1, derived with retroviruses, 
SEN#1, derived with Sendai viruses and RNA#1-2, derived with mRNA technology. Albumin 
production rate is expressed as ng/mL/day/2x10^5 cells. 
 
We next applied our methodology to derive hepatocytes on chip, consistently with 
the previously endoderm-optimized conditions, which showed higher efficiency in 
endoderm differentiation than conventional cell culture. Hepatic cells were 
robustly obtained from hES2 and ADHF#1 cells by early endoderm commitment, 
definitive endoderm specification and hepatocyte-like cell maturation steps, 
driven by specific periodic medium delivery (Fig. 3e). Characteristic polygonal-
shaped hepatocyte-like cells were obtained, with presence of bi-nucleate cells at 
the late stage, showing high expression of the specific hepatic markers albumin 
and cytochrome P450-3A (Fig. 3e-f and Supplementary Fig. S3a-b). 
Quantification of immunofluorescence of late stage albumin and CYP-3A in hES2 
cells shows higher expression in microfluidic differentiated cells compared to 
differentiation control on Petri dish (Fig. 3g and Supplementary Fig. S3c-d). 
Similar results were obtained by applying our method to other hiPSCs lines 
derived with non-integrating methods: SEN#1, derived with non-integrating 
Sendai viruses and RNA#1 and RNA#2, derived with mRNA technology 
(Supplementary methods and Supplementary Fig. S4). The hepatic cells show 
functional activity by high glycogen storage capacity (75% of total cells) and 
indocyanine green uptake and clearance (Fig. 3h), which is extremely relevant for 
hepatic drug metabolism studies. As expected from prior results, compared to 
static conditions, we obtained a shortening of the time required for differentiation 
(from 16d to 14d) and 40% greater albumin secretion rate on the last day of 
maturation (Fig. 3i). An albumin production rate comparable with hESCs derived 
hepatocytes was obtained with the four different hiPSCs lines (ADHF#1, SEN#1, 
RNA#1 and RNA#2), confirming the robustness of the method (Fig. 3j). The 
microfluidic environment together with optimized periodic perfusion frequency 
provides an effective methodology for generating hepatic-like tissues on a chip 
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with remarkable functional differentiation also compared to conventional cell 
culture methods.  
In conclusion, we derived functional tissue-specific cells on a chip through a 
robust multi-stage microfluidic technology, which allows accurate spatio-temporal 
control of cell soluble microenvironment through regulation of periodic-perfusion 
frequencies. Moreover, functionally differentiated cells derived in the microfluidic 
channels can be directly used for dynamic multi-parametric and large-scale drug 
screening or for developing micro-engineered human organ models. This 
technology opens a new perspective in generating organs-on-chips from hPSCs 
overcoming the issues related to the limited availability of human primary cell 
sources. This last aspect will require strong scientific and technological efforts for 
further mimicking the organogenesis in vitro. 
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D.4   Supplementary methods 
D.4.1   Computational Model 
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Mathematical model of signaling pathway describing gene transcriptional activity 
promoted by synergic positive effect of extrinsic exogenous and endogenous 
factors is shown in Fig. 1a. The model takes into account only relevant 
phenomena to highlight the effect of dynamic changes in extrinsic factors 
modulated by medium delivery frequency, f, on a hypothetic transcriptional 
activity. Black arrows in Fig. 1a indicate chemical reactions involved in the 
pathway. In particular, reactions (1) and (2) describe the coupling of exogenous, 
Ex, and endogenous, En, factors to specific membrane receptors, which promotes 
the activation of transcriptional factor, Tr. In addition, Tr is activated at a basal 
level through reaction (3) and induces expression of pluripotency-associated 
genes through reaction (4). Gene transcripts, Gt, in turn, produce newly En, as 
indicated by reaction (5). The model consists of four ordinary differential 
equations describing dynamic mass balance equation for the involved species Ex, 
En, Tr and Gt: 
 
  
                                                                                         (1) 
 
                                                                                                                                       
c are concentrations of species involved in the pathway (Ex, En, Tr and Gt); ~ 
symbol indicates adimensional concentration normalized for the initial 
concentration value c0. N is the molar flux, given from the product between the 
medium flow rate and the concentration of each species, at the inlet and outlet of 
the microfluidic channel. Exogenous inlet flux is constant, as exogenous factors 
are continuously supplied with medium, whereas outlet fluxes are time-dependent. 
All chemical reaction rates are assumed first order kinetics as follows: 
 
 
                                                                                                                    (2)  
V1 = k1cEx
V2 = k2 cEn
V3 = k3
d cEx
dt
= NEx
IN - NEx
OUT -V1
d cEn
dt
=- NEn
OUT -V2+V5
d cTf
dt
=V1V2+V3
d cGt
dt
=V4 -V5
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, 
where ki are constant of reaction with arbitrary value and dimension [t-1].  
As an intermittent flow perfusion for medium delivery will be used, system of 
equations (1) can be solved throughout an interval time equivalent to the 
reciprocal of the frequency, 1/f, and for a defined number of cycles, Ntot. 
Consequently, null inlet and outlet fluxes and opportune initial periodic conditions 
were set. Time for medium change in the microfluidic channel was assumed 
negligible and periodic concentration values of Ex and En were set equal to 1 and 
0 respectively after every time period (1/f). The system was solved for different 
values of f with periodic initial conditions written as follows: 
                
System of ordinary equations (3) was computationally solved with MATLAB, by 
using ode15s function. Constant rates k1, k2, k4 and k5 were arbitrarily set equal to 
1, whereas k3 was taken equal to 0.1. Ntot was chosen in order to achieve a pseudo-
stationary of all species concentrations. 
 
D.4.2   Microfluidic device micro-fabrication and protein functionalization 
The microfluidic chip was fabricated by standard soft-lithographic techniques1. 
The master was photo-lithographically patterned by using SU8-2100 negative 
photoresist (MicroChem, Newton, MA) to obtain a final thickness of 200 micron, 
according to manufacturer’s indications. A premixed 10:1 ratio of 
polydimethylsiloxane, PDMS, pre-polymer and curing agent solution (Sylgard 
184 kit; Dow Corning, Midland, MI) was casted on the silicon wafer and cured at 
70 C° for 2 h. The PDMS mold was cut, peeled off, and punched with a 21G 
V4 = k4 cTf
V5 = k5 cGt
d cEx
dt = −k1
cEx
d cEn
dt = −k2
cEn + k5 cGt
d cTf
dt = k1k2
cEx cEn + k3
d cGt
dt = k4
cTf − k5 cGt
"
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$
%
$
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$
cEx (t =
i
f ) =1
cEn (t =
i
f ) = 0
cTf (t = 0) = 0.1
cGt (t = 0) = 0.1
i = 0,1,...,N
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stainless steel needle (Small Part Inc., Logansport, IN) to obtain inlet/outlet holes. 
The PDMS mold was assembled and sealed to a 50×75 mm cleaned glass slide by 
plasma bonding. Eight independent medium reservoirs (3mm diameter and 4mm 
height for about 30microL volume), one for each channel, were obtained by 
sealing an additional PDMS block to the top of the device by plasma bonding. 
The assembled device was cleaned with isopropanol (Sigma-Aldrich, St. Louis, 
MO) and sterilized in an autoclave.  
Microfluidic channels were filled with Matrigel Reduced Factor, MRF (BD) 
diluted in IMDM (Invitrogen) to a final concentration of 20% and incubated 
overnight at 4°C. Coating solution was aspirated and microfluidic device was 
incubated at 37°C and 5% CO2 atmosphere for 1 h. 
 
D.4.3   Sendai viruses-mediated hiPSCs generation 
Human fibroblasts derived from skin-biopsy were plated and cultured in a 24-well 
plate and cultured to 70% confluence in fibroblast medium (DMEM supplemented 
with 10% FBS). CytoTune iPS Sendai Reprogramming Kit (Invitrogen) based on 
replication incompetent Sendai virus was used to deliver the four transcription 
factors Oct4, Sox2, Klf4 and c-Myc and induce reprogramming to iPSc, according 
to manufacturer instructions. After 24h transduction, cells were fed every other 
day for 7 days. Transduced cells were then transferred onto inactivated MEF 
feeder cells at a density of 1 x 104 cells on a 6-well plate and expanded as reported 
below. 
D.4.4   mRNA-mediated hiPSCs generation 
Human iPS reprogramming using modified mRNA (mmRNA) was performed 
following the protocol of Warren et al2. Briefly, inactivated human newborn 
foreskin fibroblast feeders (NuFF-RQ, AMS Biotechnology) were seeded in 6-
well tissue culture plates, coated with gelatin 0.2%, at a density of 260 cell/mm2, 
and cultured in DMEM supplemented with 10% fetal bovine serum, FBS 
(Invitrogen). Cells were always incubated at 37°C and 5% CO2. After 24 h, 
human foreskin BJ fibroblasts (Miltenyi Biotec) were seeded at 10 cell/mm2 and 
cultured in Eagle's minimal essential medium (EMEM, Invitrogen) with 10% 
FBS. After another 24 h, medium was replaced with Pluriton reprogramming 
medium (Miltenyi Biotec) supplemented with B18R interferon inhibitor (Prodotti 
Gianni) at a final concentration of 200 ng/mL, and transfections using mmRNA 
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(Miltenyi Biotec) were started and repeated for 18 days, 4 hours prior to daily 
medium changes. The transfection mix was prepared pooling two solutions: the 
first obtained diluting 5X 100 ng/µL mmRNA of  Oct4, Sox2, Klf4, c-Myc, 
Nanog, Lin28, and nuclear GFP in OptiMEM (Invitrogen), and the second 
diluting 10X lipofectamine RNAiMAX (Invitrogen) in Opti-MEM. After mixing, 
the final solution was incubated for 15 min and then added to the culture medium. 
At day 6 after the first transfection, Pluriton reprogramming medium was replaced 
with B18R-supplemented NuFF-conditioned Pluriton medium, which was 
produced culturing in parallel NuFF cells in T75 flasks with Pluriton medium 
supplemented with bFGF (Peprotech) at 4 ng/mL. Two days after the last 
transfection, iPS colonies were picked and passaged to MEF-coated 12-well plates 
and expanded as reported below. 
 
D.4.5   Human pluripotent stem cell expansion and microfluidic culture 
HiPSCs (cell line ADHF#1, obtained from Center for iPS Cell Research and 
Application, iCeMS, Kyoto University; cell line SEN#1, generated with Sendai 
viruses; cell lines RNA#1 and RNA#2, generated with mRNA technology) and 
hESCs (cell line HES2, from National Stem Cell Bank, Madison, WI) were 
cultured in gelatin-coated multiwells with mitomycin C-treated mouse embryonic 
fibroblasts (MEF; Chemicon) co-culture, in expansion medium DMEM F-12 
(Invitrogen), 20% KO serum (Invitrogen), 10% MEF conditioned medium (not 
used for hiPSCs), 20 ng/mL basic fibroblast growth factor for hESCs, 10 ng/mL 
for hiPSCs (b-FGF; Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), 1% non-
essential amino acid (Invitrogen) and 1% Pen/Strep (Invitrogen). HPSCs were 
passaged to new feeder using CTK solution (trypsin 0.25% - collagenase IV - 
Ca2+) for hiPSCs and trypsin 0.25% for hESCs (Invitrogen). For MEFs depletion 
and cell expansion and differentiation, cells were passaged on matrigel-coated 
microchannels. 
The hPSC suspension was injected into each channel and the microfluidic chip 
was incubated overnight at 37°C and 5% CO2 atmosphere without perfusion, to 
allow cell adhesion to substrate. We used proper cell seeding concentration to 
achieve 70% confluence cell culture at 24 h after seeding. 
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A 9-port pump (Cavro® XR Rocket pump, TECAN, San Jose, CA) was used to 
independently deliver the medium from the reservoirs into each microfluidic 
channels. 0.5 ID Tygon tubings (Cole-Parmer, Vernon Hills, IL) and 21G 
stainless-steel needles with a polypropylene luer (Microtest, Taipei, Taiwan) were 
used to connect the microfluidic chip to the pump. Discontinuous medium 
delivery with defined temporal frequencies was achieved by automatically 
controlling the multi-channel syringe pump through LabView 8.2 (National 
Instruments, Austin, TX). For pluripotency maintenance, hPSCs were cultured 
with a 2-cycles/day expansion medium change. A minimum of 3 independent 
microfluidic channles were used for each experimental conditions. 
 
D.4.6   HPSCs early germ layer microfluidic differentiation 
For spontaneous differentiation, no exogenous factors and cytokines were used, 
and the basal medium is composed of KnockOut DMEM, FBS 20%, NEAA 1%, 
L-glutamine 0,5% and P/S 1% (all from Invitrogen). Ectoderm differentiation was 
induced with DMEM F-12 and Neurobasal medium (both from Invitrogen), 1:1 
ratio, supplemented with B27 1% (Invitrogen), N2 1% (Invitrogen) and β-met 0.1 
mM3,4. Mesoderm differentiation was induced with StemPro-34 (Invitrogen) 
supplemented with 2 mM L-glutamine (Invitrogen), transferrin 200 ng/mL, 0.5 
mM ascorbic acid (Sigma), activin A 0.3 ng/mL (R&D), BMP-4 3 ng/mL 
(R&D)5. Endoderm differentiation was induced with RPMI1640 containing 1X 
B27 (both from Invitrogen), 1mM sodium butyrate (Sigma), 100 ng/ml activinA 
(Peprotech) and 50 ng/mL Wnt3a (R&D)6 for the first 2 days. The second 
endoderm medium was KO DMEM with KO serum 20%, L-glutamine 1 mM, 
NEAA 1%, DMSO 1%, β-met 0.1 mM, P/S 1% for other 2 days. HPSCs 
specification was induced for 4 days in all three germ layers. A minimum of 3 
independent microfluidic channles were used for each experimental conditions. 
 
D.4.7   Microfluidic cell maturation 
For cardiac differentiation cells were treated with activin A at 0.3 ng/mL (R&D) 
in RPMI/B27-insulin. After 24 h, the medium was changed to RPMI/B27-insulin 
supplemented with 5 ng/mL BMP4 (R&D) for another 4 days. At day 5, the 
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medium was changed to RPMI/B27-insulin. At day 7 the cells were transferred to 
RPMI/B277. 
For hepatic differentiation cells were treated with 100 ng/ml activin A and 0.5mM 
NaB for 3 days in RPMI/B27. Medium was changed to KO-DMEM, 20%SR 
(both from Invitrogen), 1 mML-glutamine, 1% NEAA, 0.1 mMβ-met, 1% DMSO 
(Sigma) for 6 days. Hepatic-like cells were maturated with L15 medium (Sigma) 
supplemented with 8.3% FBS, 8.3% tryptose phosphate broth, 10 µM 
hydrocortisone 21-hemisuccinate, 1 µM insulin (all from Sigma) and 2 mML-
glutamine containing 10 ng/ml hepatocyte growth factor and 20 ng/ml oncostatin 
M (both from R&D) for 6 days8. For adult specification and maturation, cells 
were cultured with f=2d-1 maturation medium change.  
The functional differentation of cardiac and hepatic cells were performed in 30 
and 50 independent microfluidic experiments, respectively. 
D.4.8   Functional tests 
For cardiac functional tests, cardiomyocytes were analyzed at confocal 
microscopy (Leica SP5) for calcium transient, and caffeine and verapamil 
treatments9. 
For hepatic functional tests, hepatocyte-like cells were stained with PAS staining 
(Sigma) according to manufacturer’s instructions, for glycogen storage revelation. 
Indocyanine green test (ICG from Sigma) was performed on living tissue on chip 
by incubating living tissue for 15 min with dye solution. Green cells retaining ICG 
were photographed. After 6 hours, same fields were photographed in order to see 
complete clearance of ICG by functional hepatocyte-like cells. Albumin 
production and excretion was assessed by collection spent medium (10 µL from 
each micro-channel) and performing enzyme linked immunosorbent assay ELISA 
(Immunology Consultants Laboratory, Inc.) following manufacturer’s 
instructions. Expression levels were detected by using plate reader Ininite F2000 
PRO (Tecan). 
D.4.9   Immunofluorescence and qRT-PCR 
Immunofluorescence analyses were performed on paraformaldehyde 4% fixed 
cells for 15 min. Blocking and permeabilization was performed with heat 
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inactivated serum 5%, TritonX-100 (Sigma) 0.1% for 1h. Cells were stained using 
primary antibodies in blocking buffer 1 h room T, or overnight 4°C, depending on 
the antibody. Immunostaining was done with secondary antibodies Alexa Fluor 
488, 594 (Invitrogen) and Hoechst nuclear staining incubation for 1 h at 37°C. 
Videos, bright fields and immunofluorescence images and merges were taken on 
Leica DMI 6000 B. 
The qRT-PCR was performed with TaqMan gene expression assay probes 
(Invitrogen) according to manufactures instructions using GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase), POU5F1 (oct4), TUBB3 (beta-III 
tubulin), AFP (alpha-fetoprotein), T (brachyury) probe sets (all from TaqMan 
Invitrogen). Reaction was done on ABI Prism 7000 machine and results were 
analyzed with ABI Prism 7000 SDS software. GAPDH expression was used to 
normalize values of gene expression, and data are shown as fold change relative to 
the value of the sample control. 
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D.5   Supplementary figures 
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Supplementary Figure 1 Pluripotency marker expression in human pluripotent stem cells 
cultured in microchannels with f=2d-1. (a) “HES2” hES cell line showing Oct-4 and Sox2 
expression. (b) “ADHF#1” hiPS cell line showing Oct-4 and Sox2 expression. High homogeneity 
in expression is shown along the microchannels with no upstream and downstream effects. Scale 
bar 500µm. 
 
 
 
Supplementary Figure 3 (a-b) HES and hiPSC-derived hepatocyte-like cells. Cells from both cell 
lines show comparable differentiation into polygonal hepatocyte-like cells with similar albumin 
secretion. (c-d) Comparison between standard static (c) and microfluidic (d) hepatic differentiation 
of hPSC. Cells show similar expression of CK-18 hepatic endoderm marker. Microfluidic 
hepatocyte-like cells show higher expression of albumin and Cyp-3A compared to standard static 
differentiated cells. Scale bar 50µm. 
a! b!
c!
d!

  
 
Supplementary Figure 4 Different hPSCs lines differentiated into hepatocyte-like cells: human 
embryonic stem cell line hES2; human induced pluripotent stem cell line ADHF#1 derived with 
retroviruses; SEN#1 derived with Sendai virus; RNA#1 and RNA#2 derived with mRNA 
tchnology. Panel shows cells in bright field and F-actin for cell morphology and polygonal-
epithelial shape structure. Hepatocyte-like cells derived from each line have been marked for 
Cytokeratin 18, showing late hepatic endoderm epithelium, and Albumin, marking hepatocyte-like 
cells producing human albumin. Scale bar 50µm. 
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E.1   Abstract  
Cyclic mechanical stimulation has been found to deeply affect cell behavior in 
terms of cytoskeleton remodeling, signaling pathways alteration and differential 
gene expression in several diseases. In Duchenne Muscular Dystrophy (DMD), 
the lack of protein dystrophin, which plays a structural and regulatory role in 
preserving membrane integrity and homeostasis, mechanical stress seems to 
deeply affect the pathogenesis of muscle fibers, as resulted in many studies on 
mdx, a DMD mouse model.  
In this study we aimed at investigate if the lack of dystrophin results in 
impairment of membrane integrity after prolonged mechanical stimulation in a 
human in vitro model. We developed an ad hoc microfluidic-based cell-stretching 
device in order to apply defined external stimuli, in terms of both frequency and 
intensity, to a primary myoblasts and myotubes cell culture. Computational 
modeling supported the design of the device and was adopted in order to estimate 
the mechanical state induced on the cells.  
In order to validate the efficacy of our system, we subjected C2C12 myoblasts to 
both static and cyclic (1Hz) mechanical stretch for 2h, showing a frequency-
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dependent cytoskeletal actin filaments remodeling along the direction of 
minimum strain. 
Thanks to the developed technology we were able to investigate the role of cyclic 
stretch in affecting membrane permeability of both healthy and dystrophic 
myotubes through a membrane impermeable dye, showing that DMD myotubes 
have a higher stretch-induced membrane permeability compared to healthy 
myotubes, both subjected to 90 min cyclic deformation of 20%. Interestingly, the 
same effect was not observed after only 45 min of the same cyclic deformation. 
We also investigated the implication of increased stretch-dependent membrane 
permeability in the activation of the calcium dependent protease, calpain-2, which 
results aberrantly expressed in dystrophic myotubes, compared to the healthy 
ones. 
In conclusion, we provide a new micro-technologic approach to effectively 
investigate early pathologic expressions of dystrophic muscle tissue, in a human 
DMD in vitro model, by mimicking mechanical stimuli to which muscle fibers are 
exposed in vivo. Moreover, the developed device could also be used as platform 
for investigating new therapeutic targets or for drug screening assays. 
 
E.2   Introduction 
Mechanical stress plays a crucial role in the investigation of new physiological 
and pathological responses to cell culture microenvironment. It is recognized that 
active deformation promotes cellular growth and survival, influence metabolic 
processes and gene expression, and governs tissue architecture in various cell 
types1,2,3,4,5. Muscle cells are highly responsive to mechanical forces; indeed, 
expression of skeletal muscle specific genes and skeletal muscle functional 
maturation, including sarcomeric structural organization and contractile apparatus 
development, can be modulated by applying an external mechanical stress2,6.  
Myofiber is the functional unit of skeletal muscle in vivo, in which a regular array 
of contractile units (sarcomeres), comprised of thin actin filaments and thick 
myosin filaments and additional structural and regulatory proteins, allow response 
to mechanical stress7. The peripheral myofibrils are connected to the sarcolemma 
along the Z-disks via interactions with sub-sarcolemmal protein complexes called 
costameres. These structures transmit contractile forces from sarcomeres of one 
myofiber to another, which prevents sarcolemma ruptures by synchronizing 
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contraction of myofibers within the muscle7. The integrity of this protein complex 
is crucial for the contracting myofiber to withstand the mechanical stress 
generated by sarcomeres and to prevent its fragile sarcolemma from contraction-
induced injuries7. Failure to attach properly results in sarcolemmal disruption, 
which is the predominant underlying cause of several forms of muscular 
dystrophies. Among them, Duchenne Muscular Dystrophy is caused by mutation 
in the gene encoding for protein dystrophin, which is a large protein and central 
membrane complex component8, compromising the mechanical stability of the 
muscle fiber and/or its sarcolemma. Muscle fibers damage is exacerbated during 
normal muscle contractions and initiates a lethal cascade of events that can cause 
death of the myofiber8 (necrosis) and fibrotic tissue formation9. 
At cellular level, cytoskeletal protein dystrophin plays a crucial role in the 
structural maintenance of myofibers membrane integrity, as well as in the 
regulation of membrane homeostasis10. Lack of dystrophin in mdx mouse, a DMD 
mouse model, has been shown to cause aberrant mechano-transduction in skeletal 
muscle fibers11,12, and mechanical stress seems to deeply affect the disease 
pathogenesis by triggering intracellular calcium increase, which finally leads to 
fiber necrosis13,14. 
Many studies recognize an increased stretch-sensible channels activity in mdx 
muscles, compared to the healthy ones10,13,15,16,17. This abnormal activity causes an 
accumulation of intracellular calcium, [Ca2+]i, which makes the membrane more 
permeable either through activation of phospholipase A2 or by excessive 
production of ROS, leading to lipid peroxidation, and enhances membrane 
permeability. Allen et al. reviewed that a variety of stretch-activated and store-
activated channels have all been shown to function abnormally in dystrophic 
muscle, although the mechanism by which the absence of dystrophin triggers 
abnormal channel activity remains unclear18.  
Conversely, there is broad evidence that muscle fibers from mdx mouse are 
weaker and more permeable to soluble factors and macromolecules when exposed 
to cycles of mechanical stimulations. Moreover, eccentric contractions allow 
soluble cytosolic proteins such as creatine kinase, to leak out of the plasma 
membrane, whereas extracellular proteins, such as albumin and fibronectin can be 
detected inside the muscle18,19. Experimentally the increased membrane 
permeability has been repeatedly confirmed by studies in which markers normally 
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membrane-impermeable, such as albumin and Evans Blue dye, can be detected 
inside muscle fibers18,20, whereas membrane damage was reduced by stretch-
activated channel blockers which would have prevented the rise in intracellular 
calcium [Ca2+]i21. These experimental evidences on mdx mice prove that cyclic 
mechanical stimulation strongly affects the maturation of dystrophic muscle 
phenotype, suggesting a central role also in humans. A human in vitro study 
directed at recapitulating physiological mechanical stress induced effects on 
dystrophic skeletal muscle has never been reported yet.  
For this reason we aim at developing a human DMD skeletal muscle in vitro 
model in order to investigate the role of cyclic mechanical stress in affecting 
membrane integrity. Mimicking stress-induced membrane damage in vitro 
requires the development of appropriate technological solutions, which allow tight 
control of stimulation distinguishing between physiologic and non-physiologic 
deformation and dynamics. A number of technological solutions have been 
proposed for stretching cultured cells using elastic membranes. Beside most 
common commercially-available cell-stretching device (Flexcell Corporation) 
largely adopted in many works1,2,22, a number of custom-made solutions have 
been proposed to perform mechanical stimulations on cell cultures in uniaxial and 
biaxial directions. For instance, Grossi et al. used a magnetic beads-based assay to 
mechanically stimulate C2C12 myoblast under the effect of a magnetic field23, 
whereas, Akbari et al. developed two sets of high-throughput single cell stretcher 
devices based on dielectric elastomer micro-actuators to stretch groups of 
individual cells with various strain levels in a single experiment24. However, the 
accurate control in space and time of mechanical-induced deformations while 
observing the cellular behavior at single cell through optical confocal microscopy, 
are not straightforward. Moreover, the relative large scale of the existing 
technology hinders to investigate high temporal resolution cell behavior under fast 
cyclic mechanical stimulations. Sophisticated technological solutions, such as by 
coupling Myotack sealant and micro-tweezers25,26, were proposed for performing 
single cell mechanical stimulation. However, the intrinsic complexity of these 
systems make difficult to simultaneously perform multi-parallel experiments 
analyzing the mechano-associated single cell response in high-throughput fashion. 
For this reason, we designed an ad hoc cell-stretching device, based on the 
microfluidic technology, in order to apply accurate cyclic mechanical deformation 
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on several micro-regions inside the same culture chamber, both in radial and 
circumferential directions. Miniaturization of the system allows a frequency up to 
1 Hz with 32 independent observations and internal, not-stimulated controls. 
Computational modeling to fully characterize elastic membrane deformation 
under application of the internal pressure and to estimate the level of local strains 
supported the development of the device. These data were adopted in order to 
accurately calibrate the mechanical bi-directional deformation induced on the 
cells. 
Thanks to the developed device we were able to investigate the effect of cyclic 
physiologic stretch on early pathological events in dystrophic myotubes using a 
human DMD in vitro model. We investigate the role of cyclic stretch in affecting 
membrane permeability of both healthy and dystrophic myotubes through the use 
of a membrane impermeable dye, showing an increase of membrane permeability 
in dystrophic myotubes, compared to the healthy control.  
 
E.3   Experimental methods!
E.3.1   Cell culture 
Human myoblasts from both healthy and diseased patients were provided by 
‘‘Telethon BioBank’’ (Telethon Research Service, Istituto Nazionale Neurologico 
‘‘Carlo Besta’’, Milano, Italy). Myoblasts were expanded in 0.1% gelatin coated 
Petri dish with proliferative medium: 60% High-Glucose Dulbecco’s Modified 
Eagle’s Medium, DMEM, with Glutamax (Invitrogen, New York, NY), 20% 
M199Medium (Sigma-Aldrich, St. Louis, MO), 20% FBS (Invitrogen), 10 ng/ml 
EGF (PeproTech, Rocky Hill, NJ), 2 ng/ml β-FGF (PeproTech), 10 ng/ml insulin 
(insulin from bovine pancreas, Sigma-Aldrich), Penicillin-Streptomycin-
Glutamine (Invitrogen). Before reaching the confluence, cells were trypsinized 
with 0.25% Tripsina-EDTA (Invitrogen) and replated either in a new dish or onto 
stretching devices. Myoblasts were induced to form myotubes in differentiating 
medium: 98% High-Glucose DMEM, 2% horse serum (Invitrogen), 30 ng/mL 
insulin, penicillin, streptomycin and glutamine. 
 !
E.3.2   Cell-stretching device fabrication and management 
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Stretching-devices were fabricated by using standard soft-lithography technique. 
High resolution-printed photo-mask was photo-lithografically patterned on a 
silicon wafer by spin-coating SU8-2050 negative photoresist (Microchem, 
Newton, MA) at 4000 rpm for 30 s to achieve a homogeneous pattern with 
thickness 50µm. Silicon wafer was treated with hexamethyldisilazane, HDMS, 
(Sigma-Aldrich) for 1h under vacuum. A premixed solution of 
polydimethylsiloxane, PDMS, pre-polymer and curing agent 10:1 ratio (Dow 
Corning, Midland, MI) was spun on the silicon wafer at 600 rpm for 1 min and 
cured at 80°C for 1h. Annular-shaped PDMS blocks were cut and assembled to 
the elastic membrane to confine cell culture medium. The assembled blocks were 
cut and peeled off, punched to obtain gas inlet holes and sealed to a glass slide by 
plasma bonding (Harrick Plasma, Ithaca, NY).  
21G stainless steel needles (Small Parts Inc., Logansport, IN) and Tygon micro-
tubings (Cole-parmer, Vernon Hills, IL) were used for fluidic connections. 
Membrane deformation was achieved by gas-pressurization of microfluidic 
channels; air pressure was accurately controlled through a 0.05bar resolution 
pressure regulator (RP1000&8G&02,!CKD Corporation, Japan). Stretch frequency 
was set through an external home-made apparatus equipped with 8 independent 
automatic electro-valves (M3MAO, CKD Corporation, Japan) controlled by a 
digital DAQ system, NI USB-6008, (National Instruments, Austin, TX), managed 
with NI-DAQmx driver and Labview software (National Instruments). 
 
E.3.3   Structural modeling 
Finite Element models of different spots were developed in order to estimate the 
mechanical state induced on the cells. Stress-strain behavior of PDMS was 
evaluated by specific tensile mechanical tests (Planar Biaxial TestBench® Test 
System, Bose ElectroForce®, Eden Prairie, MI), pointing out its non-linearity. An 
incompressible isotropic hyperelastic constitutive model was adopted to describe 
the mechanical response of PDMS.  
 
 
 
E.3.4   Substrates functionalization and cell seeding  
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PDMS substrates were coated with 2 µg/cm2 bovine fibronectin solution (Sigma-
Aldrich). Myoblasts were seeded at 50000 cells/cm2 density and incubated at 
37°C and 5% CO2 to allow cells attachment on the stretching devices. After 24 h 
proliferating medium was replaced by differentiation medium, in order to induce 
myoblasts fusion. The medium was no longer changed for 6 days. 
 
E.3.5   Stretching experiments and analysis 
Cells cultured on microfluidic devices were washed twice with PBS and loaded 
with buffer solution: 125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM MgSO4, 20 
mM Hepes, 2 mM CaCl2, 5.5 mM Glucose and NaOH to achieve pH 7.4. For 
membrane integrity assays, cells were also supplemented with 4 µM impermeant 
membrane dye FM 1-43 (Invitrogen). 
Cell culture were stretched at defined frequency for 90 or 45 min and washed 
twice with PBS or fixed for immunostaining. Images were captured with an 
optical microscope (Leica Microsystems, Wetzlar, Germany) at 40x 
magnification. In order to quantify dye uptake in stretched and control myotubes, 
fluorescence intensity was analyzed on single myotube cytosolic regions, through 
LAS AF Lite software (Leica Microsystems). Data are presented as fluorescence 
intensity means distribution. Statistical significance was analyzed through “Two-
sample Kolmogorov-Smirnov test” (MATLAB function kstest2) by considering a 
P-value<0.05 as statistically relevant.  We considered P<0.05 to be statistically 
significant.  
 
E.3.6 Immunostaining 
Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 7 min at room 
temperature, permeabilized with 0.5% Triton X-100 (Sigma-Aldrich) and blocked 
in 10% scomplemented FBS in PBS for 45 min at room temperature. Cells were 
incubated with primary antibodies against desmin, rabbit polyclonal (Sigma-
Aldrich), myosin heavy chain II, mouse mono-clonal, (Sigma-Aldrich), 
dystrophin, mouse monoclonal, (Nova Castra, Buffalo Grove, IL, USA) and 
calpain2 (rabbit polyclonal, Genetex, Irvine, CA) for 1h at room temperature. 
Cells were washed and incubated with Alexa488 and Alexa495 fluorescence-
conjugated secondary antibody (Invitrogen) against mouse or rabbit, depending on 
primary antibody for 45 min at 37°C. Finally, nuclei were counterstained with 
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DAPI (Sigma-Aldrich). Samples were mounted with Fluoshield (Sigma-Aldrich) 
and analyzed through a fluorescence microscope. 
 
E.3.7   RT-PCR analysis 
Total RNA from cell coltures was extracted with TRIzol reagent (Invitrogen) and 
treated with a Turbo DNAfree kit (Applied Biosystems) to remove genomic DNA 
contamination. First-strand complementary DNA (cDNA) synthesis was 
performed using using an oligo-(dT)20 primer and the cDNA Reverse 
Transcription Kit (Applied Biosystems). PCR was performed with cDNA using 
AmpliTaq Gold (Applied Biosystems). Amplifications were performed with an 
annealing temperature of 55 or 58 °C for 30–35 cycles, then amplified fragments 
were resolved by electrophoresis on a 2% agarose gel, followed by staining with 
ethidium bromide.  
!
E.4   Results and discussion 
E.4.1 Stretching device design and fabrication 
Cell-stretching device was properly designed in order to ensure: i) accurate 
control of mechanical stimulations at single-cell level, ii) high temporal resolution 
of cyclic mechanical stimulations, iii) optical accessibility for in line analysis, iv) 
statistical significance of treated samples, with internal un-stretched control. 
Microfluidic technology, that is recognized to provide highly reproducible and 
well-defined hydrodynamic conditions, was adopted in order to obtain accurate 
control of pressure-driven mechanical deformation of elastic membrane 
underneath cell culture, in terms of amplitude, temporal profile and frequency of 
bidirectional deformation. Cell stretching device was developed as described in 
§2.2 through standard soft-lithography technique. A thin PDMS membrane with 
underlying patterned micrometric channels was provided of gas inlet and sealed to 
a glass slide. Microfluidic channels pressurization induces mechanical 
deformation of PDMS membrane and, consequently, of cells cultured above it, as 
schematically represented in Fig.1A.  
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Figure 1 Microfluidic cell stretching device. (A) Microfluidic channel pressurization induces 
PDMS membrane deformation and, consequently, mechanical stimulation of cells cultured over it. 
(B) Schematic of the microfluidic network composed by 32 different elastic spots with diameter 
1mm (left) and integration of the microfluidic cell stretch designing device in a standard 6-well 
multiwell plate (right). (B) Experimental set up: consisting in vacuum and pressurization (C) 
Predicted distribution of radial and circumferential deformations of a single spot at 0.8 bar. (D) 
Predicted profile and experimental values of the vertical displacement in the center of the spot with 
the applied pressure. (E) Temporal profile of the mechanical stimulus at different frequencies, 
obtained by filling microfluidic channels with a dye and recording the absorbance in the center of 
the membrane at different frequencies.  
 
Biaxial mechanical deformation induced on cells was estimated by developing a 
Finite Element Model (FEM) of elastic membrane (§E.3.3), assisting microfluidic 
channel configuration design. Typical in vivo muscle fibers deformations range 
from 10 to 15% under physiological conditions. In order to reproduce similar 
elongations on myoblasts-derived myotubes in vitro, we computationally 
investigated how design parameters related to material composition and spot 
geometry affect membrane deformation with definite pressure. 
Specifically, vertical displacement in the spot center was predicted for different 
values of PDMS composition, i.e. different prepolymer:curing agent ratios (5:1, 
10:1, 20:1), membrane thickness (35, 55, 75µm) and spot radius (500, 700, 
900µm) and defined pressure intensity, as reported in Fig. 1B-C-D, where colored 
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maps refer to membrane vertical displacement from the bottom of the spot at 
defined pressure. Graph in Fig. 1B shows vertical displacement in correspondence 
to the center of circular spots as a function of applied pressure for three different 
PDMS compositions. Extremely deformable membranes can be achieved by 
increasing prepolymer:curent agent ratio, although technical issues due to 
handling very fragile PDMS layers need to be considered. Similarly, lower 
membrane thicknesses allow higher vertical displacements, although technical 
issues due to handling very fragile PDMS layers have to be taken into account. 
Spot geometry can also affect vertical displacement at constant pressure and 
increasing radius dimension gives higher vertical displacement. Considering both 
manufacturing constraints and target deformation, a membrane with the following 
features was employed: 
- PDMS with 10:1 prepolymer:curing agent ratio; 
- Membrane thickness equal to 55µm; 
- Spot radius equal to 500µm. 
Microfluidic compartment includes 32 independent deformable circular spots with 
1mm diameter. All individual spots are connected through a microfluidic channel 
network with hydraulic symmetry (constant pressure drop for each microfluidic 
path) as shown in Fig. 1E, in order to apply identical pressure-induced membrane 
deformation to all spots. Moreover, thanks to this configuration, with both 
stretchable and un-deformable areas in the same device, an internal un-stimulated 
control can be used in every single experiment. Microfluidic cell-stretching device 
can be easily integrated in standard multi-well plates (Fig. 1E) or directly coupled 
with an optical microscope for in line analysis. This latter solution requires an 
additional PDMS layer to hold medium up during observation. 
The experimental set up adopted for stretching experiments is schematically 
represented in Fig. 1F. Pressurized air-line and a vacuum apparatus are connected 
to a set of micro-valves, which are alternatively open to pressure or vacuum. An 
external electronic device automatically regulates micro-valves switch through 
labview software, controlling mechanical stretch frequency in microfluidic 
devices. 
Typical data from the FEM analysis are shown in Fig. 2A and 2B for a pressure of 
1bar, showing complete deformation of the spot in both radial and circumferential 
direction respectively.  
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Figure 2 (A-B) Predicted distribution of radial (A) and circumferential (B) deformations of a 
single spot with ΔP equal to 1 bar. (C) Predicted profile and experimental values of the vertical 
displacement in the center of the spot with the applied pressure. (D) Temporal profile of the 
mechanical stimulus at different frequencies, obtained by filling microfluidic channels with a dye 
and recording the absorbance in the center of the membrane at different frequencies. 
 
The derived model was experimentally validated by measuring vertical 
displacements of the membrane in the center of the spot, with different pressures. 
Fig. 2C shows the vertical displacement on the top of the PDMS membrane as a 
function of the applied pressure. Theoretical profile obtained by numerical 
solution results in good agreement with the experimental values.  
 
E.4.2 Stretching device validation 
Microscopic dimensions of microfluidic channels allow manipulation of few 
microliters for system pressurization, thus providing fast dynamics of the 
stimulation and uniform spatial and temporal stimulus on cells. In order to assess 
the robustness of our system and the reproducibility of mechanical stimuli during 
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direction, as shown in Fig. 3. The same result was not observed by applying a 
static deformation (Fig. 3).  
 
Figure 3 Stretch frequency-dependent cytoskeletal remodeling in C2C12 myoblasts. Bright field 
and phalloidin staining pictures of C2C12 myoblasts not stretched (A), statically stretched for 2h 
(0 Hz, 20% deformation) (B) and cyclically stretched for 2h (1 Hz, 15% deformation) (C). 
 
These experimental observations provide evidence of a frequency-dependent cell 
cytoskeletal remodeling in response to mechanical stimulations. 
 
E.5.3   Cyclic mechanical stretch affects dystrophic myotubes membrane 
integrity  
We next investigated whether lacking of dystrophin protein, which is recognized 
to preserve membrane structure and homeostasis, in human skeletal muscle is 
associated with cyclic mechanical stress. In particular, we investigated whether 
cyclic mechanical stimulation affects membrane integrity in a human DMD in 
vitro model by subjecting human healthy and DMD patient-derived myotubes to a 
series of 15% physiological deformations at 0.5Hz. 
For this purpose, microfluidic cell-stretching devices were opportunely 
functionalized as described in §2.3, in order to achieve long-term cell attachment 
during myoblasts differentiation. Human myoblasts derived from biopsies of 
healthy donors and DMD patients were seeded at high density and induced to 
differentiate into fused myotubes the day after (Day 1) for 6 days. We first 
verified dystrophin expression along with myotubes differentiation in both healthy 
and dystrophic cells. RT-PCR analysis reveals that the short ubiquitous dystrophin 
isoform Dp71 results expressed already at myoblasts stage from both healthy and 
diseased cells, whereas amplification of transcripts of the muscle-specific 
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tensile mechanical tests (Planar Biaxial TestBench® Test 
System, Bose ElectroForce®, USA), pointing out its non-
linearity. An incompressible isotropic hyperelastic 
constitutive model was adopted to describe the mechanical 
response of PDMS. Deformation of the spots and, in 
particular, strains along radial and circumferential direction 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical data from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on the outer surface of the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, which is evaluated as a function of internal 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical properties 
of PDMS. 
III. RESULTS 
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are responsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mechanical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling along circumferential direction. The same effect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cells 
showed a remodelling of cytoskeletal actin filaments and a ri-
orientation of stress fibres along the direction of minimum 
strain, i.e. the circumferential direction (Fig. 4). The same 
result was not observed by applying a static deformation, 
meaning that cellular responses, in terms of cytoskeletal 
remodelling, to mechanical stretch are frequency-dependent. 
B. Membrane integrity of human myotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Human myotubes membrane micro-ruptures due to cyclic 
mechanical stretch. Pictures taken at different time-points show the 
presence of a fluorescent membrane-impermeable dye in the cytoplasmic 
region of stretched cells after 30 min of stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a stretching spot. After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
spot are marked by an impermeable dye.  
IV. CONCLUSION 
In conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
external mechanical stimuli. Such system could be very 
useful to derive an in vitro skeletal muscle model for testing 
cell membrane integrity under defined mechanical stresses. 
REFERENCES 
[1] A. Kumar, R. Murphy, P. Robinson, L. Wei, and A. Boriek. “Cyclic 
mechanical strain inhibits skeletal myogenesis through activation of 
focal adhesion kinase, Rac-1 GTPase, and NF-B transcription factor”. 
FASEB J., vol. 18, pp. 1524–1535, June 2004. 
[2] R. R. Roy, K. M. Baldwin, and D. P. Edney. “The plasticity of skeletal 
muscle: effects of neuromuscular activity”. Exerc. Sport Sci. Rev., vol. 
19, pp. 269–312, 1991. 
[3] A. Kumar, and A. M. Boriek. “Mechanical stress activates the nuclear 
factor-kappaB pathway in skeletal muscle fibers: a possible role in 
Duchenne muscular dystrophy”. FASEB J., vol. 17, pp. 386–396, 
2003. 
[4] R. Tatsumi, A. Hattori, Y. Ikeuchi, J. E. Anderson, and R. E. Allen. 
“Release of hepatocyte growth factor from mechanically stretched 
skeletal muscle satellite cells and role of pH and nitric oxide.” Mol. 
Biol. Cell, vol. 13, pp. 2909–2918, 2002. 
[5] K. Sato, S. Kamada, and K. Minami. “Development of microstretching 
device to evaluate cell membrane strain field around sensing point of 
mechanical stimuli”. Int. J. Mech. Sci., vol. 52, pp. 251-256, 2010. 
[6] R. Gomez-Sjoberg, A. A. Leyrat, D. M. Pirone, C. S. Chen, S. R. 
Quake. “Versatile, fully automated, microfluidic cell culture system”. 
Anal. Chem., vol. 79, pp. 8557-8563, 2007. 
t = 0 min t = 15  min t = 30 min 
Cyclic stretch 0.1 Hz 
0.4 bar 
Phalloidin 
DAPI 
Control cyclic stretch (1Hz)  
0.4 bar 
static stretch 
0.4 bar 
200µm 
GNB2012, June 26th-29th 2012, Rome, Italy 
 
2 
tensile mechanical tests (Planar Biaxial TestBench® Test 
System, Bose ElectroForce®, USA), pointing out its non-
linearity. An incompressible isotropic hyperelastic 
constitutive model was adopted to describe the mechanical 
response of PDMS. Deformation of the spots and, in 
particular, strains along radial and circumferential direction 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical data from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on the outer surface of the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, which is evaluated as a function of internal 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical properties 
of PDMS. 
III. RESULTS 
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are responsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mechanical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling along circumferential direction. The same effect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cells 
showed a remodelling of cytoskeletal actin filaments and a ri-
orientation of stress fibres along the direction of inimum 
strain, i.e. the circumferential direction (Fig. 4). The same 
result was not observed by applying a static deformation, 
meaning that cellular responses, in terms of cytoskeletal 
remodelling, to mechanical stretch are frequency-dependent. 
B. Membrane integrity of human myotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Hum n myotubes membrane micro-ruptures due to cyclic 
mechanical stretch. Pictures taken at different time-points show the 
presence of a fluore cen membr ne-impermeable dye in the cytoplasmic 
region of stretched cells after 30 min of stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a stretching spot. After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
spot are marked by an imper eable dye.  
IV. CONCLUSION 
In conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
external mechanical stimuli. Such system could be very 
useful to derive an in vitro sk letal muscle model for testing 
cell membrane integrity under defined mechanical stresses. 
REFERENCES 
[1] A. Kumar, R. Murphy, P. Robinson, L. Wei, and A. Boriek. “Cyclic 
mechanical strain inhibits skeletal myogenesis through activation of 
focal adhesion kinase, Rac-1 GTPase, and NF-B transcription factor”. 
FASEB J., vol. 18, pp. 1524–1535, June 2004. 
[2] R. R. Roy, K. M. Baldwin, and D. P. Edney. “The plasticity of skeletal 
muscle: effects of neuromuscular activity”. Exerc. Sport Sci. Rev., vol. 
19, pp. 269–312, 1991. 
[3] A. Kumar, and A. M. Boriek. “Mechanical stress activates the nuclear 
factor-kappaB pathway in skeletal muscle fibers: a possible role in 
Duchenne muscular dystrophy”. FASEB J., vol. 17, pp. 386–396, 
2003. 
[4] R. Tatsumi, A. Hattori, Y. Ikeuchi, J. E. Anderson, and R. E. Allen. 
“Release of hepatocyte growth factor from mechanically stretched 
skeletal muscle satellite cells and role of pH and nitric oxide.” Mol. 
Biol. Cell, vol. 13, pp. 2909–2918, 2002. 
[5] K. Sato, S. Kamada, and K. Minami. “Development of microstretching 
device to evaluate cell membrane strain field around sensing point of 
mechanical stimuli”. Int. J. Mech. Sci., vol. 52, pp. 251-256, 2010. 
[6] R. Gomez-Sjoberg, A. A. Leyrat, D. M. Pirone, C. S. Chen, S. R. 
Quake. “Versatile, fully automated, microfluidic cell culture system”. 
Anal. Chem., vol. 79, pp. 8557-8563, 2007. 
t = 0 min t = 15  min t = 30 min 
Cyclic stretch 0.1 Hz 
0.4 bar 
Phalloidin 
DAPI 
Control cyclic stretch (1Hz)  
0.4 bar 
static stretch 
0.4 bar 
200µm 
GNB2012, June 26th-29th 2012, Rome, Italy 
 
2 
tensile mechanical tests (Plan r Biaxial TestBench® Test 
System, Bose ElectroForce®, USA), pointing out its non-
linearity. An incompressible isotropic hyperelastic 
constitutive model wa  adopted to describe the mechanical 
response of PDMS. Deformation of the spots and, in 
particular, strains along radial and circumferential direction 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical data from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on th  outer surface of the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, which is evaluated as a function of internal 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical properties 
of PDMS. 
III. RESULTS 
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are responsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mechanical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling al ng circumferential directio . The same ffect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cells 
showe  a remodelling of cytoskeletal actin filam nts nd a ri-
orientati  of stress fibres along the direction of minimum 
strain, i.e. the circumferential direction (Fig. 4). The same 
result was not observed by applying a static deformation, 
meaning that cellular responses, in terms of cytoskeletal 
remodelling, to mechanical stretch are frequency-dependent. 
B. Membrane integrity of human myotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Human myotubes membrane micro-ruptures due to cyclic 
mechanical stretch. Pictures taken at different time-points show the 
presence of a fluorescent membrane-impermeable dye in the cytoplasmic 
region of stretched cells after 30 min of stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a stretching spot. After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
spot are marked by an impermeable dye.  
IV. CONCLUSION 
I  conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
external mechanical stim li. Such system could be very 
useful to derive an in vitro skeletal muscle model for testing 
cell membrane integrity under defined mechanical stresses. 
REFERENCES 
[1] A. Kumar, R. Murphy, P. Robinson, L. Wei, and A. Boriek. “Cyclic 
mecha ical strain inhibits skelet l myogenesis through activation of 
focal adhesion kinase, Rac-1 GTPase, and NF-B transcription factor”. 
FASEB J., vol. 18, pp. 1524–1535, June 2004. 
[2] R. R. Roy, K. M. Baldwin, and D. P. Edney. “The plasticity of skeletal 
muscle: effects of neuromuscular activity”. Exerc. Sport Sci. Rev., vol. 
19, pp. 269–312, 1991. 
[3] A. Kumar, and A. M. Boriek. “Mechanical stress activates the nuclear 
factor-kappaB pathway in skeletal muscle fibers: a possible role in 
Duchenne muscular dystrophy”. FASEB J., vol. 17, pp. 386–396, 
2003. 
[4] R. Tatsumi, A. Hattori, Y. Ikeuchi, J. E. Anderson, and R. E. Allen. 
“Release of hepatocyte growth factor from mechanically stretched 
skeletal muscle satellite cells and role of pH and nitric oxide.” Mol. 
Biol. Cell, vol. 13, pp. 2909–2918, 2002. 
[5] K. Sato, S. Kamada, and K. Minami. “Development of microstretching 
device to evaluate cell membrane strain field around sensing point of 
mechanical stimuli”. Int. J. Mech. Sci., vol. 52, pp. 251-256, 2010. 
[6] R. Gomez-Sjoberg, A. A. Leyrat, D. M. Pirone, C. S. Chen, S. R. 
Quake. “Versatile, fully automated, microfluidic cell culture system”. 
Anal. Chem., vol. 79, pp. 8557-8563, 2007. 
t = 0 min t = 15  min t = 30 min 
Cyclic stretch 0.1 Hz 
0.4 bar 
Phalloidin 
DAPI 
Control cyclic stretch (1Hz)  
0.4 bar 
static stretch 
0.4 bar 
200µm 
GNB2012, June 26th-29th 2012, Rome, Italy 
 
2 
tensile mechanical tests (Planar Biaxial TestBench® Test 
System, Bose ElectroForce®, USA), pointing out its non-
linearity. An incompressible isotropic hyperelastic 
constitutive model was adopted to describe the mechanical 
response of PDMS. Deformation of the spots and, in 
particular, strains along radial and circumferential direction 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical data from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on the outer surface of the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, which is evaluated as a function of intern l 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical properties 
of PDMS. 
III. RESULTS 
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are responsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mechanical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling along circumferential direction. The same effect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cell  
showe  a remodelling f cytoskeletal actin filaments and a ri-
orientation of stress fibres along the direction of minimum 
strain, i.e. the circumferential direction (Fig. 4). The same 
result was not observed by applying a static deformation, 
meaning that cellular responses, in terms of cytoskeletal 
remodelling, to mechanical stretch are frequency-dependent. 
B. Membrane integrity of human yotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Human myotubes membrane micro-ruptures due o cyclic 
mechanical stretch. Pictures taken at different time-points show the 
presence of a fluorescent membrane-impermeable dye in the cytoplasmic 
region of stretched cells after 30 min of stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a stretching spot. After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
po are m rked by an impermeable dye.  
IV. CONCLUSION 
I  conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
external echanical stim li. Such system could be very 
useful to derive an in vitro skeletal muscle model for testing 
cell membrane integrity under defined mechanical stresses. 
REFERENCES 
[1] A. Kumar, R. Murphy, P. Robinson, L. Wei, and A. Boriek. “Cyclic 
mechanical strain inhibits skeletal myogenesis through activation of 
focal adhesion kinase, Rac-1 GTPase, and NF-B transcription factor”. 
FASEB J., vol. 18, pp. 1524–1535, June 2004. 
[2] R. R. Roy, K. M. Baldwin, and D. P. Edney. “The plasticity of skeletal 
muscle: effects of neuromuscular activity”. Exerc. Sport Sci. Rev., vol. 
19, pp. 269–312, 1991. 
[3] A. Kumar, and A. M. Boriek. “Mechanical stress activates the nuclear 
factor-kappaB pathway in skeletal muscle fibers: a possible role in 
Duchenne muscular dystrophy”. FASEB J., vol. 17, pp. 386–396, 
2003. 
[4] R. Tatsumi, A. Hattori, Y. Ikeuchi, J. E. Anderson, and R. E. Allen. 
“Release of hepatocyte growth factor from mechanically stretched 
skeletal muscle satellite cells and role of pH and nitric oxide.” Mol. 
Biol. Cell, vol. 13, pp. 2909–2918, 2002. 
[5] K. Sato, S. Kamada, and K. Minami. “Development of microstretching 
device to evaluate cell membrane strain field around sensing point of 
mechanical stimuli”. Int. J. Mech. Sci., vol. 52, pp. 251-256, 2010. 
[6] R. Gomez-Sjoberg, A. A. Leyrat, D. M. Pirone, C. S. Chen, S. R. 
Quake. “Versatile, fully automated, microfluidic cell culture system”. 
Anal. Chem., vol. 79, pp. 8557-8563, 2007. 
t = 0 min t = 15  min t = 30 min 
Cyclic stretch 0.1 Hz 
0.4 bar 
Phalloidin 
DAPI 
Control cyclic stretch (1Hz)  
0.4 bar 
static stretch 
0.4 bar 
200µm 
GNB2012, June 26th-29th 2012, Rome, Italy 
 
2 
tensile mechanical tests (Planar Biaxial TestBench® Test 
System, Bose ElectroForce®, USA), pointing out its non-
linearity. An incompressible isotropic hyperelastic 
constitutive model was adopted to describe the mechanical 
response of PDMS. Deformation of the spots and, in 
particular, strains along radial and circumferential direction 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical data from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on the outer surface f the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, which is evaluated as a function of internal 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical propertie  
of PDMS. 
III. RESULTS 
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are r sponsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mechanical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling along circumferential direction. The same effect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cells 
showed a remodelling of cytoskeletal actin filaments and a ri-
orientation of stress fibr s alo g th  direction of minim m 
strain, i.e. the circumferential direction (Fig. 4). Th  same 
result was not observed by applying a static formation, 
meaning that cellular r sponses, in terms of cytoskeletal 
remodelling, to mechanical stretch are frequency-dependent. 
B. Membrane integrity of human myotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Human myotubes membrane micro-ruptures due to cyclic 
mechanical stretch. Pictures taken at diffe nt t me-points show the 
presence of a fluorescent membrane-impermeable dy  in the cytoplasmic 
region of stretched cells after 30 min f stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a stretching spot. After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
pot are marked by an imper eable dye.  
IV. CONCLUSION 
In conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
ext rnal mechanical stimuli. Such system could be very 
useful to derive an in vitro skeletal muscle mod l for testing 
cell embrane integrity under efined mechanical stresses. 
REFERENCES 
[1] A. Kumar, R. Murphy, P. Robinson, L. Wei, and A. Boriek. “Cyclic 
mechanical strain inhibits skeletal myogenesis through activ tion of 
focal adhesion kinase, Rac-1 GTPase, and NF-B transcription factor”. 
FASEB J., vol. 18, pp. 1524–1535, June 2004. 
[2] R. R. Roy, K. M. Baldwin, and D. P. Edney. “The plasticity f skeletal 
muscle: effects of neuromuscular activity”. Exerc. Sport Sci. Rev., vol. 
19, pp. 269–312, 1991. 
[3] A. Kumar, and A. M. Boriek. “Mechanical stress activates the nuclear 
factor-kappaB pathway in skeletal muscle fibers: a possible role in 
Duchenne muscular dystrophy”. FASEB J., vol. 17, pp. 386–396, 
2003. 
[4] R. Tatsumi, A. Hattori, Y. Ikeuchi, J. E. Anderson, and R. E. Allen. 
“Release of hepatocyte growth factor from mechanically stretched 
skeletal muscle satellite cells and role of pH and nitric oxide.” Mol. 
Biol. Cell, vol. 13, pp. 2909–2918, 2002. 
[5] K. Sato, S. Kamada, and K. Minami. “Development of microstretching 
device to evaluate cell membrane strain field around sensing point of 
mechanical stimuli”. Int. J. Mech. Sci., vol. 52, pp. 251-256, 2010. 
[6] R. Gomez-Sjoberg, A. A. Leyrat, D. M. Pirone, C. S. Chen, S. R. 
Quake. “Versatile, fully automated, microfluidic cell culture system”. 
Anal. Chem., vol. 79, pp. 8557-8563, 2007. 
t = 0 min t = 15  min t = 30 min 
Cyclic stretch 0.1 Hz 
0.4 bar 
Phalloidin 
DAPI 
Control cyclic stretch (1Hz)  
0.4 bar 
static stretch 
0.4 bar 
200µm 
GNB2012, June 26th-29th 2012, Rome, Italy 
 
2 
tensile mechanical tests (Plana Biaxial T stBench® Test 
System, Bose ElectroForce®, USA), pointing out it  no -
linearity. An incompressible isotropic hyperelastic 
constitutive model was adopted to describe the echanical 
response of PDMS. Deformation of the spots and, in 
particular, strains long radial and circumferential irection 
of their outer surface were evaluated as a function of 
geometry (shape, diameter, thickness) and level of internal 
pressure. Typical ata from the FE analysis are shown in Fig. 
3 for a spot with radius of 500 µm and thickness of 50 µm. 
 
 
    Fig. 3.  Radial and circumferential strains on the outer surface of the spot 
for internal pressure of 0.4 bar. Level of strain is associated to the 
deformation of the spot, wh h is evaluat d as a function of internal 
pressure. Solid black line of chart refers to average stress-strain behavior 
of PDMS, grey lines are possible variations due to mechanical propertie
of PDMS. 
III. RESULTS
A. Static/cyclic stretch 
Due to its nature, skeletal muscle cells are sponsive to 
mechanical forces. In order to obtain a biological read-out of 
the efficacy of our system, we subjected a C2C12 myoblasts 
cell culture to both static and cyclic (1Hz) mecha ical stretch 
for 2h.  
 
 
    Fig. 4. Staining of C2C12 cells actin filaments after 2h static (0Hz) and 
cyclic mechanical stimulation (1Hz). Cyclically stretched cells shows a 
cytoskeletal remodeling along circumferential direction. The same effect 
is not observed in statically stretched cells and in the control.  
 
Immunofluorescence analysis of cyclically stretched cells 
showed a remodelling of cytoskeletal actin filaments and a ri-
orientat on of stress fibres alo g th  direction of minimum 
strain, i.e. the circumferential direction (Fig. 4). The same 
result was not observed by applying a static deformati n, 
meaning that cellular responses, in terms of cytoskeletal 
rem delling, to mechanical str tch are frequency-dependent. 
B. Membrane integrity of human myotubes 
The developed system could be very useful to test the 
membrane integrity of cells derived from both healthy and 
diseased muscle fibres.  
 
 
    Fig. 5 Human myotubes membrane micro-ruptures due to cyclic 
mechanical stretch. Pictures taken at different time-points show the 
presence of a fluorescent membrane-impermeable dy  in the cytoplasmic 
region of stretched cells after 30 min of stimulation. 
 
Fig. 5 shows skeletal muscle myotubes derived from human 
myoblasts across a st etching spo . After 30 min of cyclic 
deformation at 0.1 Hz, internal membranes of cells above the 
spot are marked by an imper eable dye.  
IV. CONCLUSION 
In conclusion we developed a microfluidic-based cell-
stretching device in order to obtain cellular responses to 
external mechanical stimuli. Such system cou d be very 
useful to derive an in vitro sk letal muscle mod l for testing 
cell membrane integrity under defined mechanical stresses. 
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dystrophin can be appreciated only in healthy myotubes with increasing 
expression during differential stages. The corresponding primer (Ex45DMD) was 
properly designed in order to recognize the exon region of the dystrophin, which 
was found to be mutated in patient biopsies. 
Expression of the late myogenic marker myosin heavy chain, MHC in both 
healthy and diseased cells at Day 6 indicates myotubes are functionally mature.  
 
Figure 4 (A) RT-PCR analysis of ubiquitous dystrophin isoform Dp71, dystrophin transcript 
corresponding to the mutated region found in dystrophic patients, late myogenic marker myosin 
heavy chain, MHC, and housekeeping gene GAPDH reveal only healthy myotubes express 
transcripts for protein dystrophin, whereas both cells express MHC. (B) Immunofluorescence 
analysis of myoblasts at Day 1 of differentiation for myogenic marker desmin. At Day 6 both 
healthy and DMD myotubes express MHC with clear sarcomeric organization, whereas only 
healthy cells show dystrophin expression with membrane localization. 
 
We also verified skeletal muscle mature phenotype of healthy and dystrophic 
myotubes on PDMS substrates at protein levels. Myoblasts positive for the 
skeletal muscle marker desmin at Day 1 formed multinucleated myotubes positive 
for the late myogenic-stage marker myosin heavy chain, with well-organized 
sarcomeric striations and defined dystrophin expression at membrane level. 
Negative staining of DMD myotubes against Dystrophin antibody confirmed 
diseased phenotype (Fig. S2). 
Large molecules membrane permeability induced by mechanical stress was 
investigated in both healthy and diseased cells through FM 1-43 membrane 
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impermeable dye; human myotubes were loaded with 4 µM dye and cyclically 
stretched for 90 min at 0.5 Hz. Immediately after stimulation, fluorescence 
intensity due to dye uptake was detected in stretched and un-stimulated myotubes 
in the same device, as described in §E.3.5.  
Cyclic deformation induces a partial increase of dye uptake in healthy myotubes, 
in comparison to un-stretched myotubes, whereas elevated and widespread up-
take of FM 1-43 dye in cytosolic regions of stretched dystrophic myotubes was 
observed if compared with un-stretched control (Fig. 5A). Taking advantage of 
having an internal un-stretched control we could analyze fluorescence intensity of 
stretched and control myotubes in the same conditions and with the same 
fluorescence background. Fluorescence intensity in the cytosolic regions of 
myotubes was quantified as described in §E.3.5 and results were represented as 
intensity means distribution of region of interests, ROIs (N=100), as shown in Fig. 
3B-C. Fig. 3B shows a not significant difference between control and stretched 
myotubes distributions (P-value=0.973); on the other hand, stretched dystrophic 
myotubes resulted in a significant (P-value=0.029) stretch-induced dye uptake 
increase in respect to un-stimulated control, as revealed by comparing 
fluorescence intensity distributions (Fig. 3C). These results demonstrate that lack 
of dystrophin strongly affects membrane permeability of human myotubes, when 
subjected to cycles of mechanical stretch that closely mimic physiological 
deformation of muscle fibers.  
 
Figure 5 (A-C) 90 min stretch-induced membrane permeability analysis in dystrophic compared to 
healthy myotubes. (A) Representative pictures of FM 1-43 dye uptake in healthy and dystrophic 
myotubes after 90 min cyclic stretch (0.5 Hz, 15% deformation), compared to un-stimulated 
control myotubes. (B) Fluorescence intensity distribution of stretched healthy myotubes is not 
statistically different from the un-stretched control. (C) Fluorescence intensity distribution of 
stretched DMD myotubes result statistically different from the un-stretched control. (D-E) 45 min 
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stretch-induced membrane permeability analysis in dystrophic myotubes. (D) Representative 
pictures of FM 1-43 dye uptake in dystrophic myotubes after 45 min cyclic stretch (0.5 Hz, 15% 
deformation), compared to un-stimulated control myotubes. (E) Fluorescence intensity distribution 
of stretched myotubes is not statistically different from the un-stretched control. 
 
We further investigated whether stretch-induced membrane permeability increase 
in dystrophic myotubes is already significant after a shorter period of cyclic 
stretch of 45 min. DMD myotubes were again loaded with FM 1-43 dye and 
stretched at 0.5Hz with 15% deformation for 45 min. Fig. 5D shows 
representative pictures of stretched and control myotubes with similar uptake of 
FM1-43 dye; quantification of fluorescence intensity confirms a not significant 
difference of the two distributions (Fig. 5E), meaning that permeability increase 
appears in a later temporal interval. This result also validates the hypothesis 
proposed by Allen et al., that increased permeability in dystrophic muscle fibers is 
likely due to the slow accumulation of intracellular calcium, which activates 
stretch-activated ion channels, rather than to the formation of membrane tears as a 
consequence of stimulation-induced membrane injury18.  
Indeed, many studies recognize an increased stretch-activated channels activity in 
DMD muscle fibers, which triggers abnormal cytosolic concentrations of 
intracellular calcium. Increased levels of intracellular calcium are also recognized 
to contribute to muscle degeneration through the aberrant activation of calcium 
dependent proteases, calpain-1 and calpain-2, rendering muscle fibers more 
permeable and eventually susceptible to fibrosis27. The implication of calpains in 
these disorders has identified them as important potential therapeutic targets and 
has raised interest in the use of specific calpain inhibitors as a potent 
treatment28,29. Observation of a four-fold increase in muscle calpain-2 mRNA 
levels in muscle fibers from DMD patients, compared to control, confirms 
enhanced expression of the calpain-2 gene in dystrophic condition, explaining the 
enhanced activity of the enzyme, and highlights its importance in DMD 
pathogenesis30. We therefore verified the role of cyclic stretch in affecting 
calpain-2 expression in dystrophic myotubes compared to the healthy ones by 
immunofluorescence analysis. Fig. 6 shows representative immuno-staining 
pictures of healthy and DMD myotubes stretched for 90 min at 0.5Hz and 15% 
deformation. Stretched healthy myotubes show an increased cytosolic signal if 
compared to the un-stretched controls, which in turn show a confined nuclear 
expression (Fig. 6A). This is probably due to a transient increase, during 
Appendix E a 
! 174 
mechanical stimulation, in intracellular calcium, which activates calcium-
dependent proteases, like clapain-2. Interestingly both control and stretched DMD 
myotubes show a widespread calpain-2 cytosolic expression (Fig. 6B).  
 
Figure 6 Calpain-2 immunofluorescence analysis of stretched healthy and DMD myotubes. (A) 
Comparison between control and stretched healthy myotubes. (B) Comparison between control 
and stretched DMD myotube. 
 
We speculated that DMD myotubes derived from dystrophic patients have an 
elevated [Ca2+]i per se and that cyclic mechanical stretch exacerbates the diseased 
phenotype leading to stretch-induced increased membrane permeability. 
 
E.6   Conclusions 
In conclusion, we investigated the role of cyclic mechanical stretch in a human 
DMD in vitro model, by developing an ad hoc microfluidic-based cell-stretching 
device in order to accurately mimic physiologic deformation to which muscle 
fibers are exposed in vivo. We first demonstrated that the developed device could 
be used to obtain a biological response on a cell culture, by showing a frequency-
dependent cytoskeletal remodeling of F-actin filament after a cyclic mechanical 
stimulation. We then focused on the role of cyclic stretch in affecting membrane 
permeability increase of dystrophic myotubes compared to the healthy ones. 
Stretch-induced membrane permeability results to increase in a temporal window 
from 45 to 90 min, probably due to a slow accumulation of intracellular calcium, 
which results already altered in non-stretched dystrophic myotubes as 
ctrl stretch A 
B ctrl stretch 
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demonstrated by immunofluorescence analysis of calcium-dependent protease 
calpain-2.  
The developed device could also be used as platform for investigate new 
therapeutic targets or for drug screening assays. 
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